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SUMMARY
Evidence for the role of cyclic AMP in animal virus infections 
was reviewed, as were current methods for the preparation of cell cultures 
and techniques for the extraction and assay of cyclic AMP.
Preliminary experiments were undertaken to develop suitable methods 
for investigation of intracellular cyclic AMP during in vitro productive 
virus infections. Selected procedures were applied to study levels of 
cyclic AMP in cell cultures of continuous cell lines during viral 
replication. Parallel monolayer cultures of VERO and HEp-2 cells, 
maintained in the absence of serum, were treated with ethanol to release 
cyclic AMP. The cell material was assayed for cyclic AMP by competitive 
protein-binding assays, and for protein by the method of Lowry et al. (1951).
No significant changes in levels of cyclic AMP were found during 
in vitro replication of herpes virus or polio virus.
Additionally theophylline, potassium fluoride and cholera toxin 
were applied to cell cultures to raise intracellular cyclic AMP, while 
the replication of herpes virus, polio virus, Mengo virus and Semliki 
Forest virus was observed. All the virus infections were found to be 
susceptible to modulation by these reagents under some conditions, 
although some of the effects were considered to be due to cytotoxicity 
rather than specific enhancement or inhibition of viral infection.
The apparent lack of cyclic AMP involvement during single cycle 
infections and the sensitivity of viruses to exogenous reagents which 
raise intracellular cyclic AMP is discussed with reference to reports 
of similar studies from other laboratories and investigations of more 
diverse subjects in biochemistry and virology.
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INTRODUCTION
The study of viral metabolism and its relationship with that of the 
host is of particular importance at present as there is a great need to 
develop effective antiviral agents. A role for cyclic AMP during virus 
infections has been implicated by investigations of the pleomorphic effects 
of stress on neonatal mice (Lee and Dubos, 1972), diseases whose symptoms 
include diarrhoea (Mishra et al•, 1973; Levy et al., 1976), reactivation 
of latent herpes virus infections (Stanwick et al., 1977), thymidine transport 
in herpes virus infected cells (Bittlingmaier et al., 1977b) and interferon 
(Friedman and Pastan, 1969; Allen et al., 1974; Weber and Stewart, 1975; 
Meldolesi et al.t 1977; Tovey et al.t 1979). However, our understanding 
of cyclic AMP's involvement with virus infections remains confused as these 
studies, which have been undertaken in several laboratories using a variety 
of viruses, hosts and experimental techniques, have led to a series of 
reports with apparently contradictory results. Experiments have shown a 
transient increase of cyclic AMP immediately after inoculation of porcine 
kidney cells with transmissible gastroenteritis virus (Mishra et al., 1973), 
increased degredation of cyclic AMP after enterovirus infection of mice 
(Lee and Dubos, 1972), a steady decrease in cyclic AMP in HEp-2 cells and 
fibroblasts infected with herpes virus (Stanwick et al., 1977), a transient 
increase in cyclic AMP in BHK cells infected with herpes virus (Bittlingmaier 
et al., 1977a) and no effect on adenyl cyclase activity in human volunteers 
suffering from viral gastroenteritis (Levy et al•, 1976).
An investigation which covers a range of viruses, hosts and techniques 
may help to clarify the role of cyclic AMP during viral infections and 
explain the apparently contradictory results. For a study of this nature 
an understanding of cyclic AMP metabolism and hypotheses regarding its 
involvement with virus infections is required.
Metabolism of Cyclic AMP
Cyclic AMP, when first isolated, was described as a low molecular weight, 
heat-stable factor, which mediated the effects of adrenalin and glucagon 
on glycogenolysis (Rail et al., 1957; Sutherland and Rail, 1958). This 
discovery and subsequent work led to a Nobel Prize for Sutherland in 1971.
The new compound was chemically characterized as adenosine 3',5' cyclic 
monophosphate (Fig. l) (Cook et al., 1957; Lipkin et al., 1959;
Watenpaugh et al., 1968)* and it was soon clear that the involvement of ; 
cyclic AMP in metabolic control was not limited to one system (Butcher and 
Sutherland, 1962; Klainer et al., 1962; Murad et al., 1962; Rail and 
Sutherland, 1962). In fact, many different control processes in a 
variety of cells and organisms were attributed to cyclic AMP (Table l) and 
since its discovery there has been an explosive increase in the number of 
publications dealing with this subject (Jost and Rickenberg, 1971).
The ubiquity and central role of cyclic AMP in metabolism was 
discussed by Kiefer and Kantor (1976) who suggested that cyclic AMP 
became a suitable mediator as it was not metabolically essential yet 
was readily available from a precursor relatively abundant in viable 
cells (ATP) and could be easily degraded (to AMP) without seriously 
upsetting the balance of metabolic compounds in a cell.
Although cyclic AMP has been found throughout the plant and 
animal kingdoms, the field most relevant to this review is those 
processes described in mammals.
The area of particular importance in mammals concerns the function 
of hormones. In this regard an enormous collection of laboratory data 
was rationalized by the development of the two messenger theory of 
hormone action which was proposed (Sutherland et al•, 1965) as an 
explanation of the diverse roles of cyclic AMP. In this scheme a
hormone is released from its storage organ, such as the pituitary gland 
or adrenal medulla, travels via the blood stream to its target tissue, 
and there binds to a highly specific surface receptor* Binding of the 
hormone to its receptor sites is followed by activation of adenyl cyclase 
which catalyses the formation of cyclic AMP. The subsequent increase in 
the intracellular cyclic AMP triggers a variety of reactions characteristic 
of the particular cell and the hormone. This chain of events is 
illustrated in Fig. 2.
This hypothesis explained how a small intracellular molecule, 
cyclic AMP, could be sensitive to a variety of extracellular molecules. 
However an explanation of the wide ranging effects of cyclic AMP required . 
further detailed research of intracellular metabolism.
A major receptor for cyclic AMP was found to be cyclic AMP-dependent 
protein kinase (Walsh et al., 1968) which effected changes by 
phosphorylating proteins in muscle tissue. Kuo and Greengard (1969a,b) 
found similar protein kinase enzymes in other systems and proposed that 
cyclic AMP-dependent protein kinases mediate all the changes due to 
cyclic AMP in living systems, and the mode of action of protein kinases 
has been reported by several laboratories (Kuraon et al,, 1970; Tao et al., 
1970; Brostrom et al•, 1971; Erlichman et al., 1971; Gill and Garren, 1971) 
A protein kinase enzyme consists of two regulatory subunits which 
bind cyclic AMP and two catalytic subunits which can phosphorylate 
proteins (Fig. 3). The evidence suggests that when the regulatory 
and catalytic subunits are associated, the enzyme is inactive, whereas 
when the catalytic subunits are dissociated from the regulatory subunits 
they are active. The binding of cyclic AMP to the regulatory subunits 
in the enzyme complex causes dissociation and thereby increases the 
activity of the enzyme.
Active protein kinase was first shown to affect metabolism by 
phosphorylating an enzyme in glycogenolysis, thereby altering the 
enzyme's activity (Walsh et al., 1968). Since then many protein 
kinases have been described, each having different substrate specificity 
and differential stimulation and depression by cyclic AMP (Kish and 
Kleinsmith, 1974; Costa et al., 1976; Lee et al., 1976).
An alternative type of regulation has been reported by Wicks and 
colleagues (1975), who found dose-response and kinetic characteristics 
of protein kinase activation which were consistent with the hypothesis 
that one protein kinase mediates the action of cyclic AMP by the process 
of enzyme induction instead of enzyme activation.
This basic model of cyclic AMP control, with little elaboration, 
could account for the two important characteristic features of cyclic AMP: 
its low intracellular concentration and its diversity of influence.
Direct binding alone of a regulator to its target molecules could not 
cause maximal effect as not all the target molecules could be bound 
unless the concentration of the regulator is much greater than the 
concentration of the target enzyme. However, because protein kinase, 
as the regulator, acts catalytically by phosphorylating its target 
molecules, maximal effect is achieved even when the concentration of 
protein kinase is much lower than the concentration of its target enzyme. 
This infers an amplification system which allows cyclic AMP, as the 
original signal, to be effective at low concentrations, with small 
changes.
Cyclic AMP has been demonstrated not only to mediate the effects 
of most hormones and neurotransraitters, but also to be involved in 
scores of biochemical and physiological events (reviewed, among others, 
by Robison et al., 1971; Kahn and Lands, 1973; Weiss, 1975; Table 2).
TABLE 1. Some of the processes affected by a rise
in intracellular cyclic AMP concentration
Tissue Process Reference
Cellular slime mould
Rat pancreas
Rat liver
Rat liver
Rat adipose
Rat and beef adrenals
Frog skin
Liver fluke
Several
Intestine
Aggregation of cells 
Release of insulin 
Urea formation 
Gluconeogenesis 
Glucose oxidation 
Steroidogenesis 
Melanocyte dispersion 
Phosphofructokinase 
Phosphorylase activation 
Permeability
Konijn et al. (1967)
Sussman and Vaughan (1967) 
Exton and Park (1968)
Exton and Park (1966) 
Blecher (1967)
Karaboyas and Koritz (1965) 
Bitensky and Burstein (1965) 
Mansour (1966)
Haugaard and Hess (1965) 
Field (1971)
TABLE 2. Some of the substances which can modulate
intracellular cyclic AMP
Tissue Reference
Exton and Park (1968) 
Exton and Park (1968)
Glucagon
Insulin
Insulin
Adrenalin
Adrenalin
Adrenalin
Adrenocorticotropin
Thyroid stimulating 
hormone
Growth hormone
Luteinizing hormone
Prostaglandins
Alloxan
Fasting
Histamine
Potassium
Transformation of cells
Acid medium
Cell cycling
Presynaptic electrical 
stimulation
Rat liver 
Rat liver
Rat skeletal muscle 
Rat diaphragm 
Rabbit liver 
Bovine uterine muscle 
Bovine adrenal gland 
Bovine thyroid
Human fat cells
Rabbit interstitial 
tissue
Ox pituitary
Rat liver
Rat liver
Rabbit brain
Guinea-pig cerebral 
cortex 
Fibroblasts
Fibroblasts
HeLa cells
Postsynaptic cells
Larner et al. (1968) 
Larner et aJL. (1968) 
Sutherland et al. (1965) 
Butcher et al. (1965) 
Haynes et al. (i960) 
Gilman and Rail (1968)
Moskowitz and Fain (1969) 
Marsh and Savard (1966)
Cooper et al. (1972) 
Jefferson et al. (1968) 
Jefferson et al. (1968) 
Kakiuchi and Rail (1968) 
Sattin and Rail (1967) 
Pastan and Johnson (1974) 
D'Armiento et al. (1973) 
Al-Bader et al. (1976) 
Beam and Greengard (1976)
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Fig, 1 Chemical formula of adenosine 3',5*-cyclic monophosphate
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3 Action of a cyclic AMP-dependent protein kinase
Key : C = catalytic unit
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Fig* 6 Chemical structure of guanosine 3*,5' cyclic monophosphate
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Fig. 7 Levels of intracellular cyclic AMP are susceptible 
to change by adenyl cyclase, phosphodiesterase and 
release from the cells
The fact that cyclic AMP has been reported to be playing an active 
role in so many mechanisms implies the existence of systems to avoid 
utter chaos and regulate specificity. Specificity is provided by the 
enzymes responsible for the biosynthesis (adenyl cyclase) and hydrolysis 
(cyclic AMP phosphodiesterase) of cyclic AMP, which are not simple 
molecular entities but rather are complex enzyme systems existing in 
multimolecular forms. These enzyme systems are unequally distributed
/
in different tissues and cell types and may be differentially activated 
and inhibited by endogenous and exogenous chemicals.
A number of models for adenyl cyclase have been proposed (Hechter
and Halkerson, 1964; Robison et al., 1967; Birnbaumer et al., 1970; 
Rodbell, 197l), all of which postulate a separate receptor or 
discriminator, a catalytic component and a transducer. The discriminator 
subunit is that part exposed to the exterior surface of the cell and 
may be indistinguishable from the hormone or extracellular messenger 
receptor. It embodies the specific structural features necessary 
for the recognition of, and binding with, the natural messenger.
The catalytic unit is that part facing the interior of the cell and
catalyses the conversion of ATP to cyclic AMP. The discriminator
or receptor unit is coupled to the catalytic unit via the transducer.
This subunit transmits the information from the receptor, after 
messenger interaction, to the catalytic subunit leading to increased 
or decreased catalytic activity (Fig. 4). Evidence for this model 
has been reported by Schimmer et al. (1968); Johnson et al. (1972); and 
Trams and Lauter (1974). Although the structural requirements for 
binding to the receptor are well defined in many systems and the cofactor 
and other requirements for optimal activity of the catalytic subunits 
are also known, little if any information is available about the
structure and function of the transducer. Since the enzyme is embedded 
in the predominantly lipid matrix of the membrane, the lipids may also 
play an important role (Birribaumer, 1977).
The control of cyclic AMP phosphodiesterase activity relies partly 
on the ability of the enzyme to exist in a number of forms which are 
interconvertible (Pichard and Cheung, 1976), differ in their affinity 
for cyclic AMP (Pichard and Cheung, 1976), and their sensitivity to 
activators and inhibitors (Amer and Kreighbaum, 1975; Fig. 5). This 
enzyme represents more than just an off-switch for the cyclic AMP system, 
and it shares with adenyl cyclase the important function of the delicate 
control of the intracellular cyclic AMP levels and consequently its 
numerous effects.
The third group of enzymes intimately involved with cyclic AMP9 
cyclic AMP-dependent protein kinases, also exist in a variety of forms. 
These forms may differ in their catalytic specificity and regulatory 
mechanisms (Costa et al., 1976; Lee et al., 1976; Rangel-Aldao and 
Rosen, 1976; Byus et al., 1977; Costa et al•, 1977). It is through 
protein kinases that cyclic AMP is able to exert its wide sphere of- 
influence.
An analogous system to the one described for cyclic AMP is the 
control of cell metabolism via cyclic GMP or guanosine monophosphate. 
Cyclic GMP is chemically similar to cyclic AMP (Fig. 6). The early 
history of cyclic GMP research is reviewed by Robison and colleagues 
(197,1). Similarly, cyclic GMP is formed by guanyl cyclase from GTP
and degraded by cyclic GMP phosphodiesterase. The effects of cyclic 
GMP are mediated by cyclic GMP-dependent protein kinases. As the 
principles of the metabolism and assay of the two molecules are so 
similar they are often studied in parallel. However, intracellular
levels of cyclic GMP are much lower than cyclic AMP, and they are more 
difficult to measure.
Cyclic AMP and virus replication
The action of cyclic AMP during intracellular changes induced by 
viral infection has attracted considerable attention. Introduction of 
a virus into a susceptible cell may lead to viral transformation of the 
cell, lytic infections, persistent infections or latent infections.
Cell metabolism is considerably altered by these pathological conditions 
and the possible involvement of cyclic AMP may differ with each state,
(a) Viral transformation of cells
There has been considerable interest in the role of cyclic AMP in 
tumour cells in vivo and transformed cells iji vitro. In 1974 Pastan 
and Johnson reviewed the literature on transformed fibroblasts and 
proposed a unifying hypothesis: in normal fibroblastic embryonic cells
the level of cyclic AMP regulates cell shape, motility, adhesiveness to 
substratum, growth rate and the synthesis of many macromolecules.
In transformation, the transforming agent, whether it be a virus, 
carcinogen or ionizing radiation, lowers cyclic AMP levels. All those 
properties under cyclic AMP control are then altered. A fall in 
cyclic AMP levels might be achieved by inactivation of the synthesizing 
enzyme, adenyl cyclase, activation of the degredative enzyme, cyclic 
AMP phosphodiesterase, or increased release of cyclic AMP from the 
cell (Fig. 7).
As tumour viruses have less nucleic acid than a cell for regulating 
metabolism, interfering with the cyclic AMP control system would be an 
ideal and extremely economic way in which to uncouple the cell from
its normal restraints and permanently set the programme for rapid growth 
and cell division.
(b) Productive viral infection
A similar argument can be proposed for productive viral infections : 
interference with the cyclic AMP system of metabolic control may divert 
energy and material from cell macromolecular synthesis to virus 
replication.
/
This type of reasoning encouraged investigation of adenovirus 
replication because of the ability of some serotypes to transform 
certain cells. Studies of oncogenic adenovirus type 12 in non-permissive 
BHK 21 cells have shown that adenovirus could be involved with the 
cyclic AMP system. For instance, dibutyryl cyclic AMP has a 
pronounced inhibitory effect upon the DNA synthesis induced in Gl-arrested 
BHK 21 cells by infection with adenovirus type 12 (Zimmerman and Raska, 
1972). In the same system intracellular levels of cyclic AMP and the 
activity of adenyl cyclase were reduced after infection (Raska, 1973). 
Parallel experiments with adenovirus type 2 in permissive cells 
established that cyclic AMP was involved with adenovirus replication 
as well as oncogenesis (Biron and Raska, 1973). Replication of 
adenovirus type 2 was inhibited by dibutyryl-cAMP in three fibroblastic 
cell lines and in transformed cells with high intracellular levels of 
cyclic AMP. In contrast, replication was not affected by dibutyryl 
cyclic AMP in cell lines with low endogenous cyclic AMP.
An investigation spanning several years led to a theory correlating 
the pleomorphic effects of a virus infection and the diversity of 
metabolic processes under cyclic AMP control.
Apart from such in vitro studies interest in a correlation between 
health, infection and cyclic AMP levels was developed by Dubos and his
colleagues. They suggested the possibility that som£ of the most 
important medical problems in underprivileged countries (and advanced 
industrial ones) have their origin in environmental influences that 
affect man during formative phases of his prenatal and neonatal 
development (Dubos et al., 1968). Their detailed study of external 
influences on development, using the mouse model, spanned several years.
They observed differences in adult size and life expectancy (Dubos et al.,
/
1968; Seravalli and Dubos, 1968), the relative sizes of different
organs and the concentration of DNA and protein in some tissues,
reduced ability to incorporate amino acids and utilize dietary
nitrogen (Lee and Dubos, 1968) in parallel with differences in
neonatal nutrition and the presence or absence of normal gut microorganisms.
They tentatively suggested that these wide-ranging effects, which
could be induced by a partially characterized "filterable agent
derived from the intestine of mice under ordinary conditions of husbandry”
(i.e. not specifically pathogen-free) were caused by an enterovirus;
their subsequent publications (Dubos et al., 1969; Lee and Dubos, 1969;
Lee and Dubos, 197l) presented data which were consistent with this 
theory.
This led to their argument that the pleomorphic effects of neonatal 
infection with enterovirus may involve the metabolism of cyclic AMP 
(Lee and Dubos, 1972). By introducing radioactively labelled cyclic AMP 
into the whole animal and counting the radioactivity after separation 
techniques they were able to show that the degradation of cyclic AMP to 
respiratory CO,, was probably more active in the infected groups; their 
plasma levels were lower, and the incorporations into various tissues 
were decreased.
With the growing evidence for a close connection between cyclic AMP
and virus replication, others interested in this field have examined 
quite different facets.
Mishra and colleagues (1973) linked two independently published 
observations: a) that elevated levels of cyclic AMP had been suggested
as the intermediate cause of the gastroenteritic symptoms of cholera 
(Sharp and Hynie, 1971); and b) that vomiting and diarrhea, symptomatic 
of cholera, were also characteristic of infection of pigs with
/
transmissible gastroenteritis (TGE) virus (Bohl and Cross, 1971), which 
they proposed could also be due to the mediation of cyclic AMP. Indeed 
Mishra and colleagues (1973) reported a dramatic rise and fall of 
cyclic AMP in primary porcine kidney cells within 30 minutes of 
infection with TGE virus.
Levy and colleagues (1976) were attracted to the study of cyclic AMP 
by a similar argument. They were interested in human winter vomiting 
disease believed to be of viral origin (Clarke et al., 1972). Two 
partially characterised viruses associated with this disease, the 
Norwalk and Hawaii agents, had been identified as the cause of a variety 
of physiological changes in the small intestine as the disease progressed. 
However, the pathogenesis of the diarrhea remained unknown. Levy and 
colleagues (1976) attempted to implicate the adenyl cyclase system with 
the development of the symptoms. As neither the Norwalk nor the 
Hawaii agents could be cultivated artificially they set up a study 
involving human volunteers. The volunteers were inoculated by mouth 
and developed characteristic clinical illness. Adenyl cyclase activity 
was assayed in biopsy material from jejunal' mucosa but no change could 
be found.
In fact both groups of investigators may have been mistaken in 
their initial assumption as the cause of diarrhea in the two viral diseases
may have developed differently to diarrhea characteristic of cholera.
In a review of water and electrolyte transport across the intestine 
Sladen (1972) described the physiology of diarrhea caused by cholera 
infection. In man, cholera is the only pathological condition in which 
an apparently normal jejunal mucosa secretes fluid. This abnormal 
intestinal secretion is a complex process which can be blocked by 
cycloheximide. Studies on intestine jln vitro suggest that the cholera 
toxin produces active transport of chloride ions from the serosa to the 
mucosa and that this process may be mediated by cyclic AMP. Very 
similar effects can be produced by theophylliiE and cyclic AMP itself.
Unlike the normal structure of the jejunal mucosa during cholera 
infection, TGE infection causes rapid cell degeneration as numerous 
vacuoles containing viral particles appear in the cytoplasm of the 
villar cells and clumps of such degenerated cells are sloughed 
prematurely from the villar tips (Ferris, 1973). Similarly, volunteers 
infected with Norwalk or Hawaii agents developed an intestinal mucosal 
lesion with altered mucosal architecture, mucosal inflammation and 
abnormal-appearing absorptive cells together with clinical gastro­
enteritis (Shreiber et al., 1974).
It was clear that a suspicion of transport abnormalities induced 
these studies. This suspicion was echoed by a later but quite different 
study of the relationship between thymidine kinase transport during 
herpes simplex infections and the involvement of cyclic AMP (Bittlingmaier 
et al., 1977a). Dibutyryl cyclic AMP was found to inhibit the increase 
of thymidine transport normally observed after infection with herpes 
simplex types 1 and 2. In addition, a rise in cyclic AMP was observed 
4 - 8  hours after infection with thymidine kinase (+) herpes strains.
On infection with thymidine kinase (-) virus, only a small elevation of
cyclic AMP could be shown. It was also found that early addition of 
actinomycin D or of cyclohexamide prevented the increase of the cyclic AMP 
level. This increase seemed to depend on the activity of the herpes 
genome, because ultraviolet irradiation of infective particles destroyed 
this ability.
(c) Viral latency
/
Cyclic AMP has been shown to be involved in viral processes of 
both productive infections and virus-induced transformations. A third 
type of virus-host interaction which has been studied in this light 
is latency. In latent infections the virus genome is present in 
cells but there is no sign of disease or virus particles for long 
periods of time. However, the virus may be reactivated by some 
change in the cells* environment. The result is virus replication 
and disease. This type of infection is particularly characteristic 
of the herpesviruses.
A variety of diverse stimuli (ultraviolet light, fever, 
menstruation and emotional stress) can reactivate latent herpes 
simplex. Rapp and Jerkofsky (1973) suggested that continued study 
of the various reactivating agents may reveal a common factor or 
mechanism underlying the ability of herpesviruses to establish latent 
infections and subsequently reactivate. Blyth et al. (1976) took up
the problem of reactivation mechanisms of herpes simplex virus (HSV) in mice.
The possible involvement of prostaglandins led them to investigate the 
effects on HSV growth in vitro of agents known to alter intracellular 
levels of cyclic AMP. They provided a preliminary report of their work 
in 1977 and a more complete publication appeared nearly two years later
(Harbour et al•, 1978). A summary of their results appears in Tables 3 and 4*>
TABLE 3. Effectors of prostaglandin (PG) and cyclic AMP metabolism 
affect the plaque size of herpes virus in VERO cells 
(Harbour et al., 1978)
Additions to medium (pg/ml)
Difference in plaque size 
when cells pretreated for
24 hours 72 hours
pge2 0.1 + 48%
1.0 + 107% ns
10.0 + 71% + 34%
PGF2a 0.1 + 30% ns
1.0 + 16% ns
10.0 + 57% + 28%
Mefejiamic acid 
(inhibitor of prostaglandin
synthesis) 50.0 - 26% - 28%
Compounds to raise
intracellular cyclic AMP
db cyclic AMP 500.0 - 36%
adrenalin 0.2 - 21%
2.0 - 28%
20.0 - 35%
theophylline 10.0
100.0
- 19%
- 38%
abbreviations: db cyclic AMP, dibutyryl cyclic AMP
ns, not significant
TABLE 4. Effectors of prostaglandin (PG) and cyclic AMP metabolism 
affect the yield of herpes virus in VERO cells 
(Harbour et al.t 1978)
increased
Virus yield 
not affected decreased
Low mo i
(0.01 pfu/cell)
PGE,C
PGF,2a
db cyclic AMP 
theophylline 
mef£namic acid 
indomethacin-
High moi 
(10 pfu/cell) PGE2
theophylline 
mefenamic acid 
db cyclic AMP
Significantly larger herpes plaques developed in cells pretreated 
for 24 hours with prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a). 
These were compared with herpes plaques developed in cells pretreated 
with an inhibitor of prostaglandin synthesis (mefenamic acid) and drugs 
which, like prostaglandins, effectively increase the intracellular 
cyclic AMP level (dibutyryl cyclic AMP, adrenalin and theophylline). 
Significantly smaller plaques developed in cells pretreated with 
mefenamic acid and dibutyryl cyclic AMP. However, when cells were 
pretreated with drugs for 72 hours the results were slightly different. 
The prostaglandins led to smaller increases in plaque size. Decreased 
plaque size followed pretreatment with theophylline and adrenalin 
as well as mefenamic acid.
The effect of drugs on virus yield was also investigated (Table 4). 
In cells inoculated with a low multiplicity of infection the two 
prostaglandins studied increased the yield of virus while dibutyryl 
cyclic AMP, theophylline, mefenamic acid and indomethacin decreased 
virus yield. At high multiplicities of infection no effect of drug 
on virus yield was observed.
The results can be summarized simply: prostaglandins, which
increase endogenous cyclic AMP, increase plaque size and virus yield 
at low multiplicities of herpes virus infection, in contrast to 
inhibitors of prostaglandin synthesis which decrease the yield and 
plaque size. However, other drugs added exogenously, which also 
increase the effective intracellular cyclic AMP levels, decrease the 
plaque size and virus yield.
The conclusion drawn from this investigation was that prostaglandins 
enable the virus to spread from cell to cell, but that the coincidental 
rise in cyclic AMP was not involved in this effect (Harbour et al•, 1978).
Stanwick and colleagues (1977) were also interested in the wide 
range of stimuli capable of reactivating latent herpes virus infections, 
and they suggested that cyclic nucleotides would be likely candidates 
for the unknown common factor postulated by Rapp and Jerkofsky (1973).
The inflammatory and immune responses to herpes simplex type 1 inferred 
a possible involvement of cyclic AMP (Stanwick et al., 1977), since 
many of these responses were known to be influenced by cyclic nucleotides 
in other systems (Bourne et al., 1974).
In similar preliminary work with VERO cells Stanwick (pers. comm.), 
contrary to reports of Harbour and colleagues (1978), found that 
dibutyryl cyclic AMP (imM) increased the plaque size and yields of 
herpes simplex types 1 and 2, while dibutyryl cyclic GMP decreased the 
plaque sizes and yields. However, the reverse was found when human 
fibroblasts and HEp-2 cells were inoculated with herpes simplex 
(Stanwick et al., 1977).
Different observations of cyclic AMP levels in cultured cells 
infected with herpes simplex have been reported from different 
laboratories.
Investigation of herpes simplex type 1 infection of human fibroblasts 
and HEp-2 cells showed a rapid increase in cyclic GMP and a slow decrease 
in cyclic AMP, both nucleotides reaching new steady levels 12 hours 
after infection (Stanwick et al., 1977). However, these changes are 
contrary to those shown in BHK cells (Bittlingmaier et al., 1977a).
In VERO cultures infected with 10 pfu/cell of herpes simplex, no rise 
in levels of cyclic AMP was seen during the 50 hours after infection 
(Harbour et al., 1978)•
It is difficult to make a comparison between the results of 
different laboratories because of the variations in experimental design.
The observations currently reported do not easily lead to a general 
hypothesis concerning the possible role of cyclic nucleotides during 
productive herpes virus infections.
Cyclic AMP and interferon
That cyclic AMP could play an important role in a wide range of 
viruses is emphasized by reports of its involvement with interferons. 
Interferons are glycoproteins secreted from virus-infected animal cells 
which are capable of interacting with similar uninfected cells and, in 
them, inhibiting the replication of a broad range of viruses (Finter, 1973) 
Evidence has suggested that interferon is not directly responsible for 
the antiviral state in interferon-treated cells, but rather that it 
acts by inducing the cells to produce one or more substances which are 
able to prevent viral growth directly or indirectly (Dianzani et al., 1969) 
In addition to inhibiting viral multiplication, interferon has been 
shown to inhibit cell multiplication (D'Hooghe et al., 1977), modify 
the cell surface (Friedman, 1978), and enhance specialized cellular 
functions (Gresser and Tovey, 1978; Fig. 8).
Cyclic AMP has been implicated in the mode of action of interferon. 
Research in this field has been stimulated by a) observations that 
low serum levels cause high cyclic AMP levels (Otten et al., 1972), 
and also favour maximum sensitivity to and production of interferon 
(Cantell and Paucker, 1963; Carver and Marcus, 1967; Rossman and 
Vilcek, 1969); and b) the observed anti-cellular effects of interferon 
(reviewed by Gresser, 1972; and Lindahl et al., 1973) , which resemble 
growth inhibitory effects associated with elevated cyclic AMP levels 
(Otten et al., 1972; Anderson et al•, 19735 Oey et al., 1974).
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Laboratory studies confirmed the suspicion that cyclic AMP is 
intimately involved with the action of interferon. Incubation of 
chick embryo fibroblasts with 100 mM cyclic AMP led to an increased 
interferon-induced antiviral effect (Friedman and Pastan, 1969).
This work was supported by a similar observation with mouse interferon 
and L-929 cells (Allen et £il., 1974). Some derivatives of cyclic AMP 
have shown a similar effect (Allen et al., 1974; Weber and Stewart,
1975). Potentiation of the interferon-mediated antiviral effect 
has been shown by combined adrenalin and theophylline treatment which 
elevated cyclic AMP levels (Weber and Stewart, 1975).
Kinetics studies were undertaken with vesicular stomatitis virus, 
interferon and L cells. The dose-response of interferon activity 
by cyclic AMP indicated that potentiation of the interferon activity 
by cyclic AMP occurred at an early stage in the development of antiviral 
activity (Weber and Stewart, 1975).
A different experimental design has shown interferon elevating 
cyclic AMP levels in L cells (Weber and Stewart, 1975). This activity 
was limited to biologically active interferon and antagonised the 
depression of cyclic AMP associated with vesicular stomatitis virus 
infection of L cells.
The involvement of cyclic AMP in the action of interferon was 
further supported by comparative studies of interferon-sensitive and 
interferon-insensitive cells (Meldolesi et al., 1977). Mouse interferon 
induced an increase in cyclic AMP levels in interferon-sensitive mouse Ly 
cells but not in interferon-insensitive human KB-3 cells. The interferon- 
induced elevation in cyclic AMP preceded the induction of antiviral 
activity.
Similar evidence supporting the hypothesis that interferon 
increases the intracellular cyclic AMP levels was obtained from 
chemostat cultures (Tovey et al., 1979), which were chosen as a model 
for study in preference to the more commonly used batch cultures, 
because of the possibility of maintaining a constant environment and 
constant cell numbers. The addition of interferon was followed by 
an immediate rise in cyclic GMP and a rise in cyclic AMP after 24 hours.
This variety of evidence involving the antiviral action of 
interferon and cyclic AMP is consistent with a correlation between the 
two substances, but these studies do not show a direct causal relationship. 
Better understanding requires closer investigation of the mode of action 
of interferon.
Evidence for a close resemblance of interferon action and hormone 
action was provided by a study of cell surface receptors (Grollman et al., 
1978)• Interferon and hormone receptors share common molecular and 
mechanistic elements including: a) the presence of a glycoprotein and
ganglioside in the receptor; b) changes in membrane structure as a 
consequence of interferon or hormone action; c) messenger-induced 
cyclic AMP changes; and d) alterations in the flux of certain ions.
Investigations of interferon action and the development of the 
antiviral state at the molecular level (Lebleu et al., 1976; Roberts et al. 
1976; Sen et stl•, 1976; Hovanessian et al., 1977; Kerr et al., 1977; 
Ohtsuki et al., 1977; Kerr and Brown, 1978) have not discovered the 
precise nature of action of cyclic AMP in the development of the 
antiviral state.
Control of protein synthesis by viruses or interferon has been 
studied by applying the same rabbit reticulocyte lysate system which 
had been developed for the study of globin synthesis. Although evidence
at the molecular level supports the suggestion that cyclic AMP acts in 
the inhibition of globin synthesis (Datta et al., 1977 ), there have been 
no such observations from biochemical studies of the parallel system 
to implicate cyclic AMP in the action of interferon on protein synthesis* 
Judgements on the role of cyclic AMP at present depend solely on the 
direct measurements of cyclic AMP in cells treated with interferon 
(Meldolesi et al#, 1977; Tovey et al., 1979) or viruses (Lee and 
Dubos, 1972; Mishra et al., 1973; Cohen and Cuatrecasas, 1976;
Levy et al *, 1976; Bittlingmaier et al., 1977a; Stanwick et al., 1977) 
or the effect of changed levels of intracellular cyclic AMP on viruses 
(Bittlingmaier et al•, 1977a; Maassab and Soltysiak, 1977; Harbour et al., 
1978) or interferon (Dianzani et al., 1972; Weber and Stewart, 1975;
Koblet et al., 1979).
Raising intracellular cyclic AMP artificially
Two obvious targets for inducing raised cyclic AMP levels are the 
enzymes for its synthesis and degradation: adenyl cyclase and cyclic AMP
phosphodiesterase. The pharmacological control of the synthesis and 
metabolism of cyclic nucleotides has been reviewed by Weiss and Fertel 
(1977). More detailed information describing regulators of cyclic 
nucleotide phosphodiesterases has also been presented as a review 
(Amer and Kreighbaum, 1975). ,
Both the catalytic units and receptor units of adenyl cyclase 
have been shown to be susceptible to modification by exogenous substances 
Although increased adenyl cyclase activity would tend to raise the 
intracellular cyclic AMP, the accumulation of cyclic AMP may not 
necessarily correspond perfectly with the enzyme activity, as other 
factors, such as phosphodiesterase activity or ATP concentration, may 
also influence the concentration of cyclic AMP.
Sodium fluoride is the most potent, most studied and least specific 
activator of adenyl cyclase (Birnbaumer et al•, 1971). Although the effect 
of fluoride ions on adenylate cyclase activity has been studied in various 
laboratories, no universally accepted hypothesis for its mechanism of action 
has emerged; however, it is believed to act directly on the catalytic unit.
Cholera toxin activates adenyl cyclase by a different mechanism 
(Ledeen and Mellanby, 1977). Cholera toxin (Fig. 9) can be dissociated 
into subunits, A and B, and the evidence indicates that binding to a 
specific ganglioside, GM1, occurs through the B subunits ( 4 - 6  per toxin 
molecule, each of molecular weight 8 - 14,000), followed by penetration 
of the membrane by the A subunit (molecular weight 27,000) and subsequent 
action of adenylate cyclase. Cholera toxin action on adenyl cyclase 
does not simulate that of neurotransmitters and hormones, but is less 
direct. However, once intact tissues have been incubated with cholera 
toxin, even after washing, the effect on adenyl cyclase lasts several days.
Xanthine analogues were the first pharmacological agents found to 
inhibit phosphodiesterase (Butcher and Sutherland, 1962) and theophylline 
(1,3-dimethylxanthine, Fig. 10) is the most common standard reference 
agent used in studies of phosphodiesterase inhibitors (Amer and 
Kreighbaum, 1975). Theophylline is the only inhibitory agent whose use 
is common to phosphodiesterases isolated from a wide variety of sources 
(Weiss and Fertel, 1977). However, there is substantial evidence 
suggesting that physiological effects of theophylline may be due to 
properties other than its ability to inhibit phosphodiesterase.
In addition to the three compounds mentioned, which are inexpensive 
and readily available, intracellular cyclic AMP may also.be raised by 
exogenous hormones (Weiss and Fertel, 1977) or high levels of cyclic AMP 
may be simulated by the addition of an analogue, dibutyryl cyclic AMP.
Although the results of experiments involving only one exogenous 
regulator may be difficult to interpret due to the possibility of 
unrelated effects, useful information regarding raised levels of 
intracellular cyclic AMP may be gained if several compounds, with 
different modes of action, are applied.
Fig. 9 Proposed mechanism for cholera toxin activation of 
adenyl cyclase (Brady and Fishman, 1979)
a) Cholera toxin attached to galactosyl and 
N-acetylneurarainyl moieties of ganglioside GM1 and 
lateral mobility of toxin-receptor complexes 
allows multivalent binding.
b) The toxin undergoes a conformational change upon 
binding to its receptor GM1 which is at its maximum 
when all 5 binding sites are occupied, and appears 
to precede dissociation of the toxin and entry of 
the A. subunit into the plasma membrane.
c) The Al subunit, released by reduction of a single 
interchain disulphide bond, catalyses the hydrolytic 
cleavage of NAD to ADP-ribose and nicotinamide and 
the transfer of ADP-ribose onto the GTP-binding 
protein that is a regulatory component of the 
adenyl cyclase system, thereby maintaining adenyl 
cyclase in an activated state.
Fig. 9a
Fig. 9b
Fig. 9c
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Fig. 10 Chemical structure of theophylline
AIMS OF THIS STUDY
A survey of recent publications revealed that two principal lines 
for studying the possible role of cyclic AMP in productive viral infections 
have been undertaken in a number of laboratories: either the levels of
cyclic AMP in a susceptible host have been measured after inoculation 
with a virus, or the intracellular levels of cyclic AMP have been altered 
while the course of viral infections have been observed. Some 
investigators have restricted their studies to one of these principal lines, 
while others studied both simultaneously.
The studies reported from different laboratories varied in the choice 
of virus, of host cell and its measurement, of methods for altering levels 
of cyclic AMP and for its preparation and assay. Such differences 
greatly diminish the value of comparative analysis.
The first investigation undertaken here was of the intracellular levels 
of cyclic AMP in cultured cells during viral infections. Two cell types, 
VERO and HEp-2, were inoculated either with herpes virus type 1 or >r 
polio virus. The age of the cultures at the time of inoculation, the 
multiplicity of infection and the serum content of the medium were all 
varied in an attempt to determine parameters which may affect cyclic AMP 
levels in cells which are the site of virus replication.
The second line of study was an investigation of virus infection 
in cultures treated with drugs to raise intracellular cyclic AMP. Two 
cell lines, VERO and HEp-2, were treated with theophylline, potassium 
fluoride or cholera toxin. Under these conditions the cultures were 
inoculated with four viruses: herpes virus type 1, polio virus,
Mengo virus or Semliki Forest virus in an attempt to find if virus 
infections are sensitive to intracellular cyclic AMP.
Considerable portions of these studies have been devoted to 
purely technical problems, such as the selection of suitable cultures 
and methods for the measurement of cyclic AMP. Although this work 
was necessary before the main subjects of the investigation could be 
attempted, these sections do not form a central position of interest 
so these details of the background and development of methods have 
therefore been presented as appendices at the end of this report.
METHODS
Cells
Two continuous cell lines were employed for this study: a
tumour derived line, HEp-2 (Moore et al., 1955), with epithelial-like 
morphology was obtained from the tissue culture department of these 
laboratories; and VERO, a line initiated from the kidney of a normal, 
adult African green monkey (Yasumura and Kawakita, 1963), was obtained 
from the Flow Laboratories at passage level 132.
Both cell lines were cultured as monolayers in 12 oz glass medical 
flats or plastic flasks (Falcon and Corning) with a cell growth area
2 g
of 75 cm • Approximately 2.10 cells were transferred into fresh
growth medium every third and fourth day alternately.
HEp-2 cells were maintained in Eagles minimal essential medium
supplemented with 10# foetal bovine serum. VERO cells were maintained
in 199 medium supplemented with 5# foetal bovine serum. In addition,
all media contained sodium bicarbonate, 0.11#, and crystamycin [30 mg/ml
benzylpenicillin (sodium) and 50 mg/ml streptomycin], 0.25#.
Cell suspensions, effected by incubation of adherent monolayers
with 0.5# versene (for HEp-2 cells) or 0.5# versene containing .
0.125# trypsin (for VERO cells) were centrifuged for one minute at
approximately lOOOg. The supernatant was discarded and the cells were
resuspended in fresh medium by gentle pipetting and dispensed as required.
2For the preparation of replicate cultures 25 cm plastic flasks 
(Falcon) or 60 mm plastic dishes (Falcon) were seeded with approximately
g
10 cells. The cultures were ready for use within 24 hours.
Serum-free cultures of non-dividing cells were prepared by replacing 
the growth medium with fresh medium containing 0.5# foetal bovine serum 
24 hours after seeding, and after a further 24 hours the maintenance medium
was replaced with serum-free medium. The cultures were ready for use
36 hours later (Stanwick et al•, 1977).
All cultures in sealed containers were incubated at 37° C, and cells
cultured in vented plates were similarly maintained at 37° C but in a
humidified atmosphere of 5#
To estimate cell numbers small volumes of cell suspensions were
diluted with equal volumes of filtered trypan blue (British Drug Houses,
Poole, England) 0.5# in double distilled water and within three minutes
the viable transparent cells were counted in a Neubauer counting chamber
(Hawksley and Sons Ltd., Lancing, England). When the proportion of
dead cells was also required, the non-viable, darkly stained cells were
counted simultaneously.
Cells were stored for long periods at low temperatures in protective
freeze medium: growth medium, 82.5#; dimethylsulphoxide, 7.5#; foetal
6
bovine serum, 10#. Glass ampoules were filled with 5.10 cells in
0.3 - 0.5 ml of freeze medium, heat sealed and stored in a liquid nitrogen
chamber. When required for culture the contents of one ampoule were
quickly thawed and resuspended in 10 ml of growth medium. The cells
2 . 
were allowed to settle in a flask with 25 cm growth area and within
8 hours, after the cells had adhered to the vessel, the medium was
replaced with fresh medium.
Viruses
A throat swab of herpes simplex type 1 was donated by Dr. Jeffries 
of St. Mary's Hospital, London. Stocks were prepared in VERO and 
HEp-2 cells.
Laboratory stocks of Mengo virus, Semliki Forest virus and the 
Sabin-2 strain of polio virus were donated by Mr. Selway, Wellcome 
Research Laboratories.
All viruses were cultured and assayed by similar methods. Stocks
2
of infectious virus were prepared at 37°C by inoculating 75 cm monolayers 
of VERO or HEp-2 cells with 5 - 10 ml of a crude suspension of virus, 
which was replaced with maintenance medium after one hour. The cultures 
were examined microscopically at intervals for evidence of viral infection: 
herpes virus caused rounding of cells, while the other viruses caused the 
cells to become detached from the culture vessel. When the cell damage 
appeared extensive (approximately 24 hours after inoculation with herpes 
virus, 16 hours after inoculation with polio virus and 7 - 1 0  hours after 
inoculation with Semliki Forest virus and Mengo virus) the cultures were 
frozen and thawed three times and sonicated in an ultrasonic cleaning 
bath. Representative samples were assayed for infectivity by the 
plaque test and the remainder was stored in 1 ml aliquots at -70°C.
The plaque assay technique : Serial tenfold dilutions of virus
stocks were applied to confluent monolayers of cells for 1 hour. The 
cells were carefully drained of the inoculum and overlaid with 0.5# 
agarose (Indubiose A37, 92 Gennevilliers, France) in maintenance medium 
at 42°C. The agarose set when cooled to room temperature and the 
cultures were transferred in incubators to allow the formation of plaques 
( 4 - 5  days for herpes virus, 1 - 2  days for Mengo virus, polio virus 
and Semliki Forest virus)• Approximately 3 ml of 10# formaldehyde in 
phosphate buffered saline was added to each culture. After an hour the 
agarose and fixative were washed off and the cells were stained with 
2 ml of 0.5# methyl violet in 20# methanol (Fiala, 1968).
The plaques were counted following the recommendations of
Cooper (1961 and 1967): it was assumed that 100 plaques in a 60 mm dish
2
or 25 cm flask gave no significant loss by overlapping as the internal 
diameter of the culture vessel was more than 25 times the diameter of a
plaque. The result was expressed as plaque forming units per volume of 
inoculating virus suspension.
Extraction of cyclic AMP
The medium from cell cultures was replaced with 70% ethanol and the 
cultures were incubated for 1 hour at 4°C. The cell extracts in ethanol 
were evaporated to dryness in an oven at 40-50°C. The samples were 
resuspended with Tris-HCl buffer containing 4 mM EDTA and 8 mM theophylline 
at pH 7.4, and assayed according to the method of Nahorski. Alternatively 
the samples were resuspended with Tris-HCl buffer containing 4 mM EDTA 
(but no theophylline) at pH 7.5, and assayed with the competitive protein- 
binding cyclic AMP assay kit supplied by the Radiochemical Centre,
Amershara. Details of other extraction procedures rejected as unsuitable 
are described in Appendix 4.
Assay of cyclic AMP
Two samples from each extract were assayed for cyclic AMP, by one 
of the two methods described below.
The first method attempted was the protein-binding cyclic AMP assay 
kit supplied, with detailed instructions, by the Radiochemical Centre, 
Amershara; this was later abandoned in favour of a method based on the 
assay developed by Brown et al. (1970) with some modifications 
introduced by Nahorski (pers. comm.).
Both assays were based on the competitive binding of unlabelled 
cyclic AMP and a known quantity of tritium-labelled cyclic AMP to 
proteins with high specificity and affinity for cyclic AMP. The amount 
of labelled protein-cyclic AMP complex formed was inversely related to
i
the amount of unlabelled cyclic AMP present. Separation of the
protein-bound cyclic AMP from the unbound nucleotide was achieved by 
adsorption of the free nucleotide to charcoal in albumin, followed by 
centrifugation to sediment the charcoal. An aliquot of the supernatant 
was then transferred to liquid scintillation fluid for counting. 
Measurement of the protein-bound radioactivity enabled the amount of 
unlabelled cyclic AMP present in the sample to be calculated from a 
standard curve.
The major difference between the two assays was the nature of the
binding material. The Radiochemical Centre's kit used a binding protein
purified from bovine skeletal muscle, while the second method employed a
crude extract from bovine adrenal cortex. The binding affinity of the
two preparations is probably similar as similar dissociation constants
have been reported for purified binding-protein from bovine skeletal
muscle (K = 10 ^M, Tovey et al., 1974) and for crude preparations from
—9bovine adrenal cortex cytosol (K= 2.10 M, Tsang et al., 1972). However, 
the binding material of the two preparations differs in its enzyme content 
adrenal cortex cytosol has more than one binding site or protein kinase 
isoenzyme (D/fskeland et al., 1977), but the bovine skeletal muscle 
preparation was restricted to a single peak of binding and protein kinase 
activity eluted from a DEAE cellulose column (Gilman, 1970).
Other differences between the two assays included the relative 
concentrations and volumes of assay constituents (Table 5), different 
methods for mixing the contents of the analysis tube (Table 6), the 
calculation of blank effects in the binding and separating reactions 
(Table 7) and the preparation of the assay ingredients.
Materials Preparation of constituents for the Radiochemical Centre 
kit involved adding distilled water to freeze-dried material, as
TABLE 5. Constituents for cyclic AMP assays
Assay Method 1 Assay Method 2
*
Reagent Radiochemical Centre kit Brown/ttahorski method
Volume Content Volume Content
[^H]eyelie AMP 50 pi 25 nci 
0.9 pmole
10 pi 25 nci 
0.9 pmole
Cyclic AMP 50 pi 0-16 pmole 100 pi 0-6 pmole
Binding protein 100 pi Purified front 
bovine muscle
200 pi Crude bovine 
adrenal cortex 
cytosol
Charcoal 100 pi 500 pi 2% Norit GSX 
1% BSA
Buffer Tris EDTA 
pH 7.5
Tris EDTA pH 7.4 
8 mM theophylline
Sample for 
counting 200 pi 500 pi
TABLE 6. Two methods for assaying cyclic AMP
Assay 1
Add to tube cyclic AMP sample 
or buffer.
Add [3H]cyclic AMP.
Add binding protein.
Vortex mix contents of tube 
for 5 seconds.
Incubate for 2 - 5  hours 
at 4°C.
Prepare charcoal suspension, 
mixing with a magnetic 
stirrer, 15 minutes before 
use.
Add charcoal.
Vortex mix contents of tube 
for 5 seconds.
Centrifuge to sediment 
charcoal•
Transfer sample of 
supernatant to 
scintillant.
Assay 2
1) Add to tube [3H]cyclic AMP.
2) Add cyclic AMP sample or buffer.
3) Add binding protein.
4) Mix contents of tube by inversion.
5) Incubate until reaction reaches 
equilibrium at 4°C.
6) Prepare charcoal suspension, 
mixing by hand with a glass rod.
7) Add charcoal.
8) Mix contents of tube by inversion.
9) Centrifuge to sediment charcoal.
10) Transfer sample of supernatant 
to scintillant.
TABLE 7. Constituents for the evaluation of blank effects 
by the two cyclic AMP assay methods
Assay 1 Assay 2
Binding protein 0 200 pi
[3H]Cyclic AMP 50 pi 10 pi
Cyclic AMP 0 100 pi of 1 mM
Buffer 150 pi 0
instructed by the manufacturer. Assay materials included :
i) 0.05 M Tris-HCl buffer at pH 7.5, containing 4 mM EDTA.
ii) Binding protein, purified from bovine muscle, 
iii) [8- H]Adenosine 31,5*-cyclic phosphate, approximately 28 ci/mmole. 
iv) Adenosine 3*,5*-cyclic phosphate standard 160 pmole/ral. 
v) Charcoal adsorbent with 2% albumin.
Preparation for the Brown/Kahorski assay was far more lengthy.
The binding reagent was a crude 5000 g supernatant obtained from bovine 
adrenal cortices suspended in Littlefields medium, pH 7.4: (Tris, 0.05 M; 
sucrose, 0.25 M; potassium chloride, 0.025 M; magnesium chloride, 0.005 M; 
mercaptoethanol, 6 mM). Bovine adrenals (10 - 12) were collected on ice 
within a few hours of slaughter, and kept at 4°C throughout the preparations. 
The adrenals were sliced to reveal the white medulla which was scraped off 
and discarded. The remaining cortex tissue was roughly chopped, added 
to Littlefields medium (3 ml volumes per 2 g tissue) and homogenised in 
a waring blender. The supernatant after centrifugation at 1250 g for 
20 minutes was recentrifuged at 5000 g for 15 minutes. The supernatant 
was divided into 0.5 ml aliquots and stored at -20°C.
The binding protein was titrated by preparing a series of dilutions 
of the prepared material (1/10 to 1/50) and measuring the binding of 
radioactive cyclic AMP in the absence of an unlabelled cyclic AMP sample, 
as described by the assay procedure. The recommended dilution of 
binding protein was that which bound 25 - 30# radioactive cyclic AMP.
For following experiments aliquots of binding protein were thawed and 
diluted as required immediately before the assay.
Assay constituents were prepared in buffer, pH 7.4: Tris, 0.05 M;
EDTA, 4 mM; theophylline, 8 mM.
3 's ’
[2,8- HjAdenosine 3*,5*-cyclic phosphate ammonium salt in
50$ aqueous ethanol with a specific activity of 52 ci/mmol was purchased 
from the Radiochemical Centre and stored at -20°C. On the day of use 
a 5 |il aliquot of this material was dried and reconstituted with the 
2 ml assay buffer (to give a final concentration equivalent to 
16,000 radioactive counts per minute in 10 pi).
Crystalline adenosine 3*,5*-cyclic monophosphoric acid was 
purchased from Sigma. Aliquots were weighed, reconstituted and diluted 
to prepare known standards of cyclic AMP.
Decolourising, purified charcoal, grade Norit GSX, was purchased 
from Hopkin and Villiams. A charcoal suspension, 2$, was prepared in 
assay buffer containing 10$ bovine serum albumin.
Assay procedure : Each assay was conducted in polythene centrifuge
tubes and automatic pipettes with disposable plastic tips were employed 
throughout.
Each analysis tube contained radioactively labelled cyclic AMP and 
unlabelled cyclic AMP, either the unknown sample, or a standard solution, 
or for some blank measurements, buffer without cyclic AMP (Table 5).
The reaction was initiated by the addition of binding protein. The 
contents of the tubes were mixed either by vortexing briefly, for 
assay method (l), or by inversion, for assay method (2). The reaction 
mixture was incubated for 2 or more hours at 4°C to allow the binding 
reaction to reach equilibrium. Aliquots of the prepared solution 
were added to the number of tubes which could be centrifuged simultaneously 
The contents were mixed by vortex or inversion (as before) and centrifuged 
immediately to sediment the charcoal. Centrifugation was either for 
20 minutes at 1250 g in a refrigerated centrifuge, or for \\ minutes 
(2 minutes including stopping) at 12,000 g in a nonrefrigerated 
microcentrifuge. Aliquots of the supernatants were transferred to 
scintillant.
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Liquid scintillation counting : Aliquots of radioactive material
were added to 10 ml volumes of PCS scintillant (Amersham/Searle) in 
disposable glass scintillation vials* After mixing, each sample was 
counted for 5 minutes by a Beckman LS-200 scintillation counter.
Analysis of results from cyclic AMP assay : Calibration curves
were prepared from the results of radioactive counts of samples containing 
known concentrations of unlabelled compound. The percentage of 
radioactivity remaining in the supernatant was plotted against the 
logarithm of the concentration of the unlabelled compound (Fig. ll). 
Alternatively a linear calibration curve was constructed by plotting 
Co/Cx against the concentration of unlabelled compound on linear graph 
paper, where Co was the radioactivity bound in the absence of unlabelled 
compound, and Cx was the counts bound in the presence of known unlabelled 
compound (Fig. 12). This type of plot was easier to construct and read, 
and was highly recommended by the Radiochemical Centre for use with their 
assay. The third method involved a curve-fitting computer program 
applying semi-empirical mathematic expressions (Rodbard and Hutt, 1974; 
Rodbard, 1978). This method was kindly adapted by Dr. R. White to 
analyse the information available from cyclic AMP assays performed for 
this study. The analysis yielded a calibration curve complete with 
9596 confidence limits (Fig. 13).
Computer analysis : This involved the construction of a calibration
curve for the radioassay of cyclic AMP, and interpolation of sample 
cyclic AMP concentration together with the associated 95# confidence limits. 
The following data were collected for a series of concentrations of 
cyclic AMP over the working range :
i. Total counts in the incubate, 
ii. Total concentration, x, of unlabelled and labelled cyclic AMP 
in the incubate.
iii. Bound counts in the incubate at a total concentration, x.
The ratio of bound to total counts was calculated as a 
percentage, y.
The ratio of bound to total counts as a percentage was also 
determined at an excess, saturating concentration of cyclic AMP.
Data were used to fit a logistic function (Rodbard and Hutt, 1974) 
of the following form :
a - d
y =    + d
1 +  < X / C ) b
where y and x are as defined previously and a, b, c and d are fitted 
parameters. The parameters are empirical in this application, but 
have the following properties: a is the value of the equation at a
zero concentration of substrate; d is the value of the equation at 
an infinite (in practice, extremely high) concentration of substrate, 
and represents 'non specific binding'; c is the half-saturation constant 
and b defines the slope of the equation. The fit was performed by 
conventional non-linear least-squares regression analysis using 
Powell's method (Powell, 1970). The goodness-of-fit was judged
from the mean sum of squares of residuals (the vertical differences
between the observed points and the fitted line), the serial correlation
» ,
coefficient and the standard errors of the fitted parameters a, b, c
and d. No weighting was found to be necessary, and a good fit was 
obtained to each set of data. The fitting routine was also used to 
calculate a variaiice-covariance matrix for the parameters, and partial 
derivatives for the equation at each concentration, x.
With respect to the four parameters: these values were used to
calculate the variance of the fitted line at each concentration. The 
variance of the observations was assumed to be homogenous (and no 
evidence to the contrary was obtained) and was estimated from a series 
of replicate measurements in the presence of labelled cyclic AMP alone. 
Corrections to the observed variance were applied using Feiller's theorem, 
to take account of the fact that the observations are expressed as the 
ratio of two variables, but the effect was minimal. The variances of 
the fitted line and the observations were then combined and used to 
estimate 95# confidence intervals for the calibration curve, assuming 
that the new observation was the mean of duplicate determinations.
The calibration curve and calculated confidence intervals were used to 
construct a graph of percentage bound against concentration. New 
observations of percentage bound were then used to interpolate the 
unknown concentrations, and the associated 95# confidence limits 
direct from the graph.
Protein determination
The total protein content of cell cultures was determined by the 
colorimetric method first described by Lowry and colleagues (1951) 
and modified for the convenient application to monolayer cell cultures 
(Oyaraa and Eagle, 1956).
A pale purple colour was produced by the biuret reaction of 
protein with alkaline copper sulphate tartrate. Further colour 
development resulted from the addition of Folin -Ciocalteau's phenol 
reagent (F-C reagent).
Two stock solutions for the development of the biuret colour 
were prepared: A, NagCO^, 20 g; NaOH, 4 g; NaK tartrate, 0.2 g; 
q.s. 100 ml: B, CuSO^.511^ 0, 0.5 g; q.s. 100 ml. Solution A
(50 parts by volume) was mixed with solution B (l part by volume) to 
form solution C, which was used on the day of preparation.
Bovine serum albumin, 6 - 50 jig in 1 ml distilled water, was 
added to 5 ml of solution C. Ten minutes later 0.5 ml of IN F-C reagent 
was added, and the mixture was vortexed immediately. After 30 minutes 
but within 2 hours the absorbance of this mixture, compared with a 
control tube which lacked bovine serum albumin, was measured with a 
Unicam SP8000 ultraviolet recording spectrophotometer at a wavelength 
of 660 nm.
Cell cultures were prepared for assay by rinsing twice with 
Earles basal salt solution, allowed to dry and then dissolved in solution C. 
If, after 10 minutes, the solution of cell material was colourless,
1 ml was taken for assay. However, if a bright purple colour developed, 
as little as 0.2 ml was taken for assay. The volume of the samples was 
made up to 5 ml with solution C, and 1 ml distilled water. Finally,
0.5 ml of IN F-C reagent was added and these test solutions were treated 
identically to the control solutions described above.
Development of plaques in cells treated with drugs known to elevate 
intracellular cyclic AMP
Three experimental designs were employed for the treatment of cells 
with drugs chosen for their ability to elevate intracellular cyclic AMP. 
Confluent cultures were either: a) infected with virus 24 hours after
seeding and overlayed with maintenance medium containing theophylline 
and/or potassium fluoride and 1# agarose; b) partially synchronized by 
stepwise reduction of serum in the medium (cells were fed with medium 
containing 0.5# serum 24 hours after seeding, and no serum 48 hours after 
seeding) before being infected with virus and overlayed with maintenance 
medium containing theophylline and/or potassium fluoride and 1% agarose,
34 days after seeding; or c) partially synchronized and pretreated by 
addition of potassium fluoride and/or theophylline with the maintenance medium 
24 hours after seeding and with the serum-free medium 48 hours after seeding 
before being inoculated with virus 3^ days after seeding and overlaid with 
maintenance medium containing 1% agarose in the absence of the drugs.
This procedure was slightly adapted when the cultures were treated with 
cholera toxin. The cholera toxin was prepared and assayed by Dr. R. Thomson 
of the Wellcome Research Laboratories. When injected intracutaneously 
in rabbits, cholera toxin evoked erythema, localised firm swelling and a 
delayed and prolonged increase in permeability of small blood vessels of 
skin to water and plasma proteins (Craig, 1966). One dose (rabbit skin 
reacting dose) was established as that amount of toxin in 0.1 ml volume 
capable of producing a skin reaction of 8 mm in diameter at 18 - 24 hours 
(Craig, 1965). The cholera toxin was not included with the overlay medium, 
nor was it included with the medium prior to the cultures being overlaid. 
Instead the cultures were incubated in the presence of cholera toxin for
4
30 minutes immediately prior to the cultures being overlaid or, in the 
case of pretreatment, 24 hours after seeding. The cultures were only 
treated once with cholera toxin, even if the medium was subsequently changed.
Measurement of plaques
Infected cell cultures stained with methyl violet to visualise 
the viral plaques were placed on a microfilm viewer which displayed a 
magnified image on a screen. The magnified size of each plaque was 
recorded by placing a sheet of paper against the screen and tracing 
round the image. The actual size of each plaque was calculated from 
measurements of the longest and shortest diameters, and assuming the 
shape of the plaque to be an ellipse.
RESULTS
Levels of cyclic AMP in cell cultures infected with herpes virus or polio viru
Cyclic AMP in 4 day old VERO cells maintained in serum-free medium was 
repeatedly found to vary between 100 and 300 pmole/mg protein (Figs. 14, 16, 
20, 22). However, in none of the four experiments did the levels of 
cyclic AMP differ between VERO cells uninfected and those infected with 
either herpes virus or polio virus. During each experiment the presence 
of viral metabolism in inoculated cultures was verified by the observation 
of typical virus-induced cytopathic effects. Fig. 19 shows the 
progression of herpes virus multiplication in VERO cells which was studied 
simultaneously with the levels of cyclic AMP described in Figs. 16 and 17.
Comparison of cyclic AMP levels with cell numbers rather than total 
protein did not generally alter the results. However, the average levels 
of cyclic AMP in VERO cells 24 hours after inoculation with herpes virus 
were higher than the control when based on cell number, but were lower 
than the control when based on total protein (Figs. 14 and 15). This 
difference was not observed 21 hours post inoculation during a repeat 
experiment (Figs. 16 and 17).
Data presented in Figs. 20 and 21 show that lower and more variable 
amounts of cyclic AMP were observed when the cells were scraped off the 
plastic vessel with a rubber policeman before being treated with ethanol.
Cyclic AMP in similarly prepared HEp-2 cells (4 days old and maintained 
without serum) was found at much lower levels of 3 - 13 pmol/mg protein 
(Tables 8 - 10). However, when the cultures were cooled to 4°C for 
40 - 60 minutes and then maintained at this temperature for 3 hours while 
inoculated with herpes virus, the range of cyclic AMP was raised to 
11 - 28 pmol/mg protein (Fig. 24). At no time was there a significant
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TABLE 8, Cyclic AMP (pmole/mg protein) in HEp-2 cells 
inoculated with herpes virus type 1 at 
various multiplicities of infection
Uninfected Low raoi High moiTime post inoculation ~ A ^cultures infected infected
1 hour 12.24 6.63 8.64
7.79 5.10
6 hours 10.65 4.17 4.14
5.56 7.14 8.04
4.57 4.39
6.06 5.06
6.44
5.37
12 hours 3.85 4.44 3.51
0.69 4.97 4.29
11.70 6.32 5.36
5.88 6.39 7.32
3.53 5.31 4.86
5.83 5.77 3.53
11.00 4.29 9.81
13.64
TABLE 9. Cyclic AMP (pmole/rag protein) in HEp-2 cells
infected with herpes virus type 1* All cultures 
were incubated with 100 (ig/ml theophylline
Time post inoculation Uninfected
Infected 
Low moi High moi
1 hour 6.17 8.04
13.41
6 hours 8.56
6.44 7.37
9.86
8.66
12 hours 12.00 10.29 7.47
4.32 8.65 6.91
5.78
TABLE 10. Cyclic AMP (pmole/mg protein) in HEp-2 cells 
infected with herpes virus type 1
Time post inoculation Uninfected
Infected 
Low moi High moi 
—  0.8 c-8
1 hour 5.5 + 1.1 6.9 + 3.0 12.9 + 6.1
6 hours 5.3 + 2.1 4.1 + 5.4 6.9 + 7.0
12 hours 3*8 + 2.4 4.0 + 2.5 9.0 + 4.3
difference in the cyclic AMP levels of infected and uninfected cultures 
(Tables 8 - 10, Fig. 24).
Figs. 18, 23 and 25 present experimental results that indicate the 
degree of error associated with each individual assay of cyclic AMP.
Each value and its 95# confidence limits were calculated by comparing 
assay results with the standard curve. The variation in levels of 
cyclic AMP between replicate flasks of VERO cells (Figs. 18 and 23) and 
HEp-2 cells (Fig. 25) was contributed to largely by the inherent error 
of the cyclic AMP assay (Fig. 13).
Virus infections in cells treated with theophylline, potassium fluoride 
and cholera toxin
Herpes virus infection of VERO cells : When VERO cells were inoculated
with herpes virus, after four days incubation, the fixed and stained
cultures contained small foci of darkly stained cells. These plaques
2varied in size, but did not exceed an area of 0.6 mm (Figs. 26, 27, 28). 
Addition of 0.125 mM theophylline to one day old or four day old
VERO cells increased the proportion of larger plaques. In both cases
2 2 the modal size was increased from 0.1 - 0.2 mm to 0.2 - 0.3 mm and the
2 2maximum size was increased from 0.5 or 0.6 mm to 0.8 mm (Figs. 26 and
27). However when the theophylline concentration was increased to
0.5 mM the opposite effect was observed: the modal size was again as low
2
as the control value and the maximum size was reduced to 0.3 - 0.4 mm •
In neither experiment was there an obvious effect resulting from 
potassium fluoride treatment.
The effect of theophylline on the formation of herpes plaques was 
studied further by careful observation of the visual appearance of the 
plaques. Each plaque was classified into one of three categories
according to its apparent structure: a) tightly packed aggregates of cells
which stained dark purple with methyl violet (against a blue background 
of uninfected cells); b) dead cells which stained black; or c) areas 
where the cells had become detached from the plastic, leaving a hole in 
the monolayer. The untreated culture of VERO cells which was inoculated 
four days after seeding contained a variety of plaques, each category being 
represented. However, when parallel cultures were treated with theophylline 
and/or potassium fluoride, the variation in appearance was markedly reduced 
(Table 12). Treatment with 0.5 mM potassium fluoride produced only 
plaques in the first category, while treatment with high concentrations 
of potassium fluoride or treatment with theophylline induced a majority, 
if not total, development of plaques of the second category.
The total number of plaques which developed under various conditions 
was noted concurrently with the record of their size. The addition of 
0.5 mM theophylline to cultures drastically reduced the number of herpes 
plaques in VERO cells (Table ll) in the presence or absence of potassium 
fluoride. On the other hand, potassium fluoride enhanced the total 
number of plaques.
Similar experiments with various drug treatments were instigated 
to compare the action of the drugs on the replication cycle of herpes.
The number of plaque forming units resulting from a single cycle of 
replication was reduced by 0.5 mM theophylline, but unaffected by 
1 mM potassium fluoride (Table 13).
To summarise, 0.5 mM theophylline inhibited the replication of 
herpes virus and the formation of plaques (size and number) in VERO cells. 
However, in contrast the replication cycle and the size of plaques was 
unaffected by potassium fluoride, while the number of plaques was 
increased.
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TABLE 11. Number of herpes virus plaques developed 4 days after 
inoculating VERO cells: cell cultures prepared over
4 days; drugs and inoculum added simultaneously
Addition of potassium fluoride . «Addition of
1 -M 0.5 mM 0 theophylline
65, 26 52, 64 40, 39 0.5 mM
144, 156 132, 133 155, 141 0.25 mM
215, 207 163, 186 161, 156 0.125 mM
212, 209 259, 236 172, 150 0
TABLE 12. Visual appearance of herpes virus plaques 4 days after
inoculation of VERO cells: cultures prepared over 4 days;
drugs and inoculum added simultaneously. Figures 
represent percentage of plaques in each descriptive class
Concentration 
of theophylline 
(mM)
Concentration 
of KF (mM)
Appearance of plaque
Foci of n 
,. ,, Dead cells live cells Hole
0 0 28.1 53.1 18.9
0 0.5 100 0 0
0 1 0.5 93.2 3
0.125 0 5.2 90.3 4.5
0.125 0.5 0.7 97.9 1.4
0.125 1 0 92.4 7.6
0.25 0 0 99.2 0.8
0.25 0.5 0 97.2 2.2
0.25 1 0 100 0
0.5 0 0 100 0
0.5 0.5 0 100 0
0.5 1 0 100 0
TABLE 13, Effect of drugs on the yield of plaque forming units
resulting from a single cycle infection of herpes virus 
in VERO cells: cultures prepared over 4 days;
drugs added immediately after inoculation
Additions to medium :
None 1 mM KF 0,5 mM Theophylline
9 16 0
16 19 7
Titre x 10“5 15 12 1
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Effect of theophylline on the size of herpes virus plaques 
in HEp-2 cells: cells inoculated and treated 24 hours after
seeding
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TABLE 14. Effect of drugs on the yield of infectious plaque forming 
units resulting from a single cycle infection of herpes 
virus in HEp-2 cells: cultures prepared within 24 hours;
drugs added immediately after inoculation
None
Additions to medium : 
0.5 mM Theophylline
0.5 mM Theophylline 
+ 0.5 mM KF
Titre x 5.10-4
58
42
55
69
50 
70 
56
51
45
34
71
40
TABLE 15. Effect of drugs on the yield of infectious particles
released from HEp-2 cells after a single cycle infection 
with herpes virus: cultures prepared within 24 hours;
drugs added immediately after inoculation
Titre of 
virus released
x lO**2
None
28
21
24
33
Additions to medium :
n k u -pl u ii • 0*5 mM Theophylline0.5 mM Theophylline + Q>g JJ ^
290
280
119
256
35
31
36
32
TABLE
TABLE 17.
Titre x
>. Effect of theophylline on the formation of herpes virus 
plaques in HEp-2 cells: cultures prepared over 4 days;
drug and inoculum added simultaneously
Concentration of ,
, / »,\ Number of plaquestheophylline IpMJ
0.5 25, 36
0.25 30, 47
0.125 64, 30
0 38, 59
Yield of herpes virus after a single replication 
cycle in HEp-2 cells pretreated with drugs
Additions to medium :
None 0.5 mM Theophylline °-5 J ^ o p h y U ine
   ^ -----  + 0.5 mM KF
55 8 15
56 14 8
41 8 7
51 8 15
TABLE 18. Effect of cholera toxin on the number of
herpes virus plaques developed 4 days after 
inoculating HEp-2 cells: cultures prepared
within 24 hours; cholera toxin added 
immediately after inoculation
Doses of cholera toxin 
0 2 200
285 213 331
240 234 327
TABLE 19. Number of herpes virus plaques in HEp-2 cells: 
cultures inoculated 4 days after seeding and 
treated immediately after inoculation
Doses of cholera toxin 
0 2 200
82 68 53
79 81
TABLE 20. Number of herpes virus plaques in
HEp-2 cells pretreated with cholera toxin
Doses of cholera toxin 
0 2 200
84 105 103
73 87
Herpes virus infection of HEp-2 cells : Herpes virus generally developed
smaller plaques in HEp-2 cells than in VERO cells: the maximum size for
2
plaques in untreated HEp-2 cultures was generally below 0,2 mm (Figs. 29 
and 30). However, the results of this study show that the size of plaques 
could be increased by treatment with suitable drugs.
An increase in the proportion of larger plaques developed in HEp-2 cells
f ■
resulted from the addition of theophylline to the medium immediately after 
the inoculation of one or four day old cultures (Figs. 29, 30 and 31).
However plaque size was not altered by pretreatment of cells with 
theophylline (Fig. 32). The number of plaques developed in a four day old 
culture in the presence of theophylline was observed. In 0.125 mM 
theophylline (which slightly inhibited the growth of larger plaques) and 
0.25 mM (which slightly enhanced the growth of larger plaques) there was 
no effect on the total number of plaques, but in 0.5 mM theophylline the 
total number of plaques was reduced (Table 16).
Plaque size was increased to a greater extent by treating one day old 
HEp-2 cultures with cholera toxin immediately after inoculation (Fig. 33).
An increase in the plaque size induced by 200 doses of cholera toxin was 
accompanied by an increase in plaque number (Table 18). No effect on the 
plaque number was observed in four day old cultures treated with 
cholera toxin (Table 19)•
The replication cycle of herpes virus in HEp-2 cells was shown to be 
susceptible to theophylline, and in some cases this parallelled the effects 
on plaque size and number. In all cultures the majority of herpes virus 
was cell bound (Tables 14 and 15); however when one day old HEp-2 cultures 
were treated with 0.5 mM theophylline the amount of virus released from 
the cells after a single cycle was greatly increased (Table 15)• This 
effect was not observed in the presence of 0.5 mM potassium fluoride 
(Table 15).
Pretreatment of HEp-2 cells with 0,5 mM theophylline alone or with 
0.5 mM potassium fluoride resulted in reduced titres of herpes virus after 
a single replication cycle (Table 17). Despite an inhibition of the 
replication cycle at 0.5 mM, pretreatment of HEp-2 cells with lower 
concentrations did not affect the size of herpes plaques subsequently 
formed (Fig. 32). In contrast to this, pretreatment with cholera toxin 
slightly increased the number of plaques formed (Table 20).
In summary, although herpes plaques in HEp-2 cells were small 
compared with those in VERO cells, the size could be increased by treating 
with theophylline or cholera toxin immediately after inoculation. In 
some cases, such as treatment of one day old cultures with theophylline, 
there was a similar effect on the replication cycle.
Polio virus infection of VERO cells : The virus produced large plaques
in the cell monolayers and the surrounding cells appeared grey rather than 
blue when stained with methyl violet. Within two days plaques had an 
area of 3 mm (Figs. 35 and 36), but one day later there was an increase 
to 15 - 20 mm^ (Fig. 34).
As with herpes virus, theophylline tended to inhibit the formation 
of plaques. Both theophylline and potassium fluoride reduced the 
proportion of large plaques produced when the cells were inoculated 
either one or four days after seeding (Figs. 34 and 35). Both drugs 
simultaneously reduced the number of plaques when four day old cultures 
were inoculated (Table 22), but not one day old cultures (Table 21)•
However, VERO cells which were pretreated with 0.125 mM theophylline 
showed enhanced development of large plaques (Fig. 36), while 
0.5 mM potassium fluoride reduced plaque development under these 
conditions: the drugs had similar effects on plaque number (Table 23) .
theophylline reducing the number and potassium fluoride increasing it.
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TABLE 21. Effect of theophylline and potassium fluoride on 
the number of polio plaques formed in VERO cells: 
cultures infected and treated 24 hours after seeding
Addition 
1 mM
of potassium 
0.5 mM
fluoride
0
Addition of 
theophylline
74, 67 86, 84 85, 98 0.5 mM
85, 82 82, 86 71, 66 0.25 mM
87, 81 70, 76 74, 83 0.125 mM
89, 99 103, 92 88, 86 0
TABLE 22. Effect of theophylline and potassium fluoride on 
the number of polio plaques formed in VERO cells: 
cultures infected and treated 4 days after seeding
Addition of potassium fluoride , .... .* Addition of
1 mM 0.5 roM 0 theophylline
0 0, 0 2, 2 0.5 roM
0 3, 4 4, 2 0.25 mM
6 3, 6 10, 10 0.125 mM
5 8,15 9, 8 0
TABLE 23. Effect of potassium fluoride and theophylline 
pretreatment of VERO cells on the number of 
polio plaques formed
Addition of drugs 
None 0.5 mM KF 0.125 mM Theophylline
246 441 203
290 372 233
y
TABLE 24. Effect of cholera toxin on the number of
polio plaques formed in VERO cells:* cultures 
inoculated and treated 24 hours after seeding
Doses of cholera toxin
_0_________ 2______200
80 67 65
76 56 69
TABLE 25. Effect of cholera toxin on the yield of
polio virus after a single replication cycle 
in VERO cells: cultures inoculated and
treated 24 hours after seeding
Doses of cholera toxin
_0________ 2______200
35 34 31
Titre of yield 32 32 26
x 10~5 29 42 33
34
TABLE 26.
Titre of yield 
x IQ'5
TABLE 27.
Effect of cholera toxin on the yield of 
polio virus after a single replication 
cycle in VERO cells: cultures inoculated
and treated 4 days after seeding
Doses of cholera toxin
_0________ 2_____ 200
36 38 44
36 45 34
33 42 40
35
Effect of cholera toxin pretreatment of 
VERO cells on the number of polio 
plaques formed
Doses of cholera toxin 
_0_________2 200
35 18 26
39 13 19
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TABLE 28. Effect of theophylline and potassium fluoride on the 
yield of polio virus after a single replication cycle 
in HEp-2 cells: cultures inoculated and treated
24 hours after seeding
Additions to medium
None 0.125 mM Theophylline °*125 ^Theophylline
+ 1 mM KF
Titre of cell- 41.6 26.4 43.4
associated 
virus x 10 6
38.0 26.4 41.8
45.4 40.8 45.0
38.6 38.8 52.6
30.0 39.2 41.6
Titre of 12.2 6.2 9.3
released 13.1 10.0 9.6
virus x 10 6
12.4 12.0 11.0
13.1 10.8 9.0
TABLE 29.
Titre of yield 
x 10‘6
TABLE 30.
—fi
Titre x 10”
Yield of polio virus after a single cycle of 
infection in HEp-2 cells in the presence of 
cholera toxin: cultures inoculated and
treated 24 hours after seeding
Doses of cholera toxin 
_0_______________ 200
38 48
48 60
39 45
32 41
Effect of cholera toxin on the yield of 
polio virus after a single replication cycle 
in HEp-2 cells: cultures inoculated and
treated 4 days after seeding
Doses of cholera toxin
_0________________ 200
49 66
83 79
39 59
61
TABLE 31. Effect of cholera toxin on the number of
polio plaques in HEp-2 cells: cultures inoculated
and treated 24 hours after seeding
Doses of cholera toxin
JO_________2_______200
143 139 131
118 119 123
TABLE 32. Effect of cholera toxin on the number of
polio plaques in HEp-2 cells: cultures inoculated
and treated 4 days after seeding
Doses of cholera toxin
_0________ 2______200
81 72 81
62 69 75
TABLE 33. Effect of cholera toxin pretreatment on the
number of polio plaques formed in HEp-2 cells
Doses of cholera toxin
_0________ 2______200
44 48 47
45 44 33
Cholera toxin had no effect on the yield of polio virus after a 
single replication cycle in one or four day old cultures (Tables 25 and 26), 
nor on the size of plaques formed in one day old (Fig. 37) or pretreated 
cultures (Fig. 38), but there was a slight reduction in the number of 
plaques in one day old (Table 24) and pretreated cultures (Table 27). J 
To summarise, theophylline and potassium fluoride inhibited 
infection of cells if cultures were treated immediately after inoculation. 
However, the reverse effect was observed when cells were pretreated with 
theophylline, which led to an increase in the size and number of plaques.
Cholera toxin was virtually ineffective.
Polio virus infection of HEp-2 cells : The size and appearance of
plaques developed in these cells were similar to those in VERO cells. 
Theophylline had a similar inhibitory effect on the production of plaques afte 
inoculation of one day old cultures (Fig. 39) but no effect after inoculation 
of four day old cultures (Fig. 40). The reduction in plaque size in 
one day old cultures was parallelled by a reduced yield after a single 
replication cycle (Table 28). In contrast to this, potassium fluoride had 
an enhancing effect on plaque size in these cultures (Figs. 39 and 40).
As with VERO cells, both these drugs had an enhancing effect on the 
subsequent development of plaques when the cells were pretreated (Fig. 41)• 
Cholera toxin did not affect the yield of single cycles of replication 
in one or four day old cultures (Tables 29 and 30). Nor did it affect the 
number or size of plaques in one day old cultures (Table 31, Fig. 42), or 
the number of plaques in four day old cultures pretreated or treated 
immediately after inoculation (Tables 32 and 33). However, pretreatment 
of HEp-2 cells with cholera toxin did increase the size of plaques 
(Fig. 43).
In summary, theophylline tended to have an inhibitory effect on 
virus infection in these cells, unless the cells were pretreated, when
the effect on plaque size was reversed. Potassium fluoride, on the 
other hand, enhanced virus infection while polio replication appeared to 
be resistant to cholera toxin treatment.
Mengo virus infection of VERO cells : Mengo produced large plaques
in these cell monolayers: after only two days there were large holes,
2
up to 35 mm in area, which appeared white against a blue background, 
with a few live cells surviving in the centre of the plaques.
The number of Mengo plaques developed in one day old VERO cells was 
unaffected by the presence of theophylline or potassium fluoride (Table 34); 
however, theophylline tended to increase the plaque size, while potassium 
fluoride decreased it (Fig. 44). Parallel effects were observed on the 
yield of virus after a single cycle of replication: theophylline increased
the yield while potassium fluoride decreased it (Table 35). However, 
cholera toxin had no effect on the yield of virus in a one day old culture.
Four day old cultures produced dissimilar results. As with one day 
old cultures, theophylline did not affect the number of plaques formed: 
in contrast, potassium fluoride reduced the number of plaques (Table 36). 
Cholera toxin, which had no effect on virus yield in one day old cultures 
(Table 37), had an inhibitory effect on the virus yield (Table 38) and 
number of plaques produced in four day old cultures (Table 39). The 
number of plaques formed in four day old cultures was unaffected by 
pretreatment with theophylline or potassium fluoride (Table 40), but was 
inhibited by pretreatment with cholera toxin (Table 41).
In contrast, pretreatment with any of these drugs ‘led to an increase 
in plaque size (Figs. 45 and 46).
These observations are easily summarised. Injone day old VERO cells 
theophylline enhanced and potassium fluoride inhibited replication of 
Mengo virus. Four day old cultures were susceptible to inhibition of
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TABLE 34. Number of Mengo virus plaques formed in VERO cells
in the presence of theophylline and potassium fluoride: 
cultures infected and treated 24 hours after seeding
Potassium fluoride (mM)
1 0.5 0
58, 73 47 64, 53
70, 62 66, 48 63, 55
70, 56 60, 62 78, 74
65, 52
COID 73 62, 56
Theophylline (mM)
0.5
0.25
0.125
0
TABLE 35. Effect of theophylline and potassium fluoride on the 
yield of Mengo virus after a single replication cycle 
in VERO cells: cultures infected and treated
24 hours after seeding
Addition of drugs 
None 0.5 mM Theophylline 1 mM KF
74 104 55
86 123 50
84 102 58
72 - 110 64
80 97 80
85
TABLE 36. Effect of theophylline and potassium fluoride on 
the number of Mengo virus plaques formed in 
VERO cells: cultures infected and treated
4 days after seeding
Potassium fluoride (mM)
1 _ 0 Theophylline (mM)
52, 45 67/ 66 71, 68 0.5
54, 44 51, 73 67, 73 0.25
39, 51 58, 59 77, 66 0.125
39, 41 59, 60 76, 80 0
TABLE 37. Yield of Mengo virus after a single replication 
cycle in VERO cells in the presence of cholera 
toxin: cultures infected and treated 24 hours
after seeding
Doses of cholera toxin
0 2 200
530 455 514
Titre of virus
515 425 494
-4
x 10
526 452 495
621
TABLE 38. Yield of Mengo virus after a single replication 
cycle in VERO cells in the presence of cholera 
toxin: cultures infected and treated 4 days
after seeding
Doses of cholera toxin
Titre of virus 
x 10-5
0 2 200
205 154 110
173 154 146
174 151 109
162
TABLE 39. Effect of cholera toxin on the number of Mengo virus 
plaques formed in VERO cells: cultures inoculated
and treated 4 days after seeding
Doses of cholera toxin 
0 2 200
61 19 22
38 17 22
TABLE 40. Effect of theophylline and potassium fluoride 
pretreatment of VERO cells on the number of 
Mengo virus plaques subsequently formed
Potassium fluoride (mM) Theophylline (mM)
1 0.5 0
99, 88 96, 95 99, 90
107, 102 117, 107 81, 91
81, 105 116, 103 88, 90
103, 101 93, 109 100, 105
0.5
0.25
0.125
0
TABLE 41. Number of Mengo virus plaques developed in 
VERO cells pretreated with cholera toxin
Doses of cholera toxin 
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TABLE 42. Number of Mengo virus plaques formed in HEp-2 cells
pretreated with potassium fluoride and theophylline
TABLE
Titre x 2.
Potassium fluoride (m>l) Theophylline
195, 209 215, 203 192, 193 0.5
186, 190 214, 237 213, 253 0.25
213, 222 247 220, 213 0.125
217, 206 264, 267 260, 252 0
43. Yield of Mengo virus after a single replication
cycle in HEp-2 cells pretreated with theophylline 
or potassium fluoride
Control
90
98
10“6 102 
117 
106
Theophylline 
(0.5 mM)
104
104
105 
102 
128
Potassium fluoride 
______ (1 mM)
138 
134 
121 
134
TABLE 44. Number of Mengo virus plaques developed in the
presence of cholera toxin in HEp-2 cells: cultures
inoculated and treated 24 hours after seeding
TABLE 45.
Titre x 
0*5.10“5
Doses of cholera toxin 
JO_________2_______200
172 162 191
165 138 138
Yield of Mengo virus after a single replication 
cycle in HEp-2 cells: cultures inoculated and
treated 24 hours after seeding
Doses of cholera toxin
_0________ 2 200
113 113 94
106 105 110
107 116 95
115
TABLE 46. Yield of Mengo virus after a single replication 
cycle in HEp-2 cells: cultures inoculated and
treated 4 days after seeding
Doses
0
of cholera 
2
toxin
200
142 220 167
Titre x 10 ^ 201 217 160
167 189 146
150 159
TABLE 47. Number of Mengo virus plaques developed in the
presence of cholera toxin in HEp-2 cells:
cultures inoculated and treated 4 days after seeding
Doses of cholera toxin
_0________ 2______ 200
281 289 298
284 245
TABLE 48. Number of Mengo virus plaques formed in HEp-2 cells 
pretreated with cholera toxin
Doses of cholera toxin
_0________ 2______ 200
210 342 224
180 314 197
Mengo replication by cholera toxin and potassium fluoride, but not by 
theophylline.
Pretreatment with any of the drugs led to an increase in plaque size 
which was not accompanied by an increase in plaque number.
Mengo virus infection of HEp-2 cells : Plaques were much smaller in
2
these monolayers than in VERO cells, growing to a maximum size of 6 mm 
after 2 days.
Theophylline and potassium fluoride tended to produce opposing effects. 
Theophylline treatment of the cells led to an increased proportion of 
larger plaques in four day cultures, even in the presence of potassium 
fluoride (Fig. 47). However, after potassium fluoride treatment there 
was a decreased proportion of larger plaques (Fig. 47). Although the 
two drugs had the same inhibitory effect on plaque number in pretreated 
cells (Table 42), theophylline increased the proportion of larger plaques 
while potassium fluoride reduced it (Fig. 48). At the same concentrations 
theophylline did not affect the single cycle yield, although potassium 
fluoride may have slightly stimulated it (Table 43).
The number of plaques (Table 44) and the single cycle yield (Table 45) 
were unaffected by cholera toxin treatment of cells immediately after 
inoculation. Postponing the inoculation and treatment for four days 
did not alter this (Tables 46 and 47). Similarly the size of plaques 
in one day old cultures was unaffected by cholera toxin (Fig. 49)•
However, pretreatment with cholera toxin was followed by an increased 
proportion of large plaques in the monolayers (Fig. 50) and an increased 
number of plaques (Table 48).
It therefore appears that Mengo plaque formation in HEp-2 cells 
may be enhanced by theophylline, inhibited by potassium fluoride, but 
is insusceptible to cholera toxin treatment. Only when the cells were 
pretreated were these general observations contradicted.
Semliki Forest virus infection of VERO cells : The size of the plaques
varied according to the age of the monolayer at the time of inoculation.
Thus, cultures inoculated one day after seeding allowed plaques as large 
2
as 12 mm to develop within 2 days, but when inoculation was postponed
until four days after seeding the maximum size of plaques after a further
22 days was only 7 mm .
In the presence of 0.125 mM theophylline inoculation of one day old
2
cultures gave rise to plaques as large as 16 mm and the maximum size was
2
further increased to 18 ram at higher concentrations of theophylline
(Fig. 51). Treatment of parallel cultures with potassium fluoride
similarly led to an increased proportion of larger plaques, with a
maximum size of 16 mm (Fig. 51). The addition of various concentrations
of theophylline together with 0.5 mM potassium fluoride also increased the
maximum plaque size. This was not always observed in the presence of
1 mM potassium fluoride and theophylline; however, in every case the
2 2modal value was increased from 2 - 4 ram to 4 - 6 mn or even higher.
The increased plaque size could not be explained by increased rates 
of replication, as both theophylline and potassium fluoride reduced the 
yield after a single cycle of replication in one day cells (Table 49).
Theophylline had a stimulatory effect on the size (Fig. 52) and 
number (Table 50) of plaques when monolayers were inoculated four days 
after seeding. Once again, the increase in size could not be explained
by an increase in the replication rate as the yield of Semliki Forest virus
after a single replication cycle in four day old cells was unaffected by 
theophylline (Table 51), but there was a reduction of virus released into 
the medium (Table 52)*
In contrast, potassium fluoride enhanced the single cycle yield 
(Table 51) and the number of particles released (Table 52), reduced the
number of plaques formed (Table 50), but had no effect on the size of
plaques (Fig. 52) in four day old cultures of cells.
Pretreatment of cells with both drugs, independently and together,
led to an increased proportion of larger plaques (Fig. 53). There was
a slight increase in the number of plaques following potassium fluoride
pretreatment, and a decrease in the number of plaques following pretreatraent
with theophylline (Table 53).
Cholera toxin did not affect the single cycle yield in one (Table 54)
or four (Table 55) day cultures, but slightly reduced the number of plaques
in one day cultures (Table 56), and cultures treated before inoculation
(Table 57), but not their size (Fig. 54).
To summarise, theophylline enhanced the size and number of Semliki
Forest virus plaques in VERO cells, whereas potassium fluoride enhanced
plaque formation in one day cultures and inhibited it in four day cultures.
Cholera toxin slightly reduced the formation of plaques. The effects of
the drugs could not be explained by a change in the rate of replication.
As with other viruses, pretreatment of cell cultures with drugs led to
larger plaques on subsequent infection.
Semliki Forest virus infection of HEp-2 cells : Semliki produced
slightly smaller plaques in these monolayers compared with VERO cultures;
when cultures were inoculated 24 hours after seeding, within 2 days
2plaques developed up to 11 mm , but when cultures were inoculated 4 days
2
after seeding, 2 days later the maximum size of plaques was only 4 mm .
The effects of theophylline and potassium fluoride on plaque size 
and replication of virus were often contradictory. Theophylline had 
no effect on the size (Fig. 55) or number (Table 58) of plaques in 
cultures inoculated and treated 24 hours after seeding, while potassium 
fluoride had an inhibitory effect on both parameters.
In four day old cultures the number (Table 59) and size (Fig. 56) of 
plaques were stimulated by the presence of theophylline and inhibited by 
the presence of potassium fluoride.
When cultures were pretreated with theophylline the size of plaques 
was increased (Fig. 57), while the number of plaques (Table 60) and the 
yield of a single cycle of replication (Table 61) were unaffected. 
Pretreatment of parallel cultures with potassium fluoride did not affect 
the size of plaques (Fig. 57), but the yield of a single replication cycle 
(Table 61) and the total number of plaques (Table 60) were reduced.
Pretreatment before inoculation (Table 64) but not treatment after 
inoculation (Tables 62 and 63) with cholera toxin increased the number 
of plaques. The yield of a single replication cycle was unaffected by 
cholera toxin treatment immediately after inoculation (Tables 65 and 66), 
but the size of plaques was slightly increased by cholera toxin treatment 
of one day old cultures (Fig. 58) or pretreatment of four day old 
cultures (Fig. 59)•
To summarise, theophylline tended to have a stimulatory effect on 
Semliki Forest virus infections of HEp-2 cells, while potassium fluoride 
was inhibitory. The cultures were generally resistant to cholera toxin 
treatment.
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TABLE 49.
Titre of 
yield x 
0*5.10"5
TABLE 50.
Yield of Seraliki Forest virus after a single 
replication cycle in one day old VERO cells, 
in the presence of theophylline and potassium 
fluoride
, . 1 mM Potassium
No drug 0.5 mM Theophylline fluoride
125 43 74
147 35 98
124 35 106
131 27 77
118
Number of Semliki Forest virus plaques formed in 
VERO cells in the presence of theophylline and 
potassium fluoride: cultures inoculated and
treated 4 days after seeding
Potassium fluoride (mM) Theophylline (mM)
1 0.5 0
39, 44 51, 51 67, 54 0.5
47, 40 49, 37 53, 50 0.25
25, 41 44, 52 44, 41 0.125
28, 12 40, 44 37, 44 0
TABLE 51.
Titre of 
virus yield 
x 0*5.10“4
TABLE 52.
Titre x 
0*2.10~4
Effect of theophylline and potassium fluoride on 
the yield of Semliki Forest virus after a single 
replication cycle in VERO cells: cultures
inoculated and treated 4 days after seeding
No drug 0.
239
219
228
242
256
mM Theophylline
233
258 
240
259 
238
1 mM Potassium 
fluoride
339
343
323
321
Yield of Semliki Forest virus released from VERO cells 
after a single cycle of replication: cultures infected
and treated 4 days after seeding
Additions to medium
~  ^ 1 mM Potassium „ , .
0.5 mM Theophylline fluoride Control
38 135 88
40 114 93
43 118 98
33 149 114
TABLE 53. Number of Semliki Forest virus plaques formed 
in VERO cells pretreated with theophylline and 
potassium fluoride
Potassium fluoride (mM) Theophylline (mM)
1 0.5 0
53, 59 64, 70 67, 64 0.5
67, 66 65, 79 64, 69 0.25
72, 84 96, 108 88 0.125
96, 79 133, 95 78 0
TABLE 54. Effect of cholera toxin on the yield of
Semliki Forest virus in VERO cells: cells
inoculated and treated 24 hours after seeding
Doses of cholera toxin
0 2 200
Titre x 469 472 472
0-2.10~3 458 478 448
435 431 502
443
TABLE 55. Effect of cholera toxin on the yield of
Semliki Forest virus in VERO cells: cells
inoculated and treated 4 days after seeding
Doses of cholera toxin 
0 2 200
Titre x 458 453 450
0*5.10“5 446 389 355
413 360 376
483
TABLE 56. Effect of cholera toxin on the number of
Semliki Forest virus plaques in VERO cells: 
cultures inoculated and treated 24 hours 
after seeding
Doses of cholera toxin
0_________ 2_____ 200
80 67 65
76 56 69
TABLE 57* Effect of cholera toxin pretreatment of VERO cells
on the number of Semliki Forest virus plaques formed
Doses of cholera toxin
_0________ 2______ 200
22 8 8
17 13 9
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\TABLE 58. Number of Semliki Forest virus plaques formed in 
HEp-2 cells: cultures inoculated and treated
24 hours after seeding
Potassium fluoride (mM) Theophylline (mM)
1 0.5 0
60, 58 - - 0.5
- 71, 76 71, 93 0.25
59, 74 64, 79 75, 75 0.125
56, 64
oCO00 80, 78 0
TABLE 59. Number of Semliki Forest virus plaques formed in 
HEp-2 cells in the presence of theophylline and 
potassium fluoride: cultures inoculated and
treated 4 days after seeding
Potassium fluoride (mM) Theophylline (mM)
1 0.5 0
289, 276 338, 292 362, 362 0.5
241, 285 296, 276 321, 290 0.25
216, 246 240, 256 347, 335 0.125
208, 187 277, 276 284, 286 0
TABLE 60. Number of Semliki Forest virus plaques formed in 
HEp-2 cells pretreated with potassium fluoride 
and theophylline
Potassium fluoride (mM) Theophylline (mM)
1 0.5 0
197, 169 246, 232 257, 280 0.5
179, 167 258, 244 245, 243 0.25
176, 179 287, 256 229, 231 0.125
212, 184 271, 238 282, 248 0
TABLE 61. Yield of Semliki Forest virus in HEp-2 cells 
pretreated with theophylline and potassium 
fluoride
Additions to medium
s u m«. . ill 1 mM Potassium
None 0.5 mM Theophylline fluoride
116 118 94
Titration of 108 105 99
yield x 10"5 104 108 86
111 103 94
101
TABLE 62. Effect of cholera toxin on the number of
Semliki Forest virus plaques in HEp-2 cells: 
cells inoculated and treated 24 hours after 
seeding
Doses of cholera toxin
0 2 200
171 170 159
141 127 149
155 132 152
TABLE 63. Number of Semliki Forest virus plaques formed
in HEp-2 cells in the presence of cholera toxin: 
cultures inoculated and treated 4 days after seeding
Doses of cholera toxin
_0________ 2______ 200
302 306 322
310 281 266
TABLE 64. Number of Semliki Forest virus plaques formed 
in HEp~2 cells pretreated with cholera toxin
Doses of cholera toxin
_0________ 2______ 200
102 166 237
141 183 198
TABLE 65. Yield of Semliki Forest virus after a single
cycle of infection in HEp-2 cells in the presence 
of cholera toxin: cultures inoculated and
treated 24 hours after seeding
Doses of cholera toxin
0 2 200
52 60 51
69 49 49
53 67 38
54
TABLE 66. Yield of Semliki Forest virus after a single 
cycle of infection in HEp-2 cells in the 
presence of cholera toxin: cultures inoculated
and treated 4 days after seeding
Doses of cholera toxin
0 2 200
57 58 65
60 48 36
53 55 39
34
DISCUSSION
In the introduction to this thesis the ubiquitous and varied role 
of cyclic AMP was stressed. Some of the apparently contradictory 
published results probably reflect the methodology of its assay and the 
failure to standardize experimental conditions.
One important feature of this work is that the measured values of 
cyclic AMP in VERO cells (100 - 300 pmole/mg protein) and HEp-2 cells 
( 3 - 1 3  pmole/mg protein) were reproducible. Thus the fact that on 
no occasion did infection with herpes virus or polio virus lead to a 
significant difference in intracellular levels of cyclic AMP must be 
accepted as valid.
One of the problems in the assay of cyclic AMP has been to decide 
against which cell parameter it should be compared. In this work, for 
instance, comparison of cyclic AMP levels against cell number rather than 
protein content did not greatly change the interpretation of the results. 
Although, for example, 24 hours after VERO cells were inoculated with 
herpes virus infected and control cultures showed approximately equivalent
Q
concentrations of cyclic AMP per 10 cells, infected cultures . 
showed reduced levels of cyclic AMP per mg protein. This possibly 
indicated reduction in viable cell numbers due to the disintegration of 
cells with consequent loss of cyclic AMP but the retention of cell protein.
Another discrepancy of experimental results concerns the unusually 
high levels of cyclic AMP found in HEp-2 cells which had been cooled to 
4°C prior to inoculation with virus. The levels of cyclic AMP in cultures 
which had been cooled were virtually double those found in cultures 
maintained at 37°C, but the intracellular cyclic AMP remained unaffected 
by the subsequent infection with herpes virus. The influence of cooling
on cyclic AMP levels has been previously recognised; for instance, in 
cooled adipose tissue there was an increased basal activity of adenyl 
cyclase (Kuriyama and Israel, 1973).
As a general rule the cyclic AMP values were calculated together with 
their standard deviation, and much of the variation was found to be due to 
error inherent in the cyclic AMP assay, which meant that any changes which 
might occur would be too slight for detection. So the apparent insensitivity 
of cyclic AMP in VERO and HEp-2 cells to infection by herpes virus or 
polio virus observed during this study can be compared with the diversity 
of effects described by other investigators. For instance, the methods 
applied in this study were similar to those described by Stanwick et al. (1977) 
who reported a decrease in cell concentration of cyclic AMP six hours after 
inoculation with herpes virus type 1, leading to a new steady level, 5056 less 
than the control cultures. Similar investigations of human skin fibroblasts 
showed reduced intracellular cyclic AMP 6 to 24 hours post inoculation 
with 50 pfu herpes virus type 1 per cell, compared with uninfected cultures 
(Trofatter and Daniels, 1980). The major difference between these 
publications and the present work is the multiplicity of infection.
Similar and consistent results for HEp-2 and human fibroblasts were 
obtained by Stanwick et al. (1977) with an inoculum of 50 pfu virus per 
cell, but in the present study the multiplicity of infection varied from 
less than 1 to 10. So since data has not been published for cultures 
infected with less than 10 pfu virus per cell, it is not possible to 
compare directly these two studies. In contrast another investigation 
of herpes virus infection, but of BHK-21 cells (Bittlingmaier et al., 1977a), 
showed a 50 - 75% increase in intracellular cyclic AMP between 4 and 
8 hours post inoculation with a multiplicity of infection of 10 - 20.
These apparently contradictory results affirm that there is no simple
correlation between herpes virus and cyclic AMP, but suggest that other 
factors may play significant roles in the altering of cyclic AMP levels in 
infected cultures, such as cell type and culture conditions, strain of 
virus, multiplicity of infection, and methods for the preparation of the 
inoculum. Of these factors the multiplicity of infection may be one of 
the most influential and is certainly a factor influencing other events; 
for instance the inoculation of BSC-1 cells with a high multiplicity of 
infection by herpes virus has been shown to lead to a reduced titre of 
infectious progeny and an increased production of defective DNA 
(Becker et al., 1978), indicating that the multiplicity of infection may 
alter the metabolism of an infected culture qualitatively as well as 
quantitatively. It is interesting to note that multiplicity of infection 
as high as 100 have only been found in the study of cyclic AMP 
(Stanwick et al., 1977) and defective DNA (Becker et al., 1978), while 
other biochemical studies have involved much lower multiplicities of 
infection: 4 - 1 0  pfu/cell for the study of thymidine kinase (Halliburton
et al., 1980; Wallace et al., 1980), antigens (Randall et al., 1980), 
and DNA (Hay and Hay, 1978); and 10 - 20 for the study of DNA (Fenwick 
and Walker, 1978), and cell surface changes (Thompson et al., 1978).
Some doubt is cast on the usefulness of the information gained from studies 
with the exceptionally high multiplicities of infection which are required 
for reproducible results of intracellular cyclic AMP concentrations, because 
of the lack of information about metabolism under these circumstances.
Other factors which influenced the relationship between cyclic AMP 
and virus infections were revealed by those complementary studies on the 
interference of cyclic AMP function in virus infected cells. Despite 
differences in culture methods and procedures for drug treatment, 
different laboratories report similar effects of theophylline on the
replication of viruses in vitro. In the present study inhibition of 
herpes virus replication in VERO cells was recorded, manifested by a 
reduction in plaque size and number which confirmed previous reports of 
herpes virus inhibition by theophylline: for instance, reduction in the
yield of herpes virus and the size of herpes virus plaques in VERO cells 
treated with theophylline (Bittlingmaier et al., 1977a; Harbour et al., 1978); 
the similar influence of theophylline on herpes virus yield in both 
HEp-2 cells and human fibroblasts (Stanwick et al•, 1977); and delay 
of growth and suppression of cell-to-cell spread of herpes virus type 1 
in human skin fibroblasts by theophylline, while the adsorption and 
penetration of the virus were unaffected (Trofatter and Daniels, 1980).
However, Stanwick (pers. comm.) has also observed that theophylline 
may enhance herpes virus replication in VERO cells, and the present study 
may provide an explanation for this apparent contradiction, where on the 
one hand an inhibition of herpes virus replication could be induced by 
theophylline when added after the inoculation of virus, but an enhancement 
of herpes virus replication when the VERO cells were pretreated with 
theophylline. That is to say, differences in the time of the administration 
of the drug may lead to a reversal of its effects.
This type of approach was extended to a range of cyclic AMP enhancing 
compounds (potassium fluoride and cholera toxin) and a variety of viruses 
(polio virus, Mengo virus and Semliki Forest virus), but without revealing 
any simple trends or general responses, although suggesting that a complex 
of factors may be important in the role of cyclic AMP during virus 
infections. Published observations along these lines include inhibition 
by dibutyryl cyclic AMP of adenovirus type 2 in three fibroblastic cell 
lines, BHK-21, HEK and WI-38, and in adenovirus 12-transformed BHK-21 cells 
with high intracellular levels of cyclic AMP, while dibutyryl cyclic AMP
had no effect on the replication of adenovirus type 2 in two tumour 
derived cell lines (Biron and Raska, 1973); stimulation by dibutyryl 
cyclic AMP of influenza and herpes virus type 1 growth in primary kidney 
cells but not WI-38 fibroblasts, while Sendai virus was unaffected 
(Maassab and Soltysiak, 1977); and enhancement of released soluble antigen 
of influenza virus when the virus interacted with isolated plasma membranes 
in high concentrations of cyclic AMP (Krizanova et al., 1977).
In the present study it was of interest that pretreatraent of cells 
which led to an increase in plaque size of the virus subsequently inoculated 
did not necessarily enhance other parameters of virus infection, for instance, 
yield of infectious virus. Thus, pretreatraent of HEp-2 cells with 
cholera toxin resulted in larger Mengo virus plaques but without a 
concurrent increase in yield after a single replication cycle. Similar 
results were observed with Semliki Forest virus in HEp-2 cells pretreated 
with theophylline, and with polio virus and Semliki Forest virus in 
theophylline pretreated VERO cells, and in no case was there an increase 
in plaque number. In some cases the application of drug at the same time 
as inoculation did not result in the enhancement of plaque size that 
resulted from pretreatment. This was true of theophylline treated HEp-2 
or VERO cells infected with polio virus. However, the enhancement of the 
size of herpes virus plaques in VERO cells following pretreatraent with 
either theophylline or potassium fluoride turned into a reduction in size 
when the cultures were treated at the time of inoculation.
The enhancement of plaque size in the absence of increased virus 
replication in pretreated cultures, but not those treated at the time of 
inoculation, was judged to be the result of toxic effects of the drugs 
on the cell cultures. This was supported by the observation that cell 
cultures kept for several days in high concentrations of drugs and
subsequently fixed and stained were visibly paler than control cultures, 
indicating fewer cells. By this criterion HEp-2 cells were more sensitive 
than VERO cells. Because of this obvious toxicity the results from 
pretreated cultures were set aside so far as the role of drugs on 
virus infections jln vitro were concerned.
Other factors which influenced the response of viruses to the drugs 
related to the age of the cell cultures at the time of inoculation and 
drug treatment. For example, theophylline markedly reduced the number 
of plaques formed in VERO cells inoculated four days after seeding, but 
not in similarly prepared HEp-2 cells. Potassium fluoride, in the 
presence and absence of theophylline, reduced the size of polio virus 
plaques in VERO cells but enhanced their size in HEp-2 cells. Cholera 
toxin reduced the yield of Mengo virus after a single replication cycle 
in VERO cells but not in HEp-2 cells, and reduced both the number of 
plaques developed in VERO cells and the single cycle yield, but had no 
effect on either parameters in HEp-2 cells. These results were not 
surprising as the cells were not only previously known to differ in 
derivation, morphology and culture conditions, but they had also been 
found to differ in their content of cyclic AMP, and furthermore,
VERO cells are known to be defective in the production of interferon 
(Desmyter et al., 1968).
The two viruses in this study which were most similar, polio virus 
and Mengo virus, differed in their responses to theophylline and potassium 
fluoride during in vitro infections. Theophylline reduced the number of 
polio virus plaques in VERO cells inoculated and treated 4 days after 
seeding, but had no effect in similarly prepared HEp-2 cultures. 
Theophylline treatment of HEp-2 cells reduced the size of polio virus 
plaques but increased the size of Mengo virus plaques, while potassium
fluoride treatment of HEp-2 cells increased the size of polio plaques but 
reduced the size of Mengo plaques. Hence, viruses which are similar in 
size, structure, RNA composition, mechanism of replication and physical 
properties (reviewed by Andrewes et al•, 1978) may show opposite responses 
to the drugs tested (Table 67).
The two viruses which reacted most similarly during these experiments 
were Mengo virus and Semliki Forest virus. Theophylline increased the 
size of plaques formed by both viruses in VERO cells inoculated the day 
after seeding, and in HEp-2 cells inoculated 4 days after seeding, 
whereas potassium fluoride had no effect on the size of plaques formed by 
either virus in HEp-2 cells inoculated and treated 4 days after seeding, 
but reduced the single cycle yield of both viruses in VERO cells inoculated 
and treated 1 day after seeding, and reduced the number of plaques formed 
by both viruses in VERO cells inoculated and treated 4 days after seeding.
Cholera toxin had no effect on the size of plaques produced by Mengo
or Semliki Forest viruses in HEp-2 cells inoculated and treated 1 day after
seeding. Nor was there any effect by cholera toxin on other parameters
of virus infections, number of plaques, single cycle yield of virus,
all in HEp-2 cells inoculated and treated either 1 or 4 days after seeding.
«
Despite these numerous similarities, there was a difference of response 
to potassium fluoride treatment by Mengo virus and Semliki Forest virus in 
VERO cells. Potassium fluoride increased the size of Semliki Forest virus 
plaques in cells inoculated and treated 1 day after seeding, but decreased 
the size of Mengo virus plaques in the parallel experiment. However, when 
the inoculation and treatment was postponed until the fourth day after 
seeding the size of Semliki Forest virus plaques was also slightly decreased 
in the presence of potassium fluoride. The other differing response was 
the yield after a single replication cycle in one day old VERO cells:
TABLE 67. Classification and some properties of the viruses investigated 
(Fenner, 1976; Andrewes et al., 1978)
Herpes virus Polio virus Mengo virus Semliki Forest virus
Family Herpetoviridae Picornaviridae Picornaviridae Togaviridae
Genus Herpesvirus Enterovirus Enterovirus Alphavirus
Nucleic Double stranded Single stranded Single stranded Single stranded RNA
acid DNA RNA RNA
Envelope + - - +
Size 180 nm 20 - 30 nm 20 - 30 nm 40 - 80 nra
Site of
replication Nucleus Cytoplasm Cytoplasm Cytoplasm
Natural
host Man Man Mice Unknown
potassium fluoride reduced the yield of Semliki Forest virus but had no 
effect on Mengo virus.
For the purposes of this study less importance may be attributed to 
these differences when the action of potassium fluoride on the metabolism 
of cyclic AMP is considered. Fluoride ions have been found to activate 
adenyl cyclase in broken cell preparations but not in whole cells although 
the ions can enter the cells (Birnbaumer et al., 197l). Fluoride ions 
have been administered to whole cells previously with the aim of enhancing 
the activity of adenyl cyclase (Maassab and Soltysiak, 1977) and on this 
occasion the titre of influenza virus was increased by serial passage in 
dibutyryl cyclic AMP, theophylline or sodium fluoride. In viral studies 
of this kind lysed cells may appear in a culture as a result of viral 
infection or trypsinizing during serial passage, whereupon the adenyl 
cyclase may be available for activation by fluoride ions. Whether the 
extra cyclic AMP formed could have any influence on intracellular metabolism 
would depend upon the permeability of the cell membranes to cyclic AMP and 
the action of cyclic nucleotide phosphodiesterases. Thus it does not 
seem reasonable to attribute effects resulting from incubating whole cells 
with potassium fluoride or sodium fluoride wholly to their action on 
adenyl cyclase. If, for these reasons, the effects of potassium fluoride 
are disregarded, it may be concluded that Mengo virus and Semliki Forest 
virus react similarly when the intracellular cyclic AMP of their hosts 
is increased.
Although Mengo virus and polio virus are classified in the same genus 
according to their physical parameters (Fenner, 1976; Andrewes et el., 1978), 
Mengo virus metabolism has been found to resemble that of Semliki Forest 
virus (Friedman and Buckler, 1972). Both Mengo virus And Semliki Forest 
virus are noted for their sensitivity to and strong induction of interferon,
and the production of Mengo virus RNA polymerase is inhibited in 
interferon-treated cells, as is the case with the analogous Semliki Forest 
virus enzyme (Miner et al., 1966; Sonnabend et al., 1967). If their 
analogous metabolism with regard to interferon is the underlying reason 
for the similar responses observed in the present work, it may be possible 
to treat cells with drugs capable of enhancing the action of interferon, 
thereby eliciting a wide spectrum antiviral activity.
The role of cyclic AMP in the action of interferon is more clearly 
defined than the role of cyclic AMP during virus infections. Interferon 
has been found to elevate intracellular cyclic AMP levels (Weber and 
Stewart, 1975; Meldolesi et al., 1977; Tovey et al., 1979), while 
cyclic AMP has been found to potentiate the antiviral activity of 
interferon (Friedman and Pastan, 1969; Allen et al., 1974; Weber and 
Stewart, 1975). The paradox of the wealth of corroborated information 
regarding cyclic AMP and interferon compared with the scanty, contradictory 
experimental findings with cyclic AMP and viruses may be explained by the 
varying ability of viruses to induce and respond to interferon, and a 
major difference in the practical procedures. The antiviral activity of 
interferon has been shown to be dependent on the multiplicity of infection 
(Stitz and Schellekens, 1980). In the studies of interferon multiplicities 
of infection of much less than 1 have been used (reviewed, Stitz and 
Schellekens, 1980); however in studies of cyclic AMP during productive 
virus infections multiplicities of infection as high as 100 have been 
applied (Stanwick et al., 1977) which, as discussed earlier, is much higher 
than for other biochemical studies. It may not be possible to solve this 
problem until cyclic AMP can be assayed without the use of large numbers of 
cells for a single value, perhaps by applying histocheraical techniques.
Despite the problems in elucidating the role of cyclic AMP in
productive virus infections, this study and others have shown that some 
viruses, under some conditions, are sensitive to alterations in 
intracellular cyclic AMP. Therefore drugs which alter levels of 
cyclic AMP should be suitable candidates for an antiviral screen.
However, it would be advisable to adapt current methods which have already 
been successful in the search for antiviral drugs (Herrmann, 1961) to 
account for the possible involvement of interferon. VERO cells which 
do not produce interferon should be avoided, and the formation of plaques 
under agarose would also be unsuitable for the detection of drug activities 
which enhance the action of interferon as the agarose would prevent the 
diffusion of interferon (Brown et al., 1980).
Already investigators have turned their attention to the possibility 
of manipulating the concentration of cyclic AMP by pharmacological means 
(reviewed by Breckenridge, 1970; Amer and McKinney, 1973; Araer and 
Kreighbaura, 1975; Weiss and Fertel, 1977). Amer (1977) believed the 
cyclic AMP system provides a powerful tool for the study of biochemical 
abnormalities in disease and could act as a useful stimulus to enhance 
and upgrade drug design.
The properties of the cyclic AMP system which should promote progress 
in this field include (a) the universal distribution of the system, 
suggesting that every cell is theoretically susceptible to exogenous 
chemical effectors; (b) the low levels of cyclic AMP, together with the 
signal amplification system which should allow drugs to be active at 
such low levels that they would be unable to exert other, possibly toxic,
effects; and (c) the existence of the system in cell cultures
(reviewed by Chlapowski et al., 1975).
By studying the cyclic AMP associated enzymes it may be possible to
develop pharmacological agents that will selectively change the activity
of the form of an enzyme that is contained in a certain cell type.
This would result in selective alteration of the intracellular concentrations 
of cyclic AMP in that cell, and thereby cause a selective modulation in the 
function of that cell. Weiss and Fertel (1977) have reviewed the evidence 
for naturally occurring selective alterations of this kind, and are 
optimistic about developments of similar artificial effectors.
Amer (1977) discussed in detail the sites at which drugs can affect 
the cyclic nucleotide system. Some of the sites are more attractive for 
drug development where tissue selectivity, specificity of desirable actions 
and minimal side effects are of paramount importance. Greater understanding 
of the factors operating at these sites and their susceptibility to 
drug effects must be achieved before successful and deliberate design of . 
useful drugs can be made. However, advances of this kind suggest that 
knowledge of cyclic AMP and its metabolism, gained in other fields, could 
lead to its fruitful application in an antiviral screening programme.
APPENDIX 1 : SELECTION OF CELL CULTURES
Introduction
The first reports dealing primarily with cyclic AMP metabolism in 
cultured cells appeared in 1971 (Clark and Perkins, 1971; Gilman and 
Nirenberg, 197l). These reports suggested that cell cultures could be 
useful models for studying cell nucleotide metabolism. Investigations 
of cyclic nucleotides in cultured cells are now widespread and have been 
reviewed by Chlapowski et al. (1975).
Monolayer cultures : The most common technique for culturing cells
is to allow them to adhere to glass or plastic under fluid medium, where 
they form thin layers, mainly monolayers. One disadvantage of this 
method is the need to treat the monolayer as a single unit when harvesting 
the cells. Careful preparation of parallel cultures (Evans et al., 1951) 
is necessary for any experimental work involving cell monolayers.
Since endogenous cyclic AMP is subject to fluctuations caused by 
changes in the environmental pH (D'Armiento et al., 1973), density of 
cells and serum levels (Oey et al., 1974) , these parameters must be kept 
constant. With care, and rapid preparation of confluent monolayers 
which is possible with fast growing cells, variation between cultures 
can be reduced to a minimum (Paul, 1965).
Suspension cultures : Some of the problems of preparing large
numbers of cells while keeping variation to a minimum may be overcome 
by growing cells in suspension. Because the cell concentration in a 
suspension is greater than in a monolayer culture, a single suspension 
culture may contain sufficient cells for the whole study and may be 
sampled at intervals without significantly altering the conditions of 
growth. The spinner culture, a stirred culture of submerged cells,
was first described by McLimans et al. (1957). Now it is so commonly
used that apparatus is commercially available. However, the choice of
cell lines available for this type of culture is limited because relatively 
few cell types have been adapted to successful growth in suspension 
(American Type Culture Collection, 1975).
Microcarrier cultures : The growth of cells on raicrocarriers
(Levine et al,., 1977) within a large single vessel has become more 
popular in recent years. However, these cultures are not easy to 
handle, and they have extra problems which are not associated with 
ordinary suspension cultures (Dr. P. Talbot, pers. comm.). The 
raicrocarriers are not of a uniform size, therefore monolayers on 
different particles reach confluency at different times. Also, 
reproducible sampling may prove to be a problem, as the microcarriers 
are unevenly distributed; the heavier particles tend to congregate in 
the lower portion of the vessel while the lighter particles are more 
evenly distributed by the stirring apparatus. Therefore the raicrocarrier 
system is best avoided unless high concentrations of anchorage-dependent 
cells are necessary.
Effect of serum on cultures : Whichever design of culture vessel
and cell system is used it is generally agreed that maintenance without 
serum would be advantageous for a biochemical study because of the 
variable or unknown factors in the serum which may affect the cell » 
metabolism (Keay, 1978). However, some experimenters have worked with 
media containing serum (Weber and Stewart, 1975; Bittlingmaier et al., 1977a). 
The problem has been avoided by others who used cells which had been 
maintained in serum-free medium for 24 hours (Stanwick et al., 1977)•
These differences in culture conditions may have important implications 
for the comparison of reports from different laboratories. This is 
substantiated by a study of the effects of serum on the mouse fibroblast
line 3T3 (Oey et al., 1974): intracellular concentrations of cyclic AMP
increased when cells were deprived of serum. It may be concluded that 
difficulties will be incurred with cultures containing serum, used in 
experiments which span sufficient time for serum factors to be decreased 
by cell metabolism, as the rate of metabolism of these factors may differ 
between the control and experimental cultures. Also differences in 
serum concentration may contribute to opposing results reported from 
different laboratories (Stanwick et al., 1977; Bittlingmaier et al., 1977a; 
Stanwick, pers. comm.).
Synchronization of cells : Since the concentration of cyclic AMP
fluctuates during the cell cycle (Seifert and Rudland, 1974; Al-Bader et al. 
1976) it is obviously desirable to test cells at the same stage, but this 
is not necessarily easy to achieve.
Partial synchrony of cells induced by reduced serum levels has been 
recommended for the preparation of cultures for monitoring cyclic AMP 
levels during virus replication (Bittlingmaier et al., 1977a; Stanwick 
et al., 1977). BHK21 cells were partially synchronized in the second 
cell cycle 32 - 36 hours after seeding by the reduction of serum in the 
medium (Bittlingmaier et al., 1977b). Stanwick et al. (1977) synchronized 
HEp-2 cells by reducing the serum stepwise, and incubating the cells for 
approximately 2 cell growth cycles prior to cyclic nucleotide analysis.
This incubation period theoretically synchronized the cells in GQ phase 
(''resting stage" of the growth cycle, Stanwick, pers. comm.). Maintaining 
the cells in a resting state has advantages over techniques designed to 
induce synchronous division, mainly because only partial synchrony is 
possible with such simple procedures as removing serum. Furthermore, 
when cells are not dividing the culture will alter its conditions less 
rapidly. Unfortunately it is not possible to compare the success of
the two alternative methods from the literature available (Bittlingmaier 
et al., 1977a; Stanwick et al., 1977) as it is impossible to deduce the 
variation in cyclic AMP levels between parallel cultures from the data 
presented in either report.
Choice of cell lines and culture conditions : Cultures which can be
maintained in a stable condition, without variation between cell populations, 
would be ideal for interpretation of measurements during a virus infection. 
This ideal is impossible, and the choice of cell line arid culture 
conditions in an attempt to approach the ideal must be, to a certain 
extent, an arbitrary decision.
Cells for biochemical studies are usually chosen because they are 
readily available and easy to handle. Those commonly used are the 
continuous cell lines, particularly HeLa, HEp-2, VERO and BHK which are 
easy to cultivate, fast growing and available in many laboratories.
For this study the choice was also limited to those cell lines which are 
susceptible to the viruses under study.
The regimen for preparing cell cultures for cyclic AMP analysis 
and virus growth studies was determined in the light of results from a 
few preliminary experiments which are described below.
Developmental Methods and Results
Cell lines : In addition to VERO and HEp-2 cells described in the
main methods section, the following cells were studied in preliminary 
experiments :
(a) VERO B2, a continuous cell line with an epithelial morphology, 
was obtained from the tissue culture department of these laboratories.
(b) HeLa, a continuous epithelial-like cell line, originally derived 
from a carcinoma of a 31 year-old Negro (Gey et al., 1952), was cultured 
from frozen laboratory stocks*
(c) HeLa S_, a clonal derivative of the parent line HeLa (Puck et al.,O —  -
1956), was a gift from Dr. P. Furman (Burroughs Wellcome, R.T.P., U.S.A.)• 
This cell line had been readily adapted to growth in suspension, but when 
grown in monolayers the cells had an epithelial-like morphology.
(d) BHK-21 cells, a continuous fibroblastic-like cell line
derived from kidneys of one day-old hamsters (Macpherson and Stoker, 1962), 
were obtained from stocks at the laboratories.
Culture methods
The procedures adopted for culturing these cells are described in 
the methods section of this thesis.
Cell lines differed in their requirements for culture medium and 
treatment required for preparing suspensions from adherent cultures.
Table 68 shows the media constituents for each cell line and the 
reagents applied for suspending cells.
Preparation of parallel cultures of cells : Preparation of cultures with
minimal variation in cell numbers and environmental conditions is possible
by seeding cultures with a sufficient number of cells to attain confluency
immediately after settling. To determine the number of cells required
for this exercise, inocula which varied in cell concentration and total
cell number were added to two different types of culture vessel :
25 cm flasks (Falcon) and 60 mm diameter plates (Falcon). The cultures
were examined on the following day and the following parameters noted :
protein content of the cultures, number of cells and the degree of
confluency (Table 69). (
To prepare overnight, confluent monolayers of HeLa cells in 60 mm 
5plates 6*5.10 inoculated cells were sufficient, but for confluency to
2 5occur in 25 cm flasks approximately 13.10 cells were required.
TABLE 68. Media for cell culture
Cell line Medium Supplements
To suspend cells 
cultures treated 
with :
VERO
HEp-2 
HeLa 
VERO B2
HeLa S3
(adherent 
cultures)
HeLa S3
(suspension
cultures)
199
Eagles MEM 
Eagles MEM 
Eagles MEM
Eagles MEM
Joklik's modification 
of Eagles MEM 
or
Eagles MEM with 10 x
concn. NaHJPO.2 4
and without CaCl-
5% FBS 0.5% Versene and
0.125% trypsin
10% FBS 0.5% Versene
10% FBS 0.5% Versene
5% FBS 0.5% Versene and
0.125% trypsin
10% FBS 0.5% Versene
10% FBS 
10% FBS
BHK 20% FBS
TABLE 69. Growth of cells within 24 hours for the
rapid preparation of confluent monolayers
Cell No. of cells
line inoculated
Volume
of
inoculum
Culture
vessel
Cell No. n , 
after Percentage .
24 hours confluency *
HeLa 6*5.10"
6*5.10"
8*6.10"
8*6.10"
6 ml 
6 ml 
8 ml 
8 ml
25cra Flask 
6 mm Dish 
Flask 
Dish
0.82 + 0.19
1.07 + 0.16
50
100
50-70
100
0.70
1.33
0.86
1.16
HeLa 10.10"
10.10"
13*4.10"
13*4.10"
6 ml 
6 ml 
8 ml 
8 ml
Flask
Dish
Flask
Dish
1.29 + 0.43
1.86 + 0.41
80
100
100
100
1.05
1.19
1.09
VERO B, 2*7.10"
2*7.10
3*6.10"
3*6.10"
8*8.10"
8*8.10"
11* 8.10
11*8.10"
6 ml 
6 ml 
8 ml 
8 ml 
6 ml 
6 ml 
8 ml 
8 ml
Flask
Dish
Flask
Dish
Flask
Dish
Flask
Dish
0.22 + 0.01
0.26 + 0.12
0.72 + 0.22
1.10 + 0.05
25
90
75
100
80
100
100
100
0.24
0.52
0.38
0.28
0.53
0.42
0.64
0.80
Fewer VERO B2 cells were required for the rapid preparation of
5 5confluent monolayers : 3*6.10 cells in 60 mm plates and 11*8.10 cells
2
in 25 cm flasks.
It is interesting to note that confluent monolayers of VERO B2 cells 
contained less protein than confluent monolayers of HeLa cells. Also, 
subconfluent cultures of both VERO B2 and HeLa cells produced more protein 
if the inoculum was added to a dish rather than a flask. This may reflect 
the differences in the incubation conditions : the dishes were incubated
in an atmosphere of 5% C02 whereas the flasks were simply sealed.
Although Tables 69 does not necessarily give the optimum conditions 
for the preparation of confluent monolayers within 24 hours, these results 
were used as a convenient guide for preparing cultures in later experiments 
Cells grown in suspension : HeLa cells were obtained from two 
sources. One cell line was a gift from P. Furman (Burroughs Wellcome, 
R.T.P., U.S.A.). These cells had been grown in Jokliks medium both as 
monolayers and in suspension. For suspension cultures they had been 
seeded at 5.10 cells/ml, and were subcultured approximately every
g
24 hours when the cell concentration reached 10 /ml. For my laboratory
work these cells have been named HeLa RTP.
The second spinner cell line was from Flow Laboratories (Irvine),
and has been renamed HeLa Flow. They were grown at the Flow
Laboratories in Eagles MEM modified for suspension cultures, using an
inoculum of 5.10^ cells/ml, and subculturing when the cells reached 
610 cells/ml, with a 1:20 split ratio, to reduce the cell concentration 
to the original level.
Cell suspension cultures : Apparatus required for growing cells
in a spinner culture included l) a bottle which could be sterilized 
easily and opened and resealed for sampling; 2) a heat-insulated magnetic 
stirrer, and a sterile magnetic follower. Preliminary experiments were
undertaken with a glass bottle sealed with a cotton wool plug covered by 
aluminium foil, a standard laboratory magnetic stirrer and 1-J11 long 
magnetic follower. For later experiments specially designed culture 
bottles and heat-insulated magnetic stirrers (Bellco) were available.
Cultures of 200 - 300 ml were set up in Bellco suspension culture 
vessels, which contained a teflon-coated magnetic rod suspended 
approximately 5 mm above the bottom of the jar. Attempts were made to 
grow both cell lines in both types of media recommended for spinner 
cultures. The viable cell concentration was calculated twice daily 
by mixing cells with trypan blue and counting the cells with a 
haeraocytometer. Values were plotted on log-normal graph paper, so 
that a subjective assessment of the state of the culture could be made. 
Sometimes the pH of a culture was adjusted by adding NaOH or sodium 
bicarbonate. The cells were subcultured by replacing a portion of the 
suspension with fresh medium, either when the cells ceased to increase 
in number, or when the cell concentration reached 10 /ml.
Successful culturing of HeLa S^ cells in suspension occurred only 
after several attempts.
Experiment 1. When culture vessels were placed on magnetic stirrers 
and insulated by an asbestos mat, HeLa S^ RTP cells inoculated in 
Eagles MEM without calcium at 5*6.10"* cells/ral increased to 8*2.10"* cells/ml 
within 24 hours, but after subculturing there was no further increase in 
viable cells, while there was a 10-fold increase in dead cells. This 
situation was partially rectified by reducing the heat flow from the 
magnetic stirrer to the culture, when asbestos mats were replaced by 
2'* thick cork rings, and washing the cells and resuspending them in 
fresh medium.
Experiment 2. Problems occurred with estimating the number of cells 
in the culture as there was considerable clumping, and many cells adhered 
to the glass. The clumping was reduced after the addition of trypsin 
and increasing the speed of the stirrer, but there was no estimation of 
the number of cells adhered to the glass.
5
Experiment 3. A culture inoculated at 10 cells/ml grew faster
than a culture inoculated at 5.10 cells/ml. When the denser culture
was growing slowly it was observed to be acid. When NaOH was added
there was an increase in the growth rate. Later the culture again
turned acid and the growth rate was slower.
Experiment 4. Cultures of HeLa RTP cells were grown continuously
for 10 days in both Jokliks and Eagles MEM modified medium for suspension
0
cultures. Jokliks medium supported logarithmic growth of cells from
5 5approximately 5.10 cells/ml to 8-10.10 cells/ml after subculturing on
I
9 consecutive occasions. Eagles MEM medium modified for suspension 
cultures supported logarithmic growth of cells at a density of below
10 /ml on 3 consecutive occasions. The growth of these two cultures 
is presented as a logarithmic plot of the cell density, and as a 
normal plot of pH (Figs. 60 and 61). The symmetrical appearance of 
this graph for HeLa RTP cells in Jokliks medium emphasises the 
phenomenon of increasing acidity with the density of the culture. This 
plot also shows that growth rate of the culture could be increased simply 
by raising its pH, without any addition of nutrients. This was done at 
160 and 215 hours after the culture was first inoculated.
i
A culture of HeLa RTP cells in Eagles MEM without calcium 
behaved differently. The fresh medium was very acid (pH 6.9) and after 
a few hours the pH was raised (see Fig. 61, hours 75-90 and 170-185)*; 
Later the culture became more acid, as the cell number increased further.
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Fig. 60 Growth of HeLa S3 (RTP) calls suspended in 
Joklik's modified minimal essential medium: 
cell density and pH
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Fig, 61 Growth of HeLa S3 RTP cells in Eagles MEM 
modified for suspension cultures
In summary, Eagles MEM modified for suspension cultures was unable 
to support a culture which continually contained more than 5.10 cells/ml,
t
instead,Jokliks medium had to be used.
Unless there was little or no transfer of heat to the culture from 
the magnetic stirrer there was a dramatic increase in the number of 
dead cells. This was avoided either by raising the culture vessels 
from the magnetic stirrer with a thick cork ring, or by using specially 
designed non-heating Bell-stir magnetic stirrers.
9
When the pH of a culture in Jokliks medium drifted outside the.
I
range 7 - 7 . 2  growth was not so rapid. In Eagles MEM without calcium 
the permissible pH range appeared to be slightly wider, possibly 6.9 - 7.3. 
These values are not the results of rigorous testing but only casual 
observation required to establish guidelines for successful culturing 
of spinning cells.
Establishment of stationary cultures : Maintenance of cells which
are not rapidly dividing is necessary for the plaque-assay of viruses, 
and for cyclic AMP analysis during a virus replication cycle.
To reduce the growth of cell cultures the serum content of the 
medium was reduced or removed entirely after the culture had been 
established.
Some cultures were successfully maintained in media with a reduced 
concentration of foetal bovine serum. Eagles MEM with only 2% foetal 
bovine serum maintained VERO, VERO B2, HeLa and HEp-2 cells for five days 
in a satisfactory condition for the plaquing of herpes virus. However,
199 medium was not suitable for the maintenance of VERO cells even though 
199 growth medium was used routinely for the culture of these cells.
Some VERO cells maintained for several days in 199 medium with 2% serum 
detached themselves from the substratum, leaving the cell layer patchy.
2 %  serum
some dead
1 /o  serum
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Fig* 62 Growth of HeLa RTP cells in Eagles MEM modified 
for suspension cultures
Subsequently Eagles MEM was found to be suitable for the maintenance of 
VERO cells.
Maintenance of cell cultures without serum was desirable but 
not always possible for cyclic AMP analysis. VERO, HeLa, and HEp-2 
were successfully maintained by reducing the serum content of the medium 
to 0.5% 24 hours after seeding, and removing the serum altogether 24 hours 
later. The cultures were continued for a further 60 hours without 
detriment to the cells. However, when this procedure was applied to 
BHK cells, within 3 hours of removing the serum some cells had rounded 
and detached themselves from the vessel, and within 6 hours the culture 
was seriously affected. Because of their inability to survive without 
serum, BHK cells were eliminated from all future experiments.
Maintenance of non-dividing cells in suspension proved to be 
difficult. Reduction of foetal bovine serum to 2% in Jokliks medium 
did not reduce the growth rate of cells (see Figs. 60, 62). Further 
reduction to 1% may have resulted in a reduced growth rate (Fig. 62); 
however, this was accompanied by a large increase in the number of 
dead cells. Due to the fast growth rate observed in suspension cultures 
and the lack of success in slowing cell division, these cultures were 
considered unsuitable for the study of cyclic AMP during virus replication, 
and work with these cultures was abandoned.
Conclusions
Suitable methods were found for the successful growth and maintenance 
of anchored HeLa, HEp-2 and VERO cells for the titration of viruses and 
cyclic AMP analysis. The use of HeLa cells in suspension and BHK cells 
was discontinued owing to their inability to comply with the requirements 
of this study, namely the viability of cells without division in the 
absence of serum.
APPENDIX 2 : QUANTIFICATION OF CELLS
Introduction
An accurate measure of cell material is necessary in order to obtain 
reliable determinations of cyclic AMP content.
In many assays for cyclic AMP the results have been related to one or 
more different features, for instance, the number of cells (Otten et al., 
1972; Seifert and Rudland, 1974; O'Neill, 1977); total culture protein 
(Anderson et al., 1973; Raska, 1973; Rozengurt et al., 1973; Oey et al., 
1974; Rudland et al., 1974; Miller et al., 1975; Ohki et al., 1975; 
Stanwick et al-, 1977); total DNA (Bittlingmaier et al., 1977) or even 
packed cell volume (Otten et al., 1972). However, some workers have 
preferred to present their results without an external standard, by 
calculating each value as a percentage of the maximum (Al-Bader et al., 1976) 
or as cyclic AMP per culture (Mishra et al., 1973). Each of these 
possible methods is discussed below, with an appraisal of their advantages 
and limitations.
Cell number : Methods include a direct count of whole cells or
nuclei in undisturbed monolayers with phase contrast microscopy 
(Martinez-Lopez and Black, 1977). This procedure has the advantage of 
being repeatable whenever desired on the same cell population.
Alternatively, cells can be removed from the culture vessel and counted with 
a haemocytometer. The relative accuracy of intact cell counts depends 
largely on the manner of sampling, the total number of cells counted and 
the extent to which cell clumping occurs (Parker, 1961). Furthermore, when 
counting cells with a haemocytometer, the ratio of viable to dead cells 
can be observed concurrently by dye exclusion methods using eosin (Hanks 
and Wallace, 1958), erythrosin B (Phillips and Terryberry, 1957) and 
trypan blue (McLiraans et al., 1957).
Some workers count extracted cell nuclei with a haemocytometer 
(Evans et al., 1951; Parker et al., 1954), and although this procedure 
is more complicated it may be usefully applied where non-nuclear material 
is extracted concurrently for other measurements.
The main disadvantage of these counting techniques, whether of cells 
or nuclei, is that the size of the cells, which is usually an important 
parameter, is ignored.
Protein determination : The Folin-Ciocalteyi method of protein 
determination (Lowry et al., 1951) is widely used and easily applied to 
cell cultures (Oyamaand Eagle, 1956). The great advantage for this work 
is that cyclic nucleotides can be extracted from cells, leaving the 
residual material available for protein analysis.
DNA content of cells : Until recently there have been numerous
practical problems with the assay of DNA. Nucleic acids contain three 
distinct chemical components : a) purine and pyrimidine bases; b) ribose
or deoxyribose; and c) phosphate. Early methods of nucleic acid 
determination were based on the strong ultraviolet absorption of the 
bases, specific reactions for the pentoses or estimations of phosphorus 
in the extract (Munro and Fleck, 1966). Methods of estimation depending 
on ultraviolet absorption or phosphorus determination did not distinguish 
between RNA and DNA and could, therefore, only be applied where the two 
nucleic acids had first been separated. Alternatively, specific colour 
reactions for ribose and deoxyribose allowed RNA and DNA to be established 
independently in the same solution. All three methods required a certain 
amount of tissue preparation.
The initial steps of traditional extraction procedures (Schmidt and 
Thannhauser, 1945; Schneider, 1945; Ogur and Rosen, 1950) were designed 
to remove small molecules and lipids (as acid-soluble and lipid components
of the cell may have interfered with the final chemical reactions for 
nucleic acid estimation), then extract the nucleic acids from the tissue 
residues before assay.
This was the basis of procedures available in the sixties (Webb and 
Levy, 1961; Munro and Fleck, 1966). Since then small developments have 
led to greater sensitivity and a reduced time required for the assay, but 
they still required overnight incubation and considerable preparation 
(Setaro and Morley, 1977). The time involved for an assay, theoretically, 
can be reduced by using methods that are very specific and not subject to 
interference from cell constituents. Until recently the only methods to 
fulfil these requirements were microbiological assays (Miller, 1961) 
which depended on micro-organisms whose growth was sensitive to nucleic 
acids. However, a microbiological assay is not suitable for a tissue 
culture laboratory where it may cause contamination in other work.
The most recent advance in DNA assay was reported by Hill (1976).
She designed two biochemical assays which were based on the specific binding 
of antibiotics to DNA which did not suffer from interference: adriaraycin
formed a complex with DNA and the absorbance at 475 nra was reduced 
proportionally to the quantity of DNA added (with adriaraycin in excess); 
and mithramycin bound to DNA and fluoresced in direct proportion to the 
amount of DNA present. The mithramycin method which is based on fluorimetry 
has been developed to give a more sensitive assay (Hill and Whatley, 1975) 
and has been used successfully on a wider variety of cells. Hill and 
Whatley (1975) reported a number of advantages for this method over 
previously designed chemical techniques: i) the assay was rapid, provided
an answer in minutes and required no overnight incubation; ii) the DNA
Cj
content of as few as 10 cells could be determined accurately; iii) the 
assay was simple and multiple samples were processed readily; iv) samples
could be stored conveniently as whole pellets at -20°C prior to assay; 
v) the assay was directly applicable to cell suspensions or monolayers, 
and no time-consuming or tedious extractions were necessary; vi) the 
method was specific for DNA and since there was no significant interference 
by RNA or protein, treatment with ribonuclease and/or removal of protein 
as in other methods were unnecessary; and vii) mithramycin, as raithracin, 
was readily available and the method only involved the preparation of 
two water based solutions, so the use of corrosive acids and inflammable 
liquids was avoided.
Despite these technical advances the use of DNA as a measure of a 
cell culture is limited. DNA does not always correlate with cell material 
the DNA content of the cell remains constant during logarithmic and 
stationary phases, but in monolayer cultures it rises to approximately 
twice the normal level during the lag phase (Salzman, 1959). For this 
reason care must be taken to avoid the use of cells which have been 
recently treated with fresh medium, if DNA measurements of this kind are 
to be applied.
As the most convenient method for measuring DNA is applied to whole 
cells its value in this work is limited, as the same samples would not be 
concurrently available for cyclic AMP analysis. This is a particular 
disadvantage with monolayer cultures as additional parallel cultures 
would be needed for the DNA assay. However, suspension cultures would 
be suitable for this work as replicate samples for different assays are 
easily obtained from a single culture.
Packed cell volume : As cyclic AMP is a soluble compound the
total cell volume may be determined in order to calculate the intracellular 
concentration of cyclic AMP. The cell volume can be calculated by 
centrifuging the cells in a capillary tube and measuring the sediment.
Comparison of haematocrit readings with haemocytometer counts gave good 
agreement unless cell cultures had grown thickly and were tightly packed 
(Parker, 1961). Kuchler (1977), reviewing an earlier study of cells 
in suspension, reported that an increase in cell size during the lag 
phase of growth of a culture accounted for an increase in packed cell 
volume in the absence of an increase in cell numbers. Packed cell volume 
would therefore appear to be the most useful parameter for the comparison 
of cyclic AMP levels. Unfortunately, as this method uses whole cells, 
cultures cannot be assayed simultaneously for cyclic AMP and packed cell 
volume.
Conclusions : Because of the complexity of cell growth cycles and
the extra metabolic changes induced by viral infections, the application 
of more than one method for acquiring a standard measure may give extra 
information which could help the interpretation of the study. However, 
valid data may be presented with only one standard measure. In this 
case the concentration of cyclic AMP present in cells is more accurately 
expressed relative to the total protein content rather than DNA or number 
of cells (Rudland et al., 1974), as the protein content changes in harmony 
with the cell volume during the cell cycle. Additionally protein \ 
determinations are advantageous as they can be applied to cell residue 
after the extraction of cyclic AMP.
Methods and Results
Cell number : Fig. 63 and Table 69 show the correlation between
protein content and number of cells in HeLa and VERO B2 cultures. The 
protein content of HeLa cells was proportional to the number of cells 
except when the cultures were confluent, when the cell number was 
disproportionately high. Similarly, with VERO cells, confluent cultures
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Fig- 63 Correlation of cell numbers and protein content of
VERO cells ( •) and HeLa cells ( □) 24 hours after seeding
had comparably higher cell numbers than would be indicated by their 
protein content.
Because an accurate measure of cell material was not possible with 
this method, and because cyclic AMP assay could not be applied to the 
same sample, haemocytometer counts were not usually undertaken for this 
work.
However, haemocytometer counts were found to be very useful for 
culturing cells in suspension, and the viability of these cell cultures 
relied upon daily cell counts. The viability of the cells was also 
noted by observing the proportion of cells which stained with trypan blue, 
and this was found to be a good indication of the health of the culture.
Protein determination : Two methods were applied to determine the
concentration of Folin-Ciocalteu's (F-C) reagent required and the kinetics 
of the colour reaction checked. The F-C reagent was standardized before 
use (Lowry et al., 1951) by titrating with hydrochloric acid in the 
presence of thyraolphthalein indicator. Flask A contained IN NaOH, 10 ml; 
distilled water, 2 ml; 0.25% (w/v) thymolphthalein in 50# ethanol, 5 drops. 
Flask B contained IN NaOH, 10 ml; F-C reagent, 2 ml; 0.25% (w/v) 
thymolphthalein in 50% ethanol, 5 drops. The contents of each flask were 
titrated to the end point with IN HC1. The concentration of F-C reagent 
was calculated as follows :
Titre A - Titre B = C = 
number of ml IN HC1 required to neutralise 2 ml F-C reagent.
Normality of F-C reagent =
' c 
2
The F-C reagent was diluted with distilled water to a IN solution on the 
day of use.
The kinetics of colour development after the addition of F-C reagent 
was studied before the method was routinely applied to unknown samples of 
protein. Solution C (defined in the main methods section), 5 ml, was 
added to bovine serum albumin, 50 pg in 1 ml distilled water. After 
5 minutes F-C reagent, 0.5 ml, was added to the protein standard in 
solution C, and the mixture was vortexed immediately. The absorbance 
at 660 nm of this solution compared with F-C reagent in solution C alone 
was measured at intervals for 2 /4 hours with a Unicam SP8000 ultraviolet 
recording spectrophotometer.
Titration of F-C reagent indicated a concentration of 3.2N for the 
stock solution. The kinetics of the colour formation were followed for 
concentrations of IN, 1.06N, 1.14N and 1.23N. Fig. 64 is a graphical 
presentation of these results. All later experiments were planned 
keeping in mind the information gained here: a IN solution of F-C was
used, and the absorbance was measured between 30 minutes and 2 hours after 
the addition of this reagent.
The absorption spectrum of bovine serum albumin in solution C with 
F-C reagent was recorded 30 minutes after mixing (Fig. 65)• The maximum 
absorbance in this system occurred at 740 nm. Table 70 shows the absorbance 
of known concentrations of bovine serum albumin at different wavelengths.
The graphical presentation of these results shows that absorbance was 
linearly related to protein concentration to 50 pg/inl but not to 100 pg/ml 
(Fig. 66). The slope of the graph (0 - 50 pg/ml) was steepest when 
absorbance was measured at 740 nm, indicating that this wavelength was 
the most sensitive to changes in protein concentration. However, when 
unknown samples contained slightly more than 50 pg/ml protein, instead of
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TABLE 70. Spectrum of absorbance of varying concentrations of 
bovine serum albumin subjected to the Lowry assay 
of protein determination
Absorbance of bovine serum albumin _ . «
lfaveleneth • Regression Slope of
100 pg 50 pg 25 pg 12.5 pg coefficient graph
630 0.215 0.108 0.038 0.005 0.9998 0.0027
640 0.220 0.112 0.043 0.006 0.9998 0.0028
660 0.227 0.118 0.045 0.011 0.9998 0.0028
680 0.233 0.123 0.050 0.011 0.9998 0.0029
700 0.240 0.125 0.049 0.011 1.0000 0.0030
720 0.241 0.126 0.052 0.013 0.9998 0.0030
740 0.239 0.134 0.053 0.013 0.9999 0.0032
760 0.234 0.132 0.053 0.012 0.9999 0.0031
780 0.224 0.123 0.046 0.010 0.9998 x 0.0030
800 0.214 0.113 0.039 0.004 0.9999 0.0029
TABLE 71. Protein content of replicate cultures
previously treated with protein precipitants
Extraction procedure 15 cm x 15 mm 
tube
Culture 
25 cm^
vessels
flask 275 cm flask
Ethanol 168.0 118.8 740.0 848.0 2400.0 2136.0
152.4 108.0 576.0 664.0 1866.0 2424.0
142.8 139.2 808.0 856.0 2196.0 2544.0
73.2 132.0 328.0 848.0 2292.0 2016.0
114.0 156.0 1000.0 2172.0
Ethanol, vortex mix 
and centrifugation
132.0
156.0 
97.2
TCA 169.2 105.6 760.0 3168.0
100.8 69.6 800.0 3084.0
75.6 85.8 880.0 2436.0
TCA, vortex mix 
and centrifugation
112.8
60.0
116.4
diluting the sample it was found more convenient to measure the absorbance 
at a wavelength where the deviation from the linear relationship was 
minimized. All subsequent measurements of absorbance were recorded 
between 660 nm and 860 nm with little more than 50 p.g protein in each 
sample.
Fig. 67 shows the variation between standard curves prepared on 
different days. Both the slope and the intercept on the y axis varied. 
When the same samples were measured in different spectrophotometer cells 
the intercept on the y axis changed, but the slope did not. This suggests 
that any change in the absorbance value in the absence of protein was due 
to the properties of the cells, while any change in the slope was due to 
differences in the chemicals and could be described as technical error.
To detect any possible effect of fixing cell material with TCA or 
ethanol on subsequent protein determinations, parallel cell cultures were 
subjected to various treatments prior to preparation for protein assay. 
Cells were flooded either with 70% ethanol or 5% TCA and incubated at 4°C 
for an hour. Cells in tubes were also subjected to vortex mixing. The 
ethanol and TCA were removed before cells were rinsed twice with Earles 
basal salt solution and assayed for protein content. There was no 
significant difference in the results of protein determinations of 
untreated cultures and those treated with TCA or ethanol (Table 71) 
as tested by analysis of variance with Bartlett's test for homogeneity.
Thus TCA and ethanol treated cultures were subsequently tested for protein 
content by the described method with confidence.
DNA Assay : The method of Hill and Whatley (1975) was followed to
assay the DNA content of cells.
Mithracin, which contained mithramycin (l part by weight), and 
mannitol and sodium diphosphate (40 parts by weight), was kindly donated
for these studies by Pfizer Ltd. (U.K.). A stock solution was prepared 
containing 200 pg/ml mithramycin, lyophilized and stored at 4°C. On the 
day of use the mithramycin was reconstituted with 300 mM MgCl^, which 
promotes DNA-mithramycin binding (Ward et ail., 1965). This solution 
was diluted in phosphate buffered saline (PBS) to give final concentrations 
of 10 pg/ml mithramycin and 15 mM MgCl^. Fluorescence of 1 ml aliquots 
of mithramycin in semi-micro quartz glass fluorimetry cells was measured 
with a Perkin-Elmer Model 1000 fluorescence spectrophotometer. A 
second fluorescence value was recorded after the addition of 0.05 ml of 
the calf thymus DNA standard (Sigma, type l).
The fluorescence of the DNA-mithramycin complex was scanned between 
400 nm and 650 nm wavelengths, after excitation through a variety of filters. 
The wavelength of the exciting radiation could be reduced by turning the 
filter up to 20° with respect to the light source. From these initial 
studies the optimum filter and its position for excitation radiation, 
available with this machine, was chosen.
To test the specificity of the assay, 0.05 ml volumes of the 
following solutions were added to mithramycin for assay: i) boiled DNA;
ii) deoxyribonuclease-treated DNA; iii) RNA; iv) bovine serum albumin.
Table 72 shows the increase in fluorescence due to the addition of 
0.8 pg DNA to mithracin using a variety of excitation filters. The 
emission was measured at 530 nm. The greatest emission occurred with 
the excitation beam passed through a filter for transmitting 451 nm 
wavelength turned to an angle of 20°.
Fig. 68 shows the fluorescence of DNA standards mixed with mithracin. 
Fluorescence was proportional to DNA concentration between 1 and 16 pg/ml 
DNA in 0.05 ml samples. However, relatively high levels of RNA or 
bovine serum albumin did not increase fluorescence, nor did boiled or 
deoxyribonuclease-treated DNA.
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TABLE 72. Fluorescence emitted by mithracin and DNA when 
excited with light of different wavelengths
Filter Degree turn
Fluorescence of
Mithracin r.M . , Mithracin _ DNA alone , alone and DNA
340 0 100 37 127
363 0 101 43 102
368 0 100 33 105
404 0 100 19 203
451 0 100 15 418
451 10 100 10 464
451 20 100 9 519
472 0 100 80 193
Conclusions
Counting cells with a haemocytometer was considered a suitable 
method for calculating the cell concentration of a suspension culture.
This method was also occasionally used in conjunction with a protein 
determination as a measure of cell material for comparison of cyclic AMP 
levels. Although the method for DNA measurement was found to be reliable 
and simple, it was not considered a valuable assay with monolayer cultures 
because of the necessity of separate samples for analysis, and it was 
abandoned when suspension cultures were found to be impractical.
APPENDIX 3 : CHOICE AND STANDARDIZATION OF VIRUSES
Introduction
For investigations of the role of cyclic AMP in productive viral 
infections it is obvious that suitable viruses should be well characterized 
and readily available, quickly and easily cultivated, able to reach high 
titres and to infect cells suitable for a laboratory study. Many such 
viruses are available but few have been examined: adenovirus type 2
(Biron and Raska, 1973), transmissible gastroenteritis virus (Mishra et al., 
1973) and herpes simplex (Bittlingmaier et al•, 1977a; Stanwick et al., 1977). 
Of the many viruses successfully cultured in this laboratory herpes virus, 
polio virus, Mengo virus and Semliki Forest virus were chosen for their 
diversity, and their ability to grow in HEp-2 cells and VERO cells.
Preparation of virus stocks : Large numbers of cells are required
to determine levels of cyclic AMP, therefore investigations of virus infected 
cells also require sufficient high titre virus pools to inoculate many 
replicate cultures.
A popular method (Peters, 1975) for preparing virus stocks is to 
inoculate a cylindrical bottle with cells and roll the bottle. The entire 
inner wall is coated with cells and the volume of the cell medium can be 
as little as 1/10 of the volume required for the equivalent number of cells 
on flat surfaces. Reported techniques (Liebhaber et al., 1969; Klevecz, 
1975; Peters, 1975; Kuchler, 1977) are not always easy to compare 
because authors have not always quoted both the size of the bottle and the 
rotational speed. The speed of rotation, for instance, must allow 
cell adherence to the bottle, as well as aeration and regular bathing of 
the cells. High rotational speeds, which would enhance aeration, have 
been shown to impede rapid attachment to the glass and result in 
cell-to-cell attachment and clumping in solution (Klevecz, 1975).
Both Klevecz (1975) and Kuchler (1977) recommended apparatus which 
rotates at variable speed, but Liebhaber et al. (1969) successfully 
cultivated rubella virus in VERO cells in roller bottles rotating at a 
constant speed for the attachment and logarithmic growth of the cells 
and the subsequent replication of the virus.
Similarly high concentrations of cells may be achieved in 
suspension cultures, and this method has been successfully applied to the 
production of high titres of foot-and-mouth disease virus in suspensions 
of BHK cells (Bartling, 1977; Nardell and Panina, 1977; Spier, 1977). 
However, monolayers of BHK cells did not survive in the absence of serum 
and therefore were found to be unsuitable for this study. HeLa S^ cells, 
which were suitable for cyclic AMP analysis, when inoculated with 
herpes virus resulted in virus titres approximately a log lower in 
suspension cultures compared with static cultures (Dr. P. Furman, 
pers. comm.).
Careful preparation of virus should be followed by recommended 
methods for storage. Suitable procedures involve preservation of 
animal viruses in material containing at least 1% or preferably 50# protein 
(such as fluids harvested from cell cultures that contain serum as an 
additive for the maintenance of cells) in vessels twice the volume, fast 
freezing for storage and fast thawing for subsequent use (Ward, 1968).
Quantification of virus : Infectivity is the most sensitive assay
of viable virus and may be determined by three different, but related 
methods (Isaacs, 1957): (l) direct counts of pocks or plaques in eggs
or cells; (2) observations of all-or-none responses by animals or cells; 
and (3) indirectly from studies of the incubation period of diseases 
following the inoculation of different dilutions of the preparation 
to be assayed.
Indirect methods are generally only used when direct observations 
do not give a satisfactory result. The use of eggs may lead to problems 
of reproducibility reflecting individual variation between eggs and 
variation associated with the development of secondary pocks. Both 
these disadvantages have been largely overcome by the use of tissue 
culture.
Provided that one is concerned simply with accurate comparisons of 
infectivity there are several reasons for preferring cell cultures to 
in vivo or iji ovo systems (Cooper, 1967): (l) the number of cell types
present can be reduced to one; (2) humoral reactions and other factors 
affecting sensitivity can be eliminated; (3) virus inactivation can be 
controlled; and (4) the production of secondary plaques can be limited.
Virus replication cycle : Biochemical changes in infected cells
are best observed when all the cells of a culture are infected 
simultaneously. Synchrony can be partially achieved either by raising 
the titre of the virus, thereby increasing the multiplicity of infection, 
or by allowing attachment to occur at 4°C then raising the temperature 
to 37°C for the remainder of the cycle (Farnhara and Newton, 1959).
The lower temperature not only synchronized the virus infection by 
inhibiting penetration (Farnham and Newton, 1959; Holmes and Watson, 1963) 
but also reduced the heat inactivation of unattached herpes virions 
(Farnham and Newton, 1959). Alternatively biochemical inhibitors may 
be employed to synchronize virus replication. Considerable information 
concerning enteroviruses has been acquired by the study of synchronous 
virus replication following the application of virus-specific, reversible 
inhibitors, 2-(a-hydroxybenzyl)benzimidazole and guanidine, but neither 
of these compounds prevent virus-induced inhibition of cell biosynthesis 
(reviewed Tamm and Caliguiri, 1972; Caliguiri and Tamm, 1972).
Metabolic inhibitors which could affect some viral activities and not 
others were considered unsuitable for this study because only selected 
reactions of viral metabolism would be synchronized.
Methods
Preparation of virus : The production of herpes virus in cell
monolayers was compared in different culture vessels. To maximize the
titre of the virus produced low volumes of maintenance medium bathed
2 2the cells during infection: 10 ml in 75 cm or 150 cm monolayers;
2
50 - 100 ml in 850 cm monolayers in roller bottles.
2Cylindrical polystyrene flasks (850 cm growth area, 11 cm diameter 
Corning) were seeded with approximately 3.10 BHK cells in 150 ml growth 
medium at 37°C. The bottles were rotated at 0*2; - 0*3 revolutions per 
minute, which was equivalent to 7 - 10 cm/minute at the outer surface. 
Attachment and growth of the cells was apparent from clarity from the 
medium and its slightly yellow colour, indicating the presence of acid. 
This was verified by microscopic examination of the interior growth 
surface. When the cells had reached confluency the growth medium was 
drained from the cultures and replaced with 10 ml virus inoculum, and 
the bottle was returned to the roller apparatus for another hour.
After this period for attachment of virus particles, the inoculating 
medium was replaced with 50 or 100 ml maintenance medium and the culture 
rolled again. After approximately 24 hours when most of the cells 
appeared rounded, the culture was subjected to the same treatment of 
alternate freezing and thawing as described in the main methods section. 
The bottle was rolled manually at intervals during freezing to ensure 
that all the cells were covered with frozen medium.
Monolayers in flat culture flasks were inoculated as described in 
the main methods section.
Inoculation for single cycle of virus replication : The volume of
inoculum, the time allowed for attachment of virus particles to cells and 
the temperature at the time of inoculation were all varied to select a 
method of inoculation which was most successful at infecting all the 
cells of a culture simultaneously.
To investigate the effect of varying the inoculum volume, HEp-2 cells 
were inoculated for 1 hour at 37° C with either 1 ml or 2 ml of diluted 
herpes virus. The cells were subsequently overlaid with agarose in 
maintenance medium as previously described, and incubated to allow the 
formation of plaques.
oCultures of HEp-2 cells prepared identically in 25 cm flasks were 
divided into two groups for inoculation with herpes virus at 4°C and 37°C. 
Cells to be inoculated at 4°C were precooled for 40 minutes. All the 
cultures were flooded with 1 ml of inoculum. At various intervals 
sample cultures were drained of their inoculum, overlaid with agarose in 
maintenance medium and incubated at 37°C to allow the formation of plaques.
Measurement of the area of virus plaques : Three methods for
measuring the area of irregular shapes were compared for their suitability 
for measuring the size of plaques: l) An Allbrit planimeter, kindly lent
by Mr. A. Fairbairn, was used to trace the circumference of irregular 
shapes and calculate the area enclosed. 2) The equation for calculating 
the area of an ellipse was applied to the measurements of the longest diameter 
of a plaque and the diameter perpendicular to it. 3) The areas of 
approximately spherical or elliptical shapes were drawn on graph paper 
and the area calculated from the number of small squares enclosed.
Ten small shapes and two larger ones were drawn freehand on graph paper, 
the approximate size and shape of herpes plaques and polio plaques in 
VERO cells when magnified by a microfilm reader. The area of each was 
calculated by all three methods.
Results
Preparation of virus stocks : Twenty-six hours after inoculation with
herpes virus at a low multiplicity of infection, monolayers of VERO cells 
o
in 75 cm flasks containing 10 ml maintenance medium yielded- a stock of
6 2 15.10 pfu/ral. In comparison, HEp-2 cells in 150 cm flasks inoculated,
6
then maintained in 10 ml medium, yielded only 0.6 - 0*7.10 pfu/ml. 
Inoculated BHK cells in roller bottles yielded 5.10 pfu/ml when maintained
g
in 100 ml medium, and 7.10 pfu/ml when maintained with 50 ml medium.
Methods applied for improving the titre of virus stocks were,
therefore, not always successful, but generally suitably infectious
material could be prepared without too much difficulty.
Experimental inoculation of cell cultures : Table 73 shows data
indicating an increase in the number of infectious herpes virus particles
2attached when the inoculum for 25 cm monolayers of HEp-2 cells was
increased from 1 ml to 2 ml. However, these figures show that an increase
of the inoculum did not result in a proportional increase in the number of
plaques formed; doubling the inoculum led to an increase of 15 - 30% of
*
plaques formed.
Table 74 shows how the attachment of herpes virus at 4°C and 37° C
increased with time. Inoculation at 4°C was not recommended for the
\ •
infection of cell cultures prior to cyclic AMP analysis as the maximum 
attachment at 4°C was considerably lower than at 37°C. Graphical .
presentation of the data (Fig. 69) shows that the faster rate of
attachment at both temperatures was during the first hour; however, 
only 30 - 40% or less of the virus was attached after an hour at 37°C,
and less than 60% of the virus was attached after an hour at 4°C.
Therefore short inoculation times of no more than an hour at 37° C were 
recommended for inducing approximately synchronous replication of 
herpes virus prior to cyclic AMP analysis.
TABLE 73. Titration of herpes virus in monolayers of 
HEp-2 cells in 25 cm^ flasks (values record 
number of plaques per culture)
Dilution 1 ml Inoculum 2 ml Inoculum
10“3 485 556
327 496
10~4 60 89
51
IQ"5 4 4
9 2
10”6 1 1
1 2
IQ’7 0 0
0 0
Cell 0 0
control 0 0
TABLE 74. Attachment of herpes virus particles to HEp-2 cells
at 4°C and 37°C
Titre of virus attached (x 10 4)
Time (hours)
4°C 37°C
0.5 6.46 18.55
1 8.75 41.50
2 11.40 46.00
4 10.70 69.50
6 19.35 89.50
8 15.55
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Fig. 69 Attachment of herpes virus to HEp-2 cells
TABLE 75. Area of "plaques" measured by 3 different methods
With a Applying the formula Counting the
planimeter for an ellipse squares enclosed
3.2 3.14 3.5
2.6 3.14 2.5
2.9 3.14 2.5
4.5 3.14 3.0
3.8 3.14 3.5
3.2 3.14 3.0
3.5 3.14 2.5
3.5 2.90 3.0
2.8 3.14 3.0
3.2 3.90 3.0
17.9 15.70 14.5
25.9 25.90 25.0
Measurement of the area of "virus plaques11 : Use of the planimeter
involved tracing the circumference of each shape several times and from 
the average of the values read on the instrument, calculating the area.
This proved to be more time-consuming than either of the other two methods. 
Table 75 shows the values for the area of each shape calculated by each of 
the three methods. The values for each method were similar, but not 
identical. The "counting of squares" method was considered the most 
accurate (Mr. A. Fairbairn, pers. comm,), but this had the disadvantage 
of expense: a sheet of A3 graph paper would be needed to calculate the
area of plaques in each culture dish. The method which assumed an 
elliptical shape and calculated the area from two diameters gave results 
which were similar to the "counting squares" method. The error associated 
with the measuring was so small compared with the variation in the size of 
plaques (Figs. 26 - 59) that the most convenient and cheap method, assuming 
elliptical plaques, was considered sufficiently accurate for this work 
and was applied to all future experiments.
Conclusions
Traditional methods were found suitable for the preparation and 
measurement of infectious virus. A simple method for measuring the area 
of virus plaques was developed and adopted to study the spread of virus 
infections in monolayer cultures.
APPENDIX 4 : EXTRACTION OF CYCLIC AMP FROM CELLS
Introduction
The efficiency and suitability of different methods for extracting 
cyclic AMP from animal tissues and cell cultures has been the subject of 
much discussion. The essential difficulties relate to the low levels of
cyclic AMP in the cell, and the fluctuations that occur due to natural or
applied stimuli.
The ideal procedure would be to stop all cell reactions 
instantaneously and extract and preserve all the cyclic AMP while 
separating it from the cell protein which can be maintained for subsequent 
assay. The procedure should avoid loss of cyclic AMP or protein, and 
not introduce interference into either of the assays to follow.
Unfortunately this situation is not easily achieved.
Experimental procedures that involve removal of tissue samples from 
the intact animal can themselves lead to rapid changes in cyclic AMP levels, 
and Goldberg et al. (1972) stated that no procedure then devised had been 
shown to eliminate such artifacts completely, but that quick-freeze 
procedures were probably the most acceptable. Extraction methods were 
then applied to frozen material.
Cultured cells, whether grown as a monolayer or in suspension, have 
less resistance to penetrating chemicals and changes in the temperature 
than have animal organs, and this allows a wider choice of techniques for 
instantaneous fixing. TCA precipitates proteins, thus the addition of 
TCA in water to a monolayer of cells results in acid-soluble cell contents 
being released into solution. A generally accepted method (Chlapowski et al. 
1975) is to replace the cell culture medium with a cold 5% TCA solution, 
leaving the cells at 4°C for 1 hour. The cells appear to be fixed almost
instantaneously by this method, and the recovery of cell cyclic AMP, as 
verified by the use of radioactive cyclic AMP and by exhaustive extraction, 
appears to be quantitative. The TCA solution, containing cyclic 
nucleotides and other acid-soluble cell contents, can be decanted, leaving 
the cell protein and other macromolecules adhered to the culture vessel. 
Ethanol has been used to extract cyclic AMP (Haksar et al., 1974) and may 
be applied to cell cultures in a similar manner to TCA.
Once cyclic AMP has been extracted it must be stored in conditions 
that do not allow any further changes. Cyclic AMP is chemically stable 
but it is subject to enzymatic degradation. This is avoided by denaturing
enzymes with TCA, ethanol or rapid heating. Alternatively cells which are
broken rapidly by physical means can be suspended in a buffer containing 
enzyme inhibitors. EDTA and theophylline are inhibitors of cyclic AMP 
phosphodiesterase and have been recommended for the preparation of crude
cyclic AMP extracts (Brown, pers. comm.; Nahorski, pers. comm.).
)
Ebadi (1972) incorporated ZnSO^ as an inhibitor of both cyclic AMP 
phosphodiesterase and adenyl cyclase.
A combination of physical and chemical procedures such as vortexing, 
sonicating or homogenising cells in TCA or ethanol may be recommended for 
rapid cell fixation and efficient extraction of cyclic AMP (Barnes, 
pers. comm.).
Variations of published methods were compared before a routine 
procedure was adopted.
Methods and Results
Three different methods, with minor modifications to each, were 
compared for their speed, efficiency, convenience and suitability for 
the protein-binding cyclic AMP assay.
(a) Trichloroacetic acid (TCA) extraction : The growth medium was
poured off cell monolayers and the cells were flooded with freshly 
prepared cold 5% (w/v) TCA, then incubated for one hour at 4°C. The 
TCA solution, containing acid-soluble cell material, was poured off, 
leaving the cell protein adhered to the culture vessel.
Removal of TCA from the sample : Three methods were used :
i) Water-saturated ether was prepared by mixing ether and water 
in a separating funnel and shaking vigorously for 20 to 30 seconds.
When allowed to separate the lower aqueous layer was discarded and the 
top ether layer pooled with other volumes prepared in the same way.
To remove the TCA the sample was washed with 4 volumes of water-saturated 
ether 6 times, again by shaking vigorously for 20 to 30 seconds. The 
excess ether was removed either by bubbling a stream of air through the 
sample or while drying in an oven. The dried sample was reconstituted 
with Gomcri’s Tris-HCl buffer, pH 7.5. The pH of the sample was adjusted, 
when necessary, to pH 7.5 with either sodium hydroxide or Tris (hydroxy- 
raethyl)methylamine crystals.
ii) As an alternative to the ether extraction, Khyras method (1975) 
of neutralising acid solutions by ion-pairing was applied. Cell extract 
in 5% TCA, 3 ml, was mixed with 3.75 ml of 0.5 M tri-n-octylamine in 
trifluorotrichloroethane (freon). This was vortexed for 20 to 30 seconds, 
left to stand for at least 2 minutes, vortexed again and centrifuged for 
10 minutes to separate the layers. The aqueous supernatant, which 
contained the cyclic nucleotides, was removed with a pipette and dried 
in an oven at 50-60°C, then reconstituted with Tris-HCl buffer, pH 7.5.
iii) A third method for neutralising TCA employed calcium carbonate 
(CaCO^). When solid CaCO^ was added to 5% TCA the solution effervesced. 
This was repeated until no more effervescence resulted and there was
some undissolved CaCO in the sample. The sample was centrifuged and theO
supernatant was tipped off, dried and reconstituted with Tris-HCl buffer, 
pH 7.5 (Tihon et al., 1977).
Extraction of cyclic AMP with TCA was found to be a practical method 
for dealing with cell monolayers in flasks. Flooding monolayers with a 
cold 5% TCA solution was quick, simple and the cells immediately 
appeared opaque, indicating TCA fixation.
Removal of TCA to prepare the samples for assay was a greater 
problem. Disappearance or neutralisation of TCA from the sample was 
monitored by its acidity.
Table 76 shows the rise in pH during repeated washes with water- 
saturated ether of two TCA solutions and one sample of TCA extracted 
cell material. This procedure was very tedious, costly in solvent, 
and only succeeded in reducing the acidity to approximately pH 4.
Table 77 shows the results of a single extraction of TCA with 
tri-n-octylamine in freon. This procedure repeatedly raised the pH 
to 5 or above with a single extraction with tri-n-octylamine in freon.
No advantage was gained by increasing the concentration of tri-n-octylaraine 
to a 1 M solution.
Neutralisation of TCA with CaCO^ was the method most successful in 
reducing the acidity of the sample (Table 78)• In the presence and 
absence of cell material the pH was raised to pH 7.7.
At this stage in the process the appearance of the samples varied 
with their differing treatments. Samples which had been treated with 
ether were cloudy and smelt strongly of ether, but after a stream of 
air had bubbled through the solutions they looked clear and there was
no trace of the ether smell (TCA extracted cell material treated with
/
CaCO^ had a pink tinge, but in the absence of cell material the solution 
was clear)•
TABLE 76. pH of solutions containing TCA after
washing with water-saturated ether
Number of times 
TCA sample washed
5% TCA solutions 5% TCA with 
cell extract
0 0.8 1.15 1-.45
1 1.6 1.90 1.95
2 2.2 2.40 2.50
3 2.7 2.90 2.80
4 3.3 3.10 3.10
5 4.2 3.45 3.40
6 4.2 3.60 3.50
TABLE 77. pH of samples containing TCA after treating
with tri-n-octylamine or solid CaCO^
Treatment 5% TCA solution Cell material
in 5% TCA
0.5 M tri-n-octylamine 5.0, 5.3
1 M tri-n-octylamine 5.0
CaC03 7.7
5.0, 5.7
5.4
7.7
After drying in an oven all the samples containing extracted cell 
material had a visible solid sediment which was easily removed by 
centrifugation after reconstitution in buffer. In addition, the vials 
containing samples which had been treated with CaCO^ had their base 
heavily lined with dense, viscous material.
After reconstitution with water or buffer it was possible, when 
necessary, to adjust the pH of all the samples with Tris crystals,
NaOH or HC1, to pH 7.5 in preparation for the assay.
(b) Ethanol extraction : After the medium was removed, cell monolayers 
were flooded with ethanol and incubated at 4°C. An hour later the 
ethanol was poured off, leaving the insoluble material adhered to the 
vessel. The ethanol was evaporated using an ’’electrothermal'1 heating 
apparatus, or an oven at 50°C. Samples were reconstituted with water 
or buffer and the pH adjusted to 7.5.
Flooding cell monolayers with cold 70% ethanol made the cells appear 
opaque immediately, just as the 5% TCA solution did. It was assumed 
that 70% ethanol was equally capable of instantaneous fixation of cells. 
Unlike treating the TCA extracted samples, there was no need for a 
special step to remove the ethanol as this occurred when the sample was 
dried at 50°C.
As with the TCA extracted material, a thin layer of sediment 
remained after drying, which was removed by centrifugation after 
reconstitution of the extract.
(c) EDTA extraction of cyclic AMP : It was assumed that badly damaged
cells would release their cyclic nucleotides, so attempts were made to 
break the cells by physical means. To assess damage cells were stained 
with methylene blue or haematoxylin and eosin and examined microscopically. 
Cells were subjected to a Diounce homogeniser, an ultrasonic cleaner, or 
snap freezing, or a combination of these methods.
Microscopic examination of cells stained with haematoxylin and 
eosin or methylene blue revealed the extent of structural damage to cells. 
Broken cells were recognised by cell material lacking a nucleus, while 
cells which retained both nucleus and cytoplasm were assumed to have 
maintained their integrity sufficiently to prevent total loss of soluble 
cell contents.
Treatment of HeLa cells in Dounce horaogenisers did not cause 
severe damage. However, pretreatment of cells with reticulocyte swelling 
buffer (RSB) or snap freezing rendered the cells very sensitive to 
physical attack by homogenisation and sonication (Table 78). Incubation 
with RSB took some time to make the cells more susceptible to damage with 
a Dounce homogeniser. This technique would therefore be unsuitable for 
studies requiring instantaneous fixing of cells.
Monitoring the extraction
Monitoring the extraction of cyclic AMP from the addition of the 
extracting reagent to the assay was a simple procedure involving the 
addition of a small amount of radioactively-labelled cyclic AMP as a 
tracer to the extraction reagent, and transferring a small volume of 
the sample, just before the assay, to scintillant for counting.
Less cyclic AMP was recovered from a TCA extract treated with 
tri-n-octylamine than an ethanol extract (Table 79). When the tracer 
was added to each monolayer individually after they had been flooded with 
extraction reagent, the variation in recovery during TCA extraction and 
ethanol extraction was similar. Greater variation occurred when tracer 
was added to 70% ethanol before the monolayers were flooded. This may 
have been due to difficulties in handling a volatile liquid: pipetting
errors were greater and there may have been some evaporation of ethanol 
despite the fact that it was stored at 4°C throughout the experiment.
TABLE 78. Extent of cell damage after various 
physical treatments to lyse cells
Treatment
% Broken cells 
HeLa VERO B2
Incubated in 4 mM EDTA, 
37° C, 1 hour
4.4 24.8
Incubated in 4 mM EDTA 
and RSB at 37°C, 1 hourI.10 Strokes with Bounce 
horaogeniser
20 Seconds in
ultrasonicator bath
10 Strokes with Bounce 
homogeniser
12.9
25.6
36.4
100
29.7
85.2
76.46
98.96
Incubated in 4 mM EDTA
Snap rozen
Thawed
10 Strokes with Bounce 
homogeniser
20 Seconds in
ultrasonicator bath
10 Strokes with D.ounce 
homogeniser
55.63
86.37
94.00
92.25
97.88
**
TABLE 79. Recovery of [ Hjcyclic AMP after treatment 
with TCA and tri-n-octylamine, or ethanol.
Cyclic AMP was added to ethanol before 
extraction of intracellular cyclic AMP in 
method 1, but was added to individual flasks 
after ethanol precipitation of cell material 
in method 2
Treatment
TCA
Ethanol method 1 87.25 + 8.06
/
% Recovery + SD 
77.47 + 5.58
Ethanol method 2 88.37 + 4.77
With both extraction methods the recovery of cyclic AMP after 
treatment and transfer between vessels was high and reproducible.
Conclusions
Extraction of cyclic AMP by physical means, i.e. snap freezing of 
cultures followed by homogenisation and sonication, was considered a suitable 
method for extracting cyclic AMP without introducing undesirable substances 
into the sample preparation. Unfortunately snap freezing of cultures in 
plastic flasks was not convenient, as the culture vessels were clumsy to 
handle. Cultures in tubes, which were much better suited to snap freezing, 
could not hold sufficient numbers of cells for cyclic AMP analysis, and for 
these reasons the method for extracting cyclic AMP into buffer was not 
applied to the study of cyclic AMP in virus-infected cultures.
Extraction of cyclic AMP with TCA produced acidic preparations which 
were unsuitable for assays which were conducted at pH 7.4 - 7.5. However, 
treatment of TCA extracted cell material with tri-n-octylamine proved to be 
successful at raising the pH of the samples. Calcium carbonate also 
raised the pH of the samples, but when dried a substantial residue 
indicated that excessive amounts of material had been introduced to the 
sample. Later experiments showed that substantial interference resulted 
from this method (p. 253). Therefore extraction of cyclic AMP with TCA 
was only considered suitable if it was subsequently treated with tri-n- 
octylamine in freon.
Extraction of cyclic AMP with 70% ethanol was found to be very
v
convenient. When extraction of cyclic AMP was monitored with a 
radioactive tracer this method was found to be more efficient than 
TCA extraction. Ethanol was therefore used more often than TCA when 
cyclic AMP was to be extracted from cell cultures.
APPENDIX 5 : ASSAY OF CYCLIC AMP
Introduction
Developing an assay for cyclic AMP in biological systems has been 
made difficult because of the extremely low levels of cyclic AMP and 
considerably higher levels of potentially interfering substances (Gilman, 
1970). To resolve these problems early studies relied on multi-stage 
assay procedures, often involving careful purification of cyclic AMP and 
production of much higher levels of a more easily detectable compound.
A choice of methods was available for direct measurement of 
cyclic AMP :
1) Tissues and cells pulse-labelled with radioactive adenosine 
incorporated it into ATP. The relative amounts of cyclic AMP newly formed 
from ATP could be determined by isolating cyclic AMP and measuring its 
radioactivity (Kebabian et al.t 1972).
2) The advanced technology of high pressure anion exchange allowed 
extensive purification and direct absorption measurement of cyclic AMP 
(Brooker, 1972).
3) Cyclic AMP from biological material quantitatively reduced the 
production of radioactively-labelled adenosine from labelled cyclic AMP 
by phosphodiesterase and snake venom: values of unknown samples were
determined by comparison with known standards (Brooker, 1972).
Indirect measurement of cyclic AMP was based on production of easily 
detectable compounds in proportion with the cyclic AMP concentration :
l) Quantitative detection of cyclic AMP after chromatographic 
separation involved enzymatic conversion to ATP followed by assay of 
ATP: either by incubating with cycling enzymes hexokinase and pyruvate
kinase to produce a proportional concentration of glucose-6-phosphate
which acted as a substrate in a reaction to form a fluorescent product 
(Breckenridge, 1964; Goldberg et al., 1972); or by a similar enzyme cycling 
procedure forming radioactively-labelled ATP (Aurbach and Houston, 1968); 
or by using ATP as a limited substrate in a luminescent reaction 
(Ebadi, 1972; Johnson, 1972).
2) Alternatively cyclic AMP could be measured by its property of 
enzyme activation. It was first assayed by its ability to activate 
liver phosphorylase in the formation of glycogen (Rail and Sutherland, 1958). 
Later cyclic AMP-dependent protein kinase activity was measured by the 
rate of incorporation of 32p into casein (Wastila et.al., 1970) or 
histone (Kuo and Greengard, 1972).
Gilman (1970) criticized the assays then available, claiming they 
were unsuitable for the estimation of cellular cyclic AMP levels as they 
lacked the extreme specificity required by the low tissue levels of the 
compound, or they were too laborious to perform, or both.
Proteins with a high affinity and specificity for binding cyclic AMP 
have been found naturally (Walsh et al., 1968; Kuo and Greengard, 1969b), 
or prepared as antibodies to cyclic AMP (Steiner et al., 1972a).
Free cyclic AMP has been separated from protein bound cyclic AMP 
by a) adsorbing free cyclic AMP to charcoal coated with dextran (Linkola 
et al., 1977) or charcoal coated with bovine serum albumin (Albano et al., 
1974; Tovey et al., 1974; Goldberg, 1977); b) precipitating and 
centrifuging the protein-cyclic AMP complex (Steiner et al., 1972b); 
and c) collecting the protein-cyclic AMP complex on a membrane filter 
(Weller et al., 1972; Brostrom and Kon, 1974; D/skeland et al•, 1977) 
or a cellulose column (Pollard and Weingrad, 1976; Sinha and Colman, 1977).
The existence of specific cyclic AMP-binding proteins, together with 
simple separation procedures, has led to the design of straightforward,
highly sensitive competitive protein-binding assays (Gilman, 1970;
Brown et al., 1971; Tovey et al., 1974; Pollard and Weingrad, 1976; 
fyfskeland and Haga, 1978), and radioimmunoassays (RIA's)(Steiner et al., 
1969; Goldberg, 1977). Unlike earlier methods, competitive binding 
assays proved to be quick, convenient and suitable for routine use 
(Tsang et al., 1972), and the necessary components could be obtained 
with relative ease and rapidity (Brostrom and Kon, 1974).
Both types of assays were based on the competitive binding of 
unlabelled cyclic AMP with a known quantity of radioactively-labelled 
cyclic AMP to a protein with a high specificity and affinity for cyclic AMP. 
The amount of labelled protein-cyclic AMP complex formed was inversely 
related to the amount of unlabelled cyclic AMP present. The relative 
advantages of RIA or naturally occurring protein-binding assay have been 
discussed by Ekins and Brown (1972). In a small research laboratory, 
where a simple routine assay is adequate, the deciding factor may be the 
time required to prepare the binding protein: whereas raising antisera
to cyclic AMP may take months, preparation of a naturally occurring 
binding protein may be completed in a day (Brostrom and Kon, 1974).
Now that both types of kits are commercially available this factor 
may not be relevant.
A reliable, reproducible binding reaction must be followed by a 
compatible efficient method to separate free cyclic AMP from bound 
cyclic AMP and preparation of samples for liquid scintillating counting. 
Suitable separation procedures used in competitive protein binding assays 
(reviewed by Ratcliffe, 1974) include charcoal adsorption of small ligands 
while larger molecules are prevented from binding by the addition of 
competing molecules such as dextran or bovine serum albumin, protein 
precipitation or collection of protein on anion exchange resins or 
membrane filters.
The ideal separation technique should completely separate the 
bound and free fractions in assay samples containing crude preparations 
of cell material and the buffers necessary for optimum binding of 
cyclic AMP to the protein, while also being quick and cheap (Ratcliffe, 
1974). With charcoal absorbants complete adsorption of low molecular 
weight ligands has been relatively easy, but 100% exclusion of protein- 
bound ligand has presented more of a problem (Tovey et al., 1974). 
Concentrations of charcoal and bovine serum albumin chosen for optimum 
separation resulted in 99% adsorption of free ligand and over 90% exclusion 
of protein-bound ligand (Tovey et al., 1974).
The separation procedure must be compatible with the conditions of
the primary binding reaction. The use of membrane filters which require
2+Mg and only have a limited capacity for adsorbed protein is unsuitable 
for assays requiring EDTA and high concentrations of protein for optimum 
cyclic AMP binding to protein (D/fskeland et al., 1977)._
The separation method may be chosen for technical rather than 
biochemical reasons: charcoal has been found cheaper and more practicable
than membrane filters for dealing with large numbers of samples 
(Albano et al., 1974).
Whatever method is chosen the quality of the separation may affect 
the results of the assay. In a protein-binding cyclic AMP assay 
standard curves obtained using resin, charcoal and membrane filters 
were similar: the binding observed using membrane filters was uniformly
lower, but if plotted as a percentage of initial binding the resin and 
membrane filter curves were superiraposable; the charcoal curve was 
slightly less sensitive (Tsang et al., 1972).
For this study, competitive ligand-binding assays were considered 
most suitable because of their apparent simplicity, sensitivity and
availability of reagents and expertise. Two similar protein-binding, 
charcoal separating assays were applied. The first assay undertaken 
(Tovey et al., 1974) was commercially available as a kit, and as such 
was recommended (Dr. J. Tateson, pers. comm.). The methods for the 
second assay were kindly provided in detail by Dr. S. Nahorski.
Liquid scintillation counting : All the results of the competitive
protein-binding cyclic AMP assay are calculated from radioactive counts 
detected by a liquid scintillation counter. A working knowledge of 
scintillants, samples and counting procedures is required to ensure that 
no variables are introduced into the assay at this last stage.
A liquid scintillator is composed of a solvent and one, two or 
three solutes. The solute with the fluorescence level highest in 
energy is called the primary solute, and the others are secondary solutes. 
The nature of the sample and the choice of scintillant must be considered 
together. Complicated processing techniques have been designed to 
convert samples by degradation into forms which allow the radioactive 
component to achieve the closest electronic association with the primary 
solvent and solute (Fox, 1976). However, when counting an aqueous 
sample these procedures may be avoided by the use of emulsion or colloid 
scintillators. Emulsion scintillators possess high counting efficiency, 
high capacity for dissolving water and aqueous samples, and high 
solubilizing power for ionic substances, small molecules and macromolecules. 
Emulsion counting systems are generally water-in-oil emulsions; they are 
complex and thermodynamically unstable and can undergo abrupt changes with 
only minor alterations in composition, so care must be taken in their 
preparation and in monitoring their stability. The counting stability 
of an emulsion system may not be identical with its colloid stability.
The latter is measured by the relative ease with which the two phases
separate, whereas the counting stability is indicated by the constancy 
of the coefficient of variation over the first 48 hours after sample 
preparation. If large numbers of samples are to be counted regularly 
it is worthwhile determining optimum conditions for a colloid 
scintillation procedure.
Passage of nuclear particles in a liquid scintillator creates 
photophysical and photochemical changes. Four stages may be distinguished:
a) absorption of energy by the solvent; b) formation of the solvent 
excited state; c) energy transfer from solvent to solute; and d) 
fluorescence emission by the solute. Interference or competition with 
the orderly progression of these steps by the presence of additives or 
the specimen to be assayed will adversely affect the maximum light output 
measured from the scintillation system. This is known as quenching.
In every technique used some form of quenching will be experienced.
It can usually be accurately assessed and allowed for in a number of 
different ways. However there are some situations where these correction 
procedures cannot be used, and it is in these circumstances that anomalous 
results usually appear and are not recognised by the experimenter (Fox, 1976)• 
Emulsion systems are the only heterogeneous systems in which quench correction 
can be used (Peng, 1970).
In the field of liquid scintillation counting, quench correction and 
efficiency determination are synonymous. There are three commonly used 
methods: internal standardization, channels ratio and external standard
ratio. After samples have been counted, radioactive standards can be 
added and the samples recounted. This is the internal standard method.
The counting efficiency is calculated from the difference between the 
counts per minute and the disintegrations per minute of the standard.
The disintegrations per minute of the unknown can then be calculated from
the counts per minute and the counting efficiency. The advantage of 
the internal standard method is that it is conceptually simple and when 
properly carried out it is the most accurate method for quench correction 
(Rogers and Moran, 1966). The disadvantages of the method are the 
required manipulation of the sample and the loss of the sample for 
recounting because of radioactive contamination by the added internal 
standard. Since the count and recount of a sample are spaced in time, 
when a large number of samples are involved, instrument drift and the 
change in sample quenching properties may introduce appreciable errors.
The channels, ratio method of quench correction is based on the 
observation that the ratio of counts in two channels, each bracketing a 
different portion of a single isotope spectrum, is an indication of 
spectral shape. Changes in this ratio indicate spectral shift, hence 
quenching (Rapkin, 1970). The procedure for carrying out the channels 
ratio method involves i) selecting two channels to count adjacent or 
different portions of the pulse-height spectrum; ii) counting a set of 
quenched standards of known counting efficiencies to obtain channels ratio 
and iii) plotting channels ratio against counting efficiency to obtain a 
correlation curve. The efficiency of any unknown sample can, therefore, 
be determined from its channels ratio value, reading from the correlation 
curve. The channels ratio method has the advantage of giving 
simultaneously both the sample counts and the counts ratio. The sample 
is counted once and no additional manipulation is required, so this is 
particularly useful for large numbers.
The external standardization technique consists of bringing a 
small pellet of a gamma-emitter to the base or the sides of the 
scintillation vial and counting the Compton electrons produced within 
the scintillant. The number of these electrons produced will depend
on the stopping power of the scintillant components and the vial wall 
thickness. The absolute level of counts derived from this procedure 
will therefore be very sensitive to differences in vial geometry and 
thickness and to the volume of scintillant used. To ensure that the 
external standard number is sensitive only to changes in quench and not 
volume, the same principle is applied as with the channels ratio method 
(Rapkin, 1970): the external spectrum is examined in two regions and a
ratio of the two counts is used as the correction factor to determine 
the effect on the counting efficiency caused by sample quenching. The 
external standard ratio is compared graphically with the counting 
efficiency of standards. The counting efficiency of unknown can then 
be computed from their external standard ratio.
The accuracy and validity of quench correction in emulsions depends 
upon the reproducibility of colloid formation after adding the standard 
and upon the type of standard used. For water-in-oil emulsions it is 
necessary to use a tritiated water standard, but for oil-in-water emulsions
which correspond to the gel region a higher efficiency is obtained with
3 3n-[ Hjhexadecane or £ H]toluene.
Methods
Development of a routine assay procedure : Preliminary experiments
were necessary to ascertain suitable methods for routine application of 
the two assays, and their reliability, in this laboratory.
To check that adrenal cortex cytosol prepared for this study had 
similar activity to the binding material prepared in Nahorski*s laboratory, 
freshly prepared material was compared with binding protein kindly donated 
by Nahorski. Their binding activity and sensitivity to theophylline 
were studied simultaneously. Both extracts were diluted by varying
degrees between l/lO and 1/50. The diluted material was incubated 
with [2,8- H]cyclic AMP and assay buffer in the presence and absence of 
unlabelled cyclic AMP at 4°C and allowed to reach equilibrium before 
separating and counting the protein-bound cyclic AMP. This experiment 
was repeated in the presence of theophylline.
Two methods were available for keeping the reaction mixture cold. 
Either the experiment could be conducted in a room maintained at 4°C, or 
in a laboratory at ambient temperature, keeping the assay tubes in an 
ice water bath at all times except during mixing and centrifugation.
The binding reaction was studied in both environments and the results 
were compared.
Kinetics of the binding reaction were followed to verify that an 
incubation period of 2 - 5| hours was suitable for assay method (l), and 
to find the time necessary for cyclic AMP binding to adrenal cortex cytosol 
to reach equilibrium for use in assay method (2). For both investigations, 
radioactive cyclic AMP was incubated with the binding material in several 
identical analysis tubes. At intervals the reaction was stopped in two 
tubes by the addition of charcoal, and the bound cyclic AMP was separated 
from the free cyclic AMP and measured by liquid scintillation counting.
The assays employed by Brown and Nahorski. differed in many details, 
one of them being the amount of charcoal and bovine serum albumin applied 
to adsorb the free cyclic AMP (Tables 5 and 80). The variable factors 
were the concentration of charcoal, the concentration of albumin, the 
total volume of the reaction mixture and the volume of the sample 
transferred to scintillant for counting. To investigate any possible 
advantages of either method, the two separation procedures were compared. 
Four adsorbent suspensions were prepared: charcoal, 2.5# and BSA 1$;
charcoal 2.5% and BSA 0.125$; charcoal 1.25$ and BSA 1$; charcoal 1.25$
TABLE 80. Preparation of charcoal suspension for cyclic AMP assays
Original
charcoal
suspension
Final concentrations 
vol.
Norit GSX 10.0$ 2.5$
400 pi Brown et al.
BSA 4.0$ 1.0$
Norit GSX 2.0$ 1.25$
800 pi Nahorski
BSA 0.2$ 1.00$
and BSA 0.125$. Radioactive cyclic AMP was added to 800 pi and 400 pi
samples of each suspension. Samples of the supernatant after
centrifugation were transferred to scintillant for counting.
The kinetics of the separation reaction with charcoal 1.25$ and
BSA 0.5$ (final concentrations) were monitored. Analysis tubes contained
3 '
binding protein or water, 200 pi; assay buffer, 100 pi; [2,8- H]cyclic AMP,
10 pi. After the constituents had been allowed to equilibrate
a charcoal suspension, 0.5 ml, was added, giving a final concentration 
of charcoal, 1.25$ and BSA, 0.5$. The tube contents were mixed by 
inversion and at intervals after the addition of charcoal duplicate samples 
were centrifuged and 500 pi of the supernatant was transferred to scintillant 
for counting.
Radioactivity in the supernatant not due to cyclic AMP bound to the 
binding protein could be due either to non-specific binding of cyclic AMP 
to material which could not adsorb to albumin-coated charcoal, or to a 
reduction in the adsorption of the free cyclic AMP to the charcoal.
These blank effects could be evaluated by measuring binding of radioactive 
cyclic AMP to the protein in the presence of 1 raM unlabelled cyclic AMP, 
or by measuring the radioactivity remaining in the supernatant in the 
absence of binding protein. The former method was recommended by 
Nahorski (pers. comm.), while the latter method was suggested by the 
Radiochemical Centre (Table 7). Combinations of varying concentrations 
of charcoal and albumin were applied to solutions of cyclic AMP to 
determine to what degree this may affect the assay.
A problem, central to the study of cyclic AMP in biological systems, 
is the possible introduction of interfering substances which may invalidate 
the results of the assay. For the purpose of laboratory investigation, 
interference was defined as any effect which led to observations other
than those expected when measuring cyclic AMP in buffer. Simple 
experiments for detecting interference involved measuring the binding 
of radioactive cyclic AMP to the binding protein, in the presence of 
substances which were suspected sources of interference: extracted cell
material or extraction reagents.
To observe the effect of extracted cell material on the assay, 
the following regime was implemented:
Cyclic AMP was extracted from cell monolayers with TCA or ethanol, 
as previously described. When the TCA or ethanol had been removed the 
sample was sterilized by filtration and cyclic AMP phosphodiesterase 
(Sigma, London) was added to a final concentration of 0.008 units/ml to 
specifically remove cyclic AMP. The samples were then incubated for 
up to 3 days at 30°C. The samples were heated to 100°C for 5 minutes 
and centrifuged at 12,000 g for 15 minutes, in order to denature and 
remove the phosphodiesterase. Similar samples containing phosphodiesterase 
alone were also prepared.
Known solutions of cyclic AMP were prepared in these extracts, and 
assayed by the Amersham method.
To detect the effect of low concentrations of TCA, a 5$ aqueous 
solution of TCA was treated with CaCO^, ether or tri-n-octylaraine, as 
previously described, and added to known quantities of cyclic AMP before 
assay.
Liquid scintillation counting: The final stage of both assays was
the counting of radioactivity in liquid scintillation fluid. Simple 
preliminary tests were conducted to ensure the method adopted was 
efficient and reliable.
Three types of scintillant were used: a) 4.4 g 2,5-diphenyloxazole
(PPO) and 0.1 g of l,4-di-2(5-phenyloxazolyl)benzene (POPOP) were dissolved
in 1 1 of toluene, added to 500 ml Triton X-100, well mixed and stored in 
a dark glass bottle. The other two scintiHants were ready made cocktails
b) multipurpose cocktail (MFC) from Fisons; and c) phase combining 
system (PCS) from Amersham/Searle.
Scintillant (10 ml volumes) was added to disposable glass 
scintillation vials. Identical samples were counted in different 
scintillants to determine which was the most suitable for the assay.
All samples were counted for 5 minutes in a Beckman LS-200 liquid 
scintillation counter.
Adsorption of radioactivity to glass was investigated by counting 
samples a second time, after they had been standing for four days, and 
a third time after they had been vortexed. This was done for several 
types of samples: those prepared to measure blank values in buffer,
cell extracts or with phosphodiesterase; and those prepared to measure 
the binding of radioactive cyclic AMP to the protein, in buffer, cell 
extract or with phosphodiesterase. Instead of vortexing some samples 
were decanted into a clean vial and the original vial refilled with fresh 
scintillant. Both vials were counted.
The most suitable volume for liquid scintillation counting after the 
cyclic AMP assay was found by calculating the counting efficiency for a 
range of volumes. For each sample size the counting efficiency was 
multiplied by the volume to find the figure of merit.
Possible reduction in the efficiency of counting due to interfering
samples (i.e. quenching) was monitored by the External Standard Ratio (ESR) 
3
method with H-hexadecane as the standard: at the end of an experiment
a few samples whose ESR values spanned the whole range were counted a
3
second time after the addition of 10 pi of H-hexadecane. The 
disintegrations per minute were calculated from the known activity of
3
the H-hexadecane, and hence the counting efficiency was found. Graphs 
of ESR against counting efficiency were drawn, and the counting efficiencies 
and hence the degree of quenching of all the samples in the experiment 
were found from their ESR values. _Samples tested included those with and 
without cell extract, with and without phosphodiesterase and with and without 
binding protein.
In addition the channels ratio method of quench detection was compared 
with the ESR method described above.
The results of all these preliminary experiments investigating the 
methods of cyclic AMP assay were carefully noted, and from these a reliable, 
convenient procedure for assaying cyclic AMP extracted from cultured cells 
was chosen and is described in the main methods section.
Results
Development of assay procedure : The binding activity of the
adrenal cortex cytosol prepared in this laboratory was compared with the 
binding material kindly donated by Dr. S. Nahorski (Fig. 70).
The extract prepared here bound more cyclic AMP per ml than did 
Nahorski*s material (Fig. 70), suggesting that it should be diluted further 
to be suitable for a sensitive cyclic AMP assay. A 1 in 30 dilution of 
Nahorski's extract bound approximately 25% of the radioactively labelled 
cyclic AMP, and that level of binding was recommended as suitable for an 
assay (Dr. B. Brown, pers. comm.). The fresh adrenal cortex material 
bound 27-37% of the cyclic AMP even when it had been diluted 1 in 50 
(Figs. 70, 71).-
The binding reaction was sensitive to the environmental temperature 
(Fig. 71). When the assay was conducted in a room maintained at 4°C 
rather than at ambient temperature with the assay tubes in an ice-water 
bath, approximately 10% more radioactivity was bound to the adrenal cortex 
cytosol. This may have been due to the rise in temperature during 
centrifugation which was less in the 4°C room.
The binding reaction was also sensitive to theophylline. Addition 
of 8 mM theophylline increased the binding by 100% or more at most 
dilutions of the binding protein (Figs. 72, 73). Addition of 0.23 pinole 
of unlabelled cyclic AMP reduced the binding of radioactivity at all 
dilutions of adrenal cortex cytosol (Fig. 72). The marked reduction 
from 29% to 26% indicates the sensitivity of the assay with binding 
material diluted 1 in 50.
The kinetics of the binding reactions were monitored to verify the 
incubation period for assay method (l) and to ascertain the time required 
for the reaction to reach equilibrium in assay method (2) (Figs. 74, 75). 
During assay method (l) the binding of radioactivity increased rapidly 
for the first hour, but there was no appreciable increase thereafter.
In subsequent experiments the separation procedure was applied any time 
between 2 and 7 hours after initiation of the reaction. During assay 
method (2) the fastest increase in radioactivity occurred during the 
first 2 hours but there was a slow but steady increase for some time 
after that. In subsequent experiments the time of initiation was noted 
for each sample and the charcoal was added after an incubation time of 
2.\ hours or longer.
Standard curves were prepared for assay method (2) using both 
preparations of binding protein (Figs. 76, 77). Both experiments 
showed a decrease in binding of radioactively labelled cyclic AMP with
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TABLE 81. Percentage of free cyclic AMP not sequestered by 
suspensions of charcoal and bovine serum albumin
BSA
BSA
Charcoal 
2.5% 1.25%
1.97 3.56
1.99 6.20
2.47 2.05
2.54 2.17
2.28 2.19
2.41 2.23
2.56 1.89
3.10 2.40
Charcoal 
2.5% 1.25%
1.25% 4.85 5.18
5.62 6.61
5.77 7.45
5.80 7.48
0.5% 3.56 6.21
3.66 6.57
4.20 3.53
4.64 3.52
Total volume 800 |il 
sample counted 500 jil
Total volume 400 jil 
sample counted 100 |il
increasing concentration of unlabelled cyclic AMP. The slope of the 
graph (Fig. 76) in the absence of unlabelled cyclic AMP was greater with 
adrenal cortex cytosol prepared in this laboratory. In a simple 
mathematical relationship this might be expected to indicate a greater 
sensitivity. However, the sensitivity of the assay does not depend on 
this factor alone, and the other factors, mentioned in the main part of 
this work, were not studied in this comparison of binding materials.
When the concentration of unlabelled cyclic AMP was plotted against the 
ratio of radioactivity bound in the absence of cyclic AMP to the 
radioactivity bound in the presence of cyclic AMP (Co/Cx), both binding 
preparations showed the expected linear relationship.
Variation of the constituents of the charcoal suspension did not 
greatly affect the adsorption of free cyclic AMP (Table 8l). However, 
increasing the total volume of the reaction mixture, including the 
charcoal, from 400 (il (volume used in assay method (l)) to 800 jil 
(volume used in assay method (2)), did reduce the percentage of 
radioactivity counted in the supernatant after centrifugation.
Centrifuging replicate samples at intervals after the addition of 
charcoal showed that as the time interval between the two procedures 
increased, so the radioactive cyclic AMP bound to protein in the 
supernatant decreased (Fig. 78). There was no effect in the absence of 
binding protein. In view of these results, the time between charcoal 
addition and centrifugation was kept to a minimum.
Measurements of cyclic AMP by assay method (l) in extracts of 
biological material : Table 82 shows the results of cyclic AMP assays
of cell material extracted with EDTA. All the cultures were monolayers 
of HeLa cells incubated in medium containing serum. The treatment for 
breaking the cells varied, but all the cultures were flooded with 4 mM EDTA,
and after various disrupting treatments all the samples were heated in a 
boiling water bath for 3 minutes, then centrifuged at approximately 2000 g 
for 1 minute. There was considerable variation between parallel cultures, 
and on every occasion in some samples the cyclic AMP content was too low 
to be measured. This suggested either a wide variation in the loss of 
cyclic AMP during the extraction process, or a wide variation in the 
cyclic AMP content of the cultures. The recovery of cyclic AMP was not 
measured. This technique was discontinued as it was considered clumsy 
and inconvenient for extracting cyclic AMP from monolayer cultures.
Measurements of cyclic AMP in material extracted from large 
monolayers of HeLa cells with TCA had less variation (Table 83).
However, much higher values were obtained when the experiment was 
repeated with smaller cultures in serum-free medium (Table 83.) • This 
discrepancy was investigated further by extracting cyclic AMP with TCA 
from cultures of three different sizes. There was a marked decrease 
in the measurement of cyclic AMP with the increasing culture size (Table 84). 
However this appeared to be a laboratory artifact as the apparent total 
cyclic AMP content of each culture was very similar, with a slight increase 
with the size of the culture (Table 84). This suggested that the measured 
values did not indicate cyclic AMP content but could be a reflection of the 
TCA content of the extracts. When the procedure for removing TCA was 
increased to washing 4 times with 4 volumes of water-saturated ether, the 
total measured cyclic AMP was higher with a larger culture (Table 85).
Ethanol extracted cell material differed in its cyclic AMP content 
depending on whether the cells were previously rinsed and incubated in 
serum-free medium or not (Table 86).
Direct comparison of parallel cultures extracted with ethanol and 
TCA revealed some problems with the measurement of cyclic AMP in
TABLE 82. Cyclic AMP from cultures flooded with 4 mM EDTA: 
after the various additional treatments described 
in the table, the samples were heated in a 
boiling water bath for 3 minutes and centrifuged 
to sediment the denatured raacromolecules
praole cyclic AMP/mg protein 
culture size
75 cm 25 cm
44
83
58
8
14
24
50
31
26
16
7
12
11
25
16
Variations in procedure
Sonicated 15 secs.
Incubated 2 hours in RSB 
10 strokes with homogeniser 
Sonicated 20 secs.
10 strokes with homogeniser
Snap frozen, thawed and 
10 strokes with homogeniser 
Sonicated 20 secs.
10 strokes with homogeniser
TABLE 83. Cyclic AMP from cultures of HeLa cells treated with TCA
praole cyclic AMP/mg protein
2
175 cm cultures of HeLa cells
extracted with TCA, 15 11
treated with 2-3 vols. water 10 9
saturated ether 3 times, 6 9
pH adjusted with Tris 10
2
25 cm cultures of HeLa cells 24 10
in serum free medium, 13 50
treated as above 25 11
26 9
19 5
18 8
43 8
17 14
TABLE 84. Cyclic AMP from HeLa cells extracted with 5% TCA, 
treated with 2-3 volumes water-saturated ether,
3 times
Size of flask
g
praole/10 cells pmole/flask
25 11 21
25 14 26
75 4 27
75 4 29
150 3 37
150 2 30
TABUS 85* Cyclic AMP from HeLa cells extracted with 5% TCA,
treated 4 times with 4 volumes water-saturated ether
Total cyclic AMP content
2 2 25 cm flask 75 cm flask
8
12
25
25
20
2
TABLE 86. Cyclic AMP from HeLa cells in 25 cm flasks flooded
with absolute ethanol and incubated at 48C for 1 hour. 
The samples were dried and reconstituted with 
Tris/EDTA buffer, pH 7.5
2
praole cyclic AMP/25 era culture
) 74
Rinsed in serum- ) 100
free medium ) 116
) 134
Not rinsed ))
20
8
TABLE 87. Cyclic AMP from HeLa cells in serum-free medium
2 2 25 cm 75 cm
TCA extracted 8 (0) 25 (0)
12 (0) 25 (0)
20 (0)
Ethanol extracted 46 148 (58)
34 284 (14)
36 138 (40)
(Values in brackets represent cyclic AMP remaining 
after 30 minutes at 30°C with 2m units 
phosphodiesterase)
cell extracts (Table 87). Ethanol extracted cultures appeared to 
contain many times more cyclic AMP than TCA extracted cultures. However, 
phosphodiesterase treatment removed all the measured material in the 
TCA extracts, but only some in the ethanol extracts.
These preliminary measurements of cyclic AMP in cell material 
extracted by a variety of methods instigated a number of more detailed 
investigations and changes in procedure.
The observed influence of TCA on cyclic AMP measurements demanded 
an improved method for removing TCA.
The failure of phosphodiesterase to remove all the material which 
was measured as cyclic AMP suggested that increasing the phosphodiesterase 
treatment and investigating possible interference from cell extracts 
would be worth while.
Interference observed in cyclic AMP assay : Samples of cyclic AMP,
1 pmole/50 jil, which contained traces of TCA after extraction by water- 
saturated ether, as shown by their low pH values, gave artificially high 
assay results (Table 88).
Table 89 shows that the binding of cyclic AMP to the binding protein 
was sensitive to the presence of other substances introduced with the 
cell material or during the sample preparation. The figures show the 
percentage of radioactive cyclic AMP bound to the protein after a 2 hour 
incubation period at 4°C, as routinely used in assay method (l). Of the 
three methods used to remove TCA, tri-n-octylaraine left the sample most 
resembling the buffer. This is shown by the similarity in values for 
cyclic AMP binding to the protein in buffer and in the residue of a 
TCA solution and a TCA cell extract treated with tri-n-octylamine (Fig. 79). 
The least suitable method for treating TCA was neutralisation with CaCO^ 
as this drastically reduced the binding. It is interesting to note that
TABLE 88. 1 pmole samples of cyclic AMP in buffer, treated with TCA
and water-saturated ether, showing elevated assay results
No. of ether pH after ether pH prior Value of cyclic AMP 
extractions extraction to assay measured (pmole)
0 0.8 1.2
1 1.6 7.5 1.9
2 2.2 7.6 2.2
3 2.7 7.7 1.4
4 3.3 7.5 2.2
5 4.2 7.7 1.1
6 4.2 7.4 1.2
7 4.4 7.5 . 1.3
3
TABLE 89. Binding of [ H]cyclic AMP to protein after various methods 
employed to remove TCA. Values expressed as a percentage
Procedure for In the presence of In the absence of
removal of TCA: cell material cell material
Ether 43.8 52.5
Tri-n-octylamine 45.8 50.2
CaC03 38.0 43.9
No TCA added 49.5
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Fig, 80 Standard curve for cyclic AMP assay: cyclic AMP diluted in
buffer (A), in ethanol extracted cell Material (A) and 
in ethanol extracted cell Material diluted 1 in 256 ( ■)
the presence of cell material other than cyclic AMP also reduced the 
binding slightly.
The effect of interfering substances can be seen more clearly from 
a graphical presentation of the binding of radioactive cyclic AMP in the 
presence of known amounts of non-radioactive cyclic AMP. Figure 79 shows 
the effect of traces of TCA remaining after extensive washing with water- 
saturated ether (6 times with 4 volumes), which affected the standard 
curve of the cyclic AMP assay. Identical TCA samples treated with the 
quicker, improved method with tri-n-octylamine in freon were indistinguishable 
from buffer when incorporated in a cyclic AMP assay.
Standard curves of cyclic AMP prepared in cell material treated with 
ethanol and phosphodiesterase confirmed the observations recorded in 
Table 89 that cell material other than cyclic AMP reduced the binding of 
radioactivity (Fig. 80). Dilution of the material did not greatly reduce 
this effect. However, when computer-assisted analysis was applied to 
standard curves of cyclic AMP assays, the 9596 confidence limits appeared 
sufficiently far apart (Fig. 13) to assume that error due to ethanol 
extraction would not greatly reduce the accuracy of measurements.
Liquid scintillation counting : PPO and POPOP did not easily dissolve
in toluene, so this system was replaced by the more convenient ready-rto-use 
cocktails whose constituents were evenly distributed throughout the mixture.
Both PCS and MPC could be diluted with xylene. The approximate 
counting efficiency and its coefficient of variance of [ H]cyclic AMP 
was calculated from the specific activity of the labelled sample, and 
from 13 counts of 5 minutes after the vials had been in the counter 
undisturbed for 2 hours (see Fig. 81), the low counts obtained for samples 
containing 55% to 75% PCS in xylene coincided with the production of an 
opaque mixture characteristic of these ratios of scintillant and solvent
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for a 0.2 ml volume aqueous sample. Samples should never be counted in 
opaque mixtures such as these. Addition of PCS or water rendered the 
mixtures transparent. This problem did not arise with 0.2 ml aqueous 
volumes in MPC. Generally, PCS allowed a higher counting efficiency 
for identical samples than did MPC, even when both cocktails were diluted 
with xylene. The general rise in counting efficiency with scintillant 
dilution agrees with data provided by Hopkins and Williams on behalf of 
their parent company, Searle. Company data record that 10 ml PCS 
containing 0.2 ml of 0,5 M Tris-HCl, pH 7.5 with EDTA, spiked with 
tritiated water, was counted with 47# efficiency. When PCS was mixed 
with xylene at a ratio of 2 : 1, the counting efficiency was increased to 
49#, and further increased to 51# when PCS was mixed with xylene at a 
ratio of 2 : 3. However, these data were accompanied by a warning that 
protein may cause some cloudiness, and dilution of PCS may cause problems 
with chemical quenching.
Stability of samples in scintillant was checked by counting at 
intervals after preparation. Table 90 shows the results for identical 
samples of radioactive cyclic AMP in PCS and MPC. The figures show that 
the counts per minute recorded in PCS had a smaller standard deviation, 
and the samples maintained their original value over 2 days. The slight 
decline in counts per minute in MPC over 2 days was not statistically 
significant, but may indicate that long delays in counting the samples 
may reduce the values found. As the counts per minute were not raised 
after the vials were vortexed, there was unlikely to be adsorption of the 
sample to the glass.
A second experiment to test for adsorption of samples to the glass 
vials also gave negative results. This was shown by decanting the
TABLE 90. Repeated counts of radioactive samples to
monitor stability of samples in scintillant
Time cpm in PCS + SD cpm in MPC + SD
30 minutes 86798 + 544 70899 + 768
1 hour 86948 + 565 70806 + 710
lj hours 86923 + 665 70729 + 923
18 hours 86882 + 602 70587 + 684
2 days 87085 + 425 70181 + 442
After vortexing 
at 2 days 86362 + 552 70282 + 596
TABIE 91. Repeated counts of non-radioactive samples in
scintillant to detect possible chemiluminescence
Time cpm in PCS ± SD cpm in MPC + SD
30 minutes 35 1 5 38 + 11
1 hour 29 + 5 28 + 5
\\ hours 32 + 9 28 + 5
18 hours 26 1 + 29 + 5
2 days 22
+1 25 + 8
After vortexing 
at 2 days 22 + 4 23 + 3
radioactive scintillant into a second vial and filling the first with 
fresh scintillant.
Vials containing
[%] cyclic AMP in PCS for 2 days ------------86252 + 529
decanted into second vial  *•- 84977 + 724
first vial refilled with scintillant ---► 1488 + 106
total 86465
Vials containing
[3H] cyclic AMP in MPC for 2 days -►- 69779.5 + 1010
decanted into second vial  ►  68882 + 1102
first vial refilled with scintillant ------- 1123 + 196
total 70005
As the majority of the counts transferred with the scintillant 
this is more evidence to suggest that the sample did not adsorb to the 
glass in either scintillant.
Cherailuminescence and its disappearance cannot explain the decline 
of counts in MPC either. Vials containing scintillant and nonradioactive 
cyclic AMP were prepared and treated by the same procedure as above 
(Table 91). In no case is there a raised background count to indicate 
chemiluminescence.
Because MPC did not count radioactive disintegrations as efficiently 
as PCS, and because the samples were less stable, MPC was not used for 
any further experiments. To ensure that PCS was suitable for the samples, 
the stability of samples with and without assay constituents was recorded 
(Table 92).
TABLE 92. Repeated counts of radioactive samples prepared during assay
of cyclic AMP to show stability of samples in scintillant
Time of count
Samples prepared Immediately After 2 hours After 4 days
to measure : *
Blank in buffer 246.2
271.8
254.5
280.0
247.8
277.0
Blank in ethanol extracted 528.2
cell material 431.4
521.0
445.5
516.4
431.2
Total counts in buffer 11436.8
11263.6
Total counts in buffer 10390.2
after phosphodiesterase 10243.0
treatment
11364.5
11219.0
10449.5
10234.0
11272.0
11125.0
10348.4
10159.0
Total counts in TCA 
extracted material
10487.8
9651.6
Total counts in ethanol 10848.2
extracted material 10492.2
Binding of [3H]cyclic AMP 6179.6
to protein in buffer 6325.6
Binding of [3Hjcyclic AMP 5524.2
to protein after 6089.2
phospho d i est erase 
treatment
Binding of [^3H]cyclic AMP 5718.6
in TCA extracted 5591.0
material
Binding of [3H]cyclic AMP 4820.4
in ethanol extracted 5810.6
material
10302.5
9718.5
10887.0
10508.0
6115.5 
6316.0
5569.5
6013.5
5798.5
5578.5
4846.0
5744.5
10291.4
9606.0
10754.8
10426.6
6113.0
6274.0
5461.6
5976.0
5685.2
5524.4
4893.4
5796.0
TABLE 93, Figure of merit values for various volumes of 
radioactive samples in a solution of bovine 
serum albumin
Volume
1% BSA
Efficiency Figure of 
counting merit
0.5% BSA
Efficiency Figure of 
counting merit
0.125$ BSA
Efficiency Figure of 
counting merit
0.7 38.64 27.05 41.49 29.04 44.50 31.15
0.6 44.41 26.65 43.62 26.17 41.13 24.68
0.5 44.82 22.41 44.34 22.17 42.35 21.18
0.4 37.36 14.94 38.16 15.26 45.25 18.10
0.3 41.20 12.36 47.92 14.37 47.19 14.15
0.2 44.61 8.92 47.22 9.44 46.49 9.30
0.1 46.89 4.69 54.00 5.40 47.38 4.74
TABLE 94. Example of output from liquid scintillation counter
H, channel C.A channel3 14
5761.2 9.6 R = 0.001
916.8 10.6 R = 0.010
512.0 8.6 R = 0.015
13038.8 12.8 R = 0.000
39
37
O)
u
0 5 20 5 10-48 049 050046 047
external standard ratio
.Fig. 82 Standard curve to detect quenching and calculate
counting efficiency from the external standard ratio
The change in counts at different times was not statistically 
significant, as tested for by analysis of variance, whether samples were 
prepared to measure blank values, Co or total counts, and whether they 
contained phosphodiesterase, cell extracted material or only buffer.
To determine the most appropriate volume for sample counting during 
the assay of cyclic AMP, the counting efficiency was calculated for 
radioactive cyclic AMP in assay buffer containing bovine serum albumin 
(0,1 - 0,7 ml volumes). Although the counting efficiency decreased with 
increasing volume of sample, the figure of merit (counting efficiency X 
volume) increased, indicating that higher counts, and therefore greater 
accuracy, would be obtained from larger samples (Table 93). Therefore 
the largest convenient volume of supernatant (0.5 ml) was taken for liquid 
scintillation counting at the end of each assay.
To monitor quenching, the channels ratio method was found to be 
unsuitable. As the counts in channel A varied over a 20-fold range 
(Table 94), whereas the counts in channel B were stable, the ratio between 
the two would depend almost entirely on the activity of the sample while 
any small degree of quenching would be entirely hidden.
However, the external standard ratio was found to be more reliable.
It did not vary with the activity of the sample. When compared graphically 
with counting efficiency a linear relationship was observed (Fig. 82), 
but the regression coefficients were as low as 0.422 and 0.400. However, 
as the ESR value observed during cyclic AMP assays did not vary more than 
5%, quenching was not considered to be a problem.
Conclusions
Both protein binding assays were found to be simple to operate.
Assay method (2) was preferred because the blank effects could be evaluated
in the presence of the binding protein and the information acquired 
could be more easily adapted for the preparation of standard curves 
by computer analysis. In addition the binding protein was cheap 
and could be prepared in a single batch sufficient for the whole study.
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